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Abstract 
 
Cyclin-CDK complexes initiate S-phase and mitosis, but how these events are 
temporally separated is not fully understood. In S. pombe a single Cyclin-CDK is 
sufficient to order the cell cycle. Understanding how and when CDK substrates are 
phosphorylated, during the cell cycle, will inform how CDK orders cell cycle events. 
To this end, I have combined in vivo chemical inhibition of CDK and 
phosphoproteomics to study the behaviour of CDK-mediated phosphorylation.  
 
Hundreds of CDK-dependent phosphorylation events have been identified and their 
cell cycle phosphorylation dynamics quantified. CDK substrates falls into three 
categories: i) the vast majority become phosphorylated during mitosis, ii) S-phase 
substrates, which are first phosphorylated at G1/S and are stable until mitosis, and 
iii) biphasic substrates that increases in phosphorylation at both transitions but 
peak at G2/M. All three classes are dephosphorylated simultaneously at mitotic exit. 
 
S-phase substrates are more sensitive to CDK activity in vivo than mitotic 
substrates. The causal relationship between CDK activity, substrate 
phosphorylation, and cell cycle fate is corroborated by the fact that when the timing 
of substrate phosphorylation is reordered, the order of cell cycle events is 
correspondingly reorganised. These data argue that rising CDK activity orders the 
cell cycle via the attainment of substrate-specific thresholds. Low activity results in 
S-phase substrate phosphorylation, and the initiation of DNA synthesis, whilst 
higher CDK activity results in mitotic substrate phosphorylation and chromosome 
segregation. Furthermore, the timing of mitotic substrate phosphorylation during 
G2/M correlates with sensitivity to CDK activity, indicating that passage through 
sequential CDK activity thresholds orders substrate phosphorylation, and likely 
mitotic events, during the entry into mitosis.  
 
Phosphoproteomic analysis also indicates that G1/S cyclins contribute mainly to 
the accumulation of CDK activity, and that phosphorylation by other mitotic kinases 
is organised into sequential waves, allowing the amplification and diversification of 
CDK signalling. 
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Chapter 1. Introduction - Cyclin-Dependent Kinases 
and the control of eukaryotic cell division  
“Omnis cellula e cellula” 
Rudolf Virchow, 1855 
 
“Cells. . . they make wise decisions and act upon them” 
Barbara McClintock, 1983 
 
Cell proliferation involves the coordination of cell growth and division, including the 
replication and segregation of a cell's DNA complement. The control over, and 
execution of, these processes underpins the proliferation of all living systems, but 
also ranks as some of the most dangerous and critical decisions a eukaryotic cell 
makes. The complexity of the eukaryotic cell and its genome necessitates a far 
greater level of control over the organisation of events during cellular division than 
that for prokaryotic life. More specifically, genomic fidelity during cell division 
requires the temporal separation of DNA replication, in S-phase, and chromosome 
segregation, at mitosis. The eukaryotic cell division cycle is driven by the protein 
kinase activity of multiple bipartite Cyclin-CDK complexes. Both the budding yeast, 
Saccharomyces cerevisiae, and the fission yeast, Schizosaccharomyces pombe, 
have a single CDK (Cdc28 and Cdc2 respectively) which were first identified in 
seminal screens in the 1970s for mutant alleles involved in cell cycle control, 
establishing these two organisms as model systems for cell cycle research 
(Hartwell et al., 1970, Hartwell et al., 1973, Nurse, 1975, Nurse et al., 1976). CDKs 
are Serine/Threonine kinases that are dependent on the association of the 
activating cyclin and are universal to eukaryotic cell division control, conserved 
from yeast to humans as was first demonstrated by the functional complementation 
of S. pombe cdc2 with its human ortholog (Lee and Nurse, 1987, Nurse, 1990). 
Cyclin-CDK was subsequently demonstrated to be the enigmatic M-phase 
Promoting Factor (MPF) that peaks in mitosis and can initiate nuclear division when 
transplanted from an egg into an oocyte (Masui and Markert, 1971, Wasserman 
and Smith, 1978, Gerhart et al., 1984, Dunphy et al., 1988, Labbe et al., 1988a, 
Lohka and Maller, 1988, Labbe et al., 1989). The cell cycle control network of 
higher eukaryotic organisms is more complex than that of the yeasts and involves 
Chapter 1 - Introduction 
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Figure 1.01 | Cyclin-CDK complexes drive different stages of the cell cycle 
The Cyclin-CDK complexes and the respective cell cycle events they are associated with, in the model 
systems: a S. cerevisiae b S. pombe and c vertebrates.  
 
multiple CDKs and cyclins (Santamaria et al., 2007, Malumbres et al., 2009, 
Satyanarayana and Kaldis, 2009). Different Cyclin-CDK complexes contribute to 
the orderly progression through different stages of the cell cycle, from yeast to 
higher eukaryotes (Figure 1.01). 
 
Following the demonstration in the early 1980s that CDK is required for both 
mitosis and S-phase (Nurse and Bissett, 1981, Piggott et al., 1982) there have 
been a range of models proposed as to how CDK temporally organises the 
initiation of DNA replication and chromosome segregation (Hartwell and Weinert, 
1989, Murray and Kirschner, 1989, Stern and Nurse, 1996). However, a coherent 
mechanistic picture of how the different biochemical properties and behaviours of 
Cyclin-CDKs order cell cycle events via the phosphorylation of their substrates is 
still largely lacking. 
 
In the Introduction to this thesis, I will first outline the current understanding of how 
multiple regulatory parameters control the activity and expression of Cyclin-CDK 
complexes. I will then discuss the functional outputs of CDK activity in the control 
over DNA replication and mitosis and then how the dephosphorylation of CDK 
substrates, by counteracting protein phosphatases, is regulated. Finally, I will 
consider the conflicting bodies of genetic and biochemical data regarding how 
CDKs ensure the appropriate temporal organisation of the critical events of the 
eukaryotic cell division cycle.  
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1.1 The activation and regulation of CDK  
CDK catalyses the phosphorylation of hundreds of target substrates, to bring about 
the events of S-phase and mitosis. The protein kinase activity of CDK is 
dynamically regulated over the cell cycle and requires the association between 
CDK and its binding partner cyclin. The first cyclin was identified in sea urchins as 
a protein whose levels oscillate, peaking during the mitosis of each cell cycle 
(Evans et al., 1983). Multiple cyclins have since been defined by their capacity to 
bind CDKs and the presence of the conserved cyclin box, which contributes to CDK 
association (Kobayashi et al., 1992, Noble et al., 1997). The mechanism of 
activation of CDKs has been informed by structural studies on the human S-phase 
Cyclin-CDK complex CyclinA2-Cdk2, during the 1990s. However iit is important to 
note that what is known for CyclinA2-Cdk2 might not always be reflective of other 
Cyclin-CDK complexes. 
 
Monomeric and unmodified CDK proteins have no detectable kinase activity but 
can bind ATP (De Bondt et al., 1993, Solomon et al., 1990). Crystal structures of 
Cdk2 show the ATP binding site lies between the upper N and lower C-terminal 
domains, which are composed predominantly of beta-sheets and alpha-helices 
respectively (De Bondt et al., 1993) (Figure 1.02). The C-terminal domain contains 
a single highly conserved alpha helix (PSTAIRE helix) that binds directly with cyclin. 
Cyclin A2 binding to Cdk2 does not alter the cyclin tertiary structure but does drives 
major conformational rearrangements in the CDK molecule: the L12 helix is re-
organised into a beta-sheet partially exposing the substrate-binding site, whilst the 
PSTAIRE helix also shifts toward the kinase upon cyclin binding (Jeffrey et al., 
1995, Brown et al., 1995). In S. cerevisiae and S. pombe the chaperone Hsp90 
(Cdc37) is important in Cyclin-CDK complex formation (Turnbull et al., 2006, 
Gerber et al., 1995, Farrell and Morgan, 2000, Mort-Bontemps-Soret et al., 2002).  
 
The dynamics of CDK activity are highly non-linear as CDK activity rises during the 
cell cycle and is reported to peak abruptly upon mitotic entry (Draetta and Beach, 
1988, Labbe et al., 1988b, Moreno et al., 1989). In early embryo extracts CDK  
Chapter 1 - Introduction 
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Figure 1.2 | Crystal structure of CyclinA-Cdk2-ATP (Y15-P, T160-P) 
 
undergoes a switch-like jump in activity at a threshold concentration of cyclin, which 
occurs at mitotic entry. Once over this threshold, cyclin levels need to be reduced 
further than below the original threshold before CDK flips back into a low activity 
state, this property is called hysteresis and is reflective of the bistability in the 
system (Pomerening et al., 2003). Bistability likely ensures the system is robust to 
fluctuations and that once a cell commits to mitotic division the decision becomes 
irreversible. The activity of CDK is controlled at multiple levels; by the accumulation 
of the associating cyclins, regulatory phosphorylation, stoichiometric CDK inhibitors 
and subcellular localisation. The regulatory output of CDK is the net 
phosphorylation of its substrates and as such is a function of the activity of both 
CDK and CDK-counteracting phosphatases.  
 
1.1.1 CDK activity is precisely regulated by phosphorylation 
The association of cyclin with CDK alone is not sufficient to explain the dynamics of 
CDK activity (Pines and Hunter, 1989). Phosphorylation is another major regulatory 
input that controls CDK activity: CDK can be phosphorylated on three residues in a 
cyclin-association dependent manner: Threonine 14, Tyrosine 15 and at a 
conserved Threonine residue in the T-loop of the CDK (Cdc2-T167 in S. pombe).  
T160-P
Y15-P
ATP
Figure 1.02 | Crystal 
structure of CyclinA-
Cdk2-ATP (Y15-P, 
T160-P)  
Cyclin A2 (grey) Cdk2 
(blue) complex (PDB 
2CJM).  
ATP, phosphorylated 
Cdk2 Tyrosine 15 and 
phosphorylated Cdk2 
Threonine 160 are 
shown and labelled. 
Adapted from Welburn 
et al., 2007. 
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1.1.1.1 T-loop phosphorylation activates and stabilises Cyclin-CDK 
T-loop phosphorylation is essential for Cyclin-CDK activation, occurs after Cyclin-
CDK association, at least for Cdk1, (Gould et al., 1991, Solomon et al., 1992) and 
enhances in vivo Cyclin-CDK complex stability in vivo (Larochelle et al., 2007) 
(Larochelle et al., 1998). Crystal structures of human CyclinA2-Cdk2 show that 
T160 phosphorylation re-positions the T loop from the catalytic cleft to fully expose 
the substrate binding site as well as re-orientating residues critical for ATP binding 
(Jeffrey et al., 1995, Russo et al., 1996b) (Figure 1.02). Phosphorylation of this 
conserved Threonine residue is brought about by the constitutively active Cdk-
activating kinases (CAKs) (Kaldis, 1999). The major human and S. pombe CAK is 
Cdk7 (S. pombe Msc6), which itself is a cyclin dependent kinase that associates 
with Cyclin H (Msc2) and is also part of the TFIIH basal transcription factor (Fisher, 
2005) (Larochelle et al., 2007) (Hermand et al., 2001). In S. cerevisiae Cdk7 is not 
involved in T-loop phosphorylation but instead a related but distinct monomeric 
kinase, Cak1, activates CDK through T-loop phosphorylation (Kaldis et al., 1996) 
(Cismowski et al., 1995). The S. pombe Cak1 ortholog can also phosphorylate 
Cdc2 in vitro, but its in vivo role is probably upstream of Msc6 (Hermand et al., 
2001). CAK phosphorylation of CDK is dependent on cyclin association with CDK, 
except in S. cerevisiae, where the distinct CAK appears to have differing substrate 
requirements (Ross et al., 2000). The Xenopus Cdc2 T-loop is dephosphorylated 
during mitosis, and as such must be re-phosphorylated every cycle after novel 
cyclin synthesis and Cyclin-CDK complex formation (Lorca et al., 1992).  
 
1.1.1.2 Tyrosine 15 phosphorylation negatively regulates CDK activity 
The kinase Wee1 was the first described dose dependent inhibitor of mitotic entry 
(Nurse, 1975) (Russell and Nurse, 1987) and functions by catalysing inhibitory 
phosphorylation on CDK Tyrosine 15 (Y15) (and the adjacent Threonine 14 in 
some situations) (Featherstone and Russell, 1991, Parker et al., 1992, McGowan 
and Russell, 1993). Y15 is positioned on the roof of the ATP binding pocket and 
Y15 phosphorylation prevents the appropriate alignment of the bound ATP to 
transfer its gamma-phosphate to the substrate peptide (Welburn et al., 2007) 
(Figure 1.02). A second kinase also cooperates to phosphorylate Y15 with Wee1 in 
Chapter 1 - Introduction 
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fission yeast (Mik1) and higher eukaryotes (Myt1) (Lundgren et al., 1991, Mueller et 
al., 1995b). CDK Y15 phosphorylation occurs in interphase and is removed upon 
mitotic entry (Gould and Nurse, 1989). Cdc25 antagonises Wee1 to promote mitotic 
entry (Russell and Nurse, 1986) by dephosphorylating CDK Y15 (Dunphy and 
Kumagai, 1991, Gautier et al., 1991, Kumagai and Dunphy, 1991, Strausfeld et al., 
1991). Humans have three Cdc25 isomers (Cdc25A-C) that can function to activate 
Cyclin-CDK during the cell cycle (Boutros et al., 2006). 
 
1.1.1.3 Multiple signalling pathways regulate CDK Tyrosine 15 phosphorylation  
Wee1 and Cdc25 act as signalling hubs to process multiple upstream inputs, 
allowing them to converge upon CDK activity and integrate cell intrinsic and 
extrinsic information into the decision to undergo mitosis. For example in S. pombe 
the, so-called, cell geometry sensing pathways includes the Cdr1 and Cdr2 kinases, 
which phosphorylate and inhibit Wee1, and are in turn phosphorylated and inhibited 
by the tip-localised kinase Pom1. This led to the proposal of a cell-sizing model 
where a gradient of Pom1 inhibits medial Cdr1/2, allowing Wee1 activity only in 
small cells when polar Pom1 and Cdr1/2 overlap (Martin and Berthelot-Grosjean, 
2009, Moseley et al., 2009, Hachet et al., 2011). This pathway clearly modulates 
the timing of nuclear division via Wee1 but what information it actually conveys to 
CDK is not clear given that pom1∆ cells are still able to appropriately coordinate 
growth and division, albeit with a reduced size at mitosis (Wood and Nurse, 2013). 
Cdc25 activation is promoted by the spindle pole body (SPB) localisation and 
activation of the Polo-like kinase (Plo1) in S. pombe (Mulvihill et al., 1999, MacIver 
et al., 2003). Changes in nitrogen quality are monitored via Tor2 (TORC1) that in 
turn regulates the activity of the MAP kinase Sty1 (Petersen and Nurse, 2007). 
Increased Sty1 activity results in Plo1-S402 phosphorylation, promoting Plo1 
recruitment to the SPB and in turn activating Cdc25 to bring about earlier mitotic 
onset when nitrogen is limiting (Petersen and Hagan, 2005). Sty1 also works 
downstream of a number of glucose sensing/cAMP signaling proteins that influence 
the timing of mitotic commitment (Navarro and Nurse, 2012).  
 
One of the most important and ubiquitous cell-intrinsic signals that impinges upon 
Chapter 1 - Introduction 
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CDK Y15 phosphorylation is the surveillance of genomic integrity. In S. pombe the 
PIKK checkpoint kinase Rad3 (ATR) activates effector kinases Chk1 and Cds1 in 
response to DNA damage and stalled replication forks respectively (Walworth et al., 
1993) (Rhind and Russell, 2000). In higher eukaryotes this role of Rad3 is split 
between ATM and ATR but still signals via the Chk1 and Chk2 (Cds1 ortholog) 
(Rhind and Russell, 2012). In fission yeast Chk1 and Cds1 phosphorylate Cdc25 at 
multiple sites to inactivate Cdc25, for instance by generating a docking site for 14-
3-3 proteins (Rad24 and Rad25) that drives the nuclear exclusion of Cdc25 
(Walworth et al., 1993, Lopez-Girona et al., 1999, Karlsson-Rosenthal and Millar, 
2006). Across eukaryotes there are comparable mechanism of Chk1/Chk2-
dependent control of Wee1 and Cdc25 localisation/proteolysis/activity that function 
to impose a cell cycle arrest downstream of DNA damage signalling (Karlsson-
Rosenthal and Millar, 2006, Reinhardt and Yaffe, 2009). Monitoring of DNA 
damage and on-going DNA replication is also signalled through the Mik1 kinase in 
S. pombe but Mik1 is insufficient to produce a robust checkpoint arrest by itself 
(Rhind and Russell, 2000). In S. cerevisiae Cdc28-Y19 aligns with Y15 of other 
CDKs but is both non-essential and dispensable for checkpoint arrests in response 
to DNA-damage or on-going DNA replication (Sorger and Murray, 1992, Amon et 
al., 1992). However, Cdc28-Y19 phosphorylation by Swe1, the Wee1 ortholog, is 
responsible for the morphogenesis checkpoint, which delays mitosis when 
polarised bud growth is disrupted (Lew and Reed, 1995, Lew, 2003).  
 
1.1.1.4 CDK activity promotes Tyrosine 15 dephosphorylation  
As well as regulating CDK activity, Wee1 and Cdc25 are in turn regulated by CDK 
through a double negative feedback loop, in which CDK phosphorylates and 
inactivates Wee1, and a positive feedback loop, in which CDK phosphorylation 
activates Cdc25. (McGowan and Russell, 1995, Mueller et al., 1995a, Kumagai and 
Dunphy, 1992, Hoffmann et al., 1993, Okamoto and Sagata, 2007, Lu et al., 2012). 
In Xenopus, Wee1 and Cdc25 phosphorylation is highly ultrasensitive as a function 
of CDK activity, meaning that their phosphorylation responds to CDK activity over a 
narrow range of activities in an abrupt, step-wise manner (Kim and Ferrell, 2007, 
Trunnell et al., 2011). The combination of feedback and ultrasensitivity allows CDK 
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activity to switch between two steady states, explaining the highly non-linear and 
bistable dynamics of CDK activation at mitotic entry (Novak and Tyson, 1993).  
 
The CDK-Cdc25-Wee1 feedback system is important for sustained and robust 
oscillations in CDK activity. T14AY15F mutations in CDK, which bypass this auto-
regulatory network, result in attenuated oscillations in CDK activity in Xenopus 
extracts and the precocious termination of G1 as well as failure to appropriately 
complete mitotic events in HeLa cells (Pomerening et al., 2005, Pomerening et al., 
2008). CDK activity, as measured by a phosphorylation FRET reporter, shows that 
T14A/Y15F CDK activity can undergo multiple attenuated oscillations that fail to 
properly initiate nuclear envelope breakdown (NEB) before reaching a CDK activity 
that is sufficiently high to initiate nuclear division. The rise in CDK(T14A/Y15F) 
activity, as it approaches the mitotic threshold, is slower and more linear than for a 
wild-type CDK (Gavet and Pines, 2010a). A Y15F substitution in S. pombe Cdc2 
results in premature and pathological entry to mitosis (Gould and Nurse, 1989). 
Surprisingly viable fission yeast strains harbouring this mutation can be engineered 
when the CDK network is simplified (Coudreuse and Nurse, 2010). This network of 
feedback loops also allows CDK activation to behave as a trigger wave, facilitating 
the rapid spatial propagation of the mitotic state (Chang and Ferrell, 2013). This is 
of particular physiological relevance in cells in which events need to be coordinated 
over sizable distances, such as the Xenopus egg that is greater than a millimeter in 
diameter. In S. pombe the polo like kinase (Plo1) has also been implicated in the 
CDK activating feedback loop and is in turn positively regulated by CDK activity 
(Tanaka et al., 2001, Mulvihill et al., 1999, MacIver et al., 2003). 
 
1.1.2 Proteolysis and transcriptional feedback loops generate oscillations in 
cyclin levels across the cell cycle 
In addition to the phospho-regulation of CDK, sequential waves of cyclin 
expression coordinate the rise in CDK activity during the cell cycle. Robust 
oscillations in cyclin expression are generated via a series of nested positive and 
negative feedback loops.  
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1.1.2.1 The regulation of cyclin expression in budding yeast 
The expression of the nine different S. cerevisiae cell cycle cyclins has been 
extensively studied over the last three decades and serves as a model example of 
how transcription factors (such as SBF and MBF) and ubiquitin targeted proteolysis 
(e.g. downstream of the E3 ubiquitin ligases APC/C and SCF) contribute to such 
waves of cyclin expression.  
 
The G1-phase cyclins (Cln1-3) are involved in the G1 events of bud emergence 
and SPB duplication, as well as initiating a transcriptional program to drive the 
subsequent expression of Clbs (B-type cyclins). Of the six Clbs in S. cerevisiae 
Clb5&6 protein levels rise first and initiate DNA replication, followed by Clb3&4 then 
Clb1&2, which associate with Cdc28 to initiate mitosis. Destruction of Clb-Cdc28 
then drives cells through mitotic exit. Both transcription and ubiquitin mediated 
degradation coordinate these sequential waves of cyclin expression (Morgan, 
1997, Mendenhall and Hodge, 1998, Bloom and Cross, 2007). G1 cyclins, in the 
first instance only Cln3, inhibit the transcriptional repressor Whi5 allowing SBF and 
MBF to transcribe ~200 genes including the G1 cyclins Cln1&2, Cln1&2 then 
further activate their own expression as part of a positive feedback loop (Johnson 
and Skotheim, 2013, Bertoli et al., 2013). The dilution of a fixed amount of Whi5, 
against a constant concentration of Cln3, has been proposed to form the basis of a 
G1 size homeostasis mechanism in budding yeast (Jan Skotheim, personal 
communication). Cdc28-mediated phosphorylation of Cln-Cdc28 complexes then 
provides a binding site for F-box phospho-degron recognition proteins (Grr1 and/or 
Cdc4) to target Cln1-3 for SCF-mediated ubiquitination and proteasomal 
degradation (Lanker et al., 1996, Skowyra et al., 1999, Landry et al., 2012).  
 
The G1/S peak in Cln1/2 SBF-dependent transcription is followed by sequential 
waves of Clb transcription, dependent at first on MBF (Clb5&6), which is 
subsequently repressed by Nrm1, and later on Fkh2-Mcm1 and Ndd1 transcription 
factors (Clb1-4). Rising Clb levels later in the cycle repress SBF to inhibit G1 cyclin 
expression and phosphorylate Fkh2 and Ndd1 to promote mitotic Clb expression 
(Bloom and Cross, 2007) (Bertoli et al., 2013). Clb6 is degraded by the SCF in a 
manner analogous to the Clns (Jackson et al., 2006) whilst the APC/C targets all 
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other B-type cyclins for ubiquitin-mediated proteolysis (Shirayama et al., 1999, 
Wasch and Cross, 2002). The APC/C, complexed to its co-activator Cdc20, is 
activated during early mitosis by Clb2-Cdc28 phosphorylation (Rudner and Murray, 
2000) but later in M/G1 Cdc20 exchanges for a second co-activator, Cdh1, which 
alters the substrate specificity of the APC/C and completes the degradation of 
mitotic cyclins (Visintin et al., 1997). Cdh1 is phosphorylated and repressed by Clns 
and Clbs so APC/CCdh1 only becomes active during mitotic exit and in early G1 
(Zachariae et al., 1998, Jaspersen et al., 1999). S-phase Clbs are less sensitive to 
APC/CCdh1 so the exchange of Cdc20 for Cdh1 also allows the re-accumulation of 
Clb5 during the subsequent G1/S, which in turn can phosphorylate and repress 
Cdh1 to allow the re-expression of mitotic B-type cyclins during the subsequent 
cycle (Yeong et al., 2001). Recently, small temporal differences in the timing of 
APC/C substrate proteolysis have been reported in budding yeast, for example 
Clb5 is degraded before Clb2 (Lu et al., 2014). APC/C co-activators recognise 
APC/C substrates via D-box or KEN box motifs (Glotzer et al., 1991, Pfleger and 
Kirschner, 2000) but the early degradation of Clb5 has been attributed to the newly 
identified ABBA motif as well as Cks1-mediated recruitment of Clb5-Cdc28-Cks1 to 
phospho-docking sites on APC/C (Lu et al., 2014). The precise significance of 
these timing differences is not yet clear.  
 
1.1.2.2 Fission yeast cyclin expression is less complex 
A more limited body of work in S. pombe suggests fission yeast cyclin expression is 
regulated in a related but perhaps simpler manner to budding yeast. S. pombe has 
four cyclins that differentially associate with CDK during the cell cycle: Puc1, Cig1, 
Cig2 and Cdc13 (Booher and Beach, 1988, Hagan et al., 1988, Bueno et al., 1991, 
Bueno and Russell, 1993, Connolly and Beach, 1994, Martin-Castellanos et al., 
2000). The G1/S cyclin Cig1 is degraded at anaphase by the APC/C, increases 
again at the subsequent G1/S and is maintained at relatively unchanged levels until 
the next mitosis (Blanco et al., 2000). Cig2 is the major G1/S-phase cyclin in fission 
yeast (Mondesert et al., 1996) and is the only S. pombe cyclin that is strongly 
transcriptionally regulated during the cell cycle (Rustici et al., 2004). Cig2 transcript 
and protein levels peak at G1/S and then decline during G2 (Connolly and Beach, 
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1994) (Yamano et al., 2000). Cig2 is transcribed downstream of the S. pombe MBF 
transcription factor but also inhibits MBF as part of an auto-regulatory feedback-
loop by binding one MBF subunit (Res1) and phosphorylating another (Res2) (Ayte 
et al., 2001). This negative feedback loop works either via or alongside the E3 
ubiquitin ligase SCFPop1/Pop2, which also regulates Cig2 levels by reducing transcript 
levels (Yamano et al., 2000). Cig2 protein stability is decreased by the SCF during 
G2, in part dependent on the cullin Pop1 or F-box protein Pop2 (Yamano et al., 
2000, Yamano et al., 2004). If SCF mediated proteolysis of Cig2 in G2 is bypassed, 
the degradation of Cig2 in mitosis by APC/C becomes essential for cell viability 
(Ayte et al., 2001). The major mitotic B-type cyclin Cdc13 starts to rise at G1 and 
peaks at G2/M before being degraded by the APC/C at anaphase, an event 
essential for mitotic exit (Moreno et al., 1989, Yamano et al., 1996). Presumably 
the S. pombe APC/C in mitosis is bound to the Cdc20 co-activator ortholog; Slp1, 
as in other organisms. The non-essential Cdh1 ortholog in S. pombe, Ste9/Swr1, 
promotes G1 specific degradation of Cig1 and Cdc13 but is also inactivated by 
CDK phosphorylation during the rest of the cycle because phosphorylation triggers 
its proteolysis and dissociation from APC/C (Blanco et al., 2000, Yamaguchi et al., 
2000).  
 
1.1.2.3 The regulation of cyclin expression, from yeast to humans  
Within the networks that controls cyclin expression and degradation in budding and 
fission yeast there are numerous examples of a given cyclin regulating the 
transcription or proteolysis of its own or other cyclin’s mRNA or protein. This 
underscores the prevalence of crosstalk, positive feedback and negative feedback 
in the control of expression of cell cycle machinery. Much of the network 
architecture and the principles of proteolysis and transcriptional regulation are 
present in the current understanding of the control over cyclin expression in higher 
eukaryotic cell division (Cross et al., 2011) (Pines, 2011). Briefly the current 
paradigm suggests that RB proteins repress E2F transcription factors until cells 
commit to division (i.e. the restriction point). Growth factor-induced CyclinD-Cdk4/6 
phosphorylates and inactivates RB, allowing E2F-dependent transcription. The 
induced G1/S transcripts include Cyclin E, which initiates a positive feedback loop 
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enhancing its own transcription, in a manner analogous to Cln1/2 (Bertoli et al., 
2013, Johnson and Skotheim, 2013). However the details of this mechanism still 
remain unclear, for example a recent study has demonstrated that CyclinD-Cdk4/6 
is not responsible for the activating hyper-phosphorylation of RB seen at the late 
G1 restriction point, but instead is only responsible for mono-phosphorylation of RB 
earlier in G1 (Narasimha et al., 2014). Cyclin E levels peak at G1/S and are then 
depleted as S-phase progresses (Koff et al., 1992, Dulic et al., 1992) via Cdk2-
mediated phosphorylation, which targets Cyclin E for SCFFbw7-mediated 
ubiquitination (Won and Reed, 1996, Hwang and Clurman, 2005). Cyclin A mRNA 
is an E2F-regulated transcript, and as such, Cyclin A protein levels starting to rise 
in S-phase and peaking in G2 (Bertoli et al., 2013, Pines and Hunter, 1991). 
 
Cyclin B levels rise during late S and G2 downstream of numerous transcription 
factors (including E2F, NF-Y, FoxM1, and B-Myb) that are thought to be activated 
by CyclinA-Cdk2 (Fung and Poon, 2005). Once CDK becomes fully activated in 
mitosis it phosphorylates and activates the APC/C, which in turn ubiquitylates 
Cyclin A and Cyclin B targeting them for proteolysis (Pines, 2011). In Xenopus 
extracts APC/C activation is highly ultrasensitive to CDK activity and occurs on a 
~15min time-delay which ensures that the negative feedback between CDK and 
APC/C drives robust alternating oscillations in CDK and APC/C activity (Yang and 
Ferrell, 2013). In vivo the spindle assembly checkpoint (SAC) inactivates the 
APC/C, delaying Cyclin B degradation until all kinetochores have microtubule 
attachments (Pines, 2011). However, Cyclin A degradation precedes Cyclin B 
proteolysis and can occur in the presence of an active SAC. This difference in 
timing/sensitivity is because of Cks1-mediated recruitment of CyclinA-Cdk1-Cks1 to 
the phosphorylated APC/C in a manner analogous to Clb5 proteolysis in S. 
cerevisiae (Di Fiore and Pines, 2010).  
 
1.1.3 CDK inhibition by stoichiometric binding inhibitors and system level 
feedback 
Proteins that bind CDKs stoichiometrically can act to negatively regulate CDK 
activity. These CDK inhibitors both transduce external signals to regulate CDK 
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activity in response to environmental stimuli and participate in the regulatory 
networks that control the dynamics of CDK activation that are characterised by 
multiple feedback motifs (Sherr and Roberts, 1999).  
 
S. cerevisiae has two stoichiometric CDK inhibitors; Far1, involved in the 
pheromone arrest, and Sic1, involved in mitotic exit and the commitment to division. 
Pheromone signalling results in the Fur3 (MAPK) dependent activation of Far1 as 
well as the transcriptional up-regulation of Far1 levels. Far1 inhibits Cln-Cdc28 to 
impose a cell cycle arrest in response to pheromone to allow cell mating (Elion, 
2000). The inhibition of CDK by Sic1 plays two major roles during the cell cycle. 
Firstly it is important to maintain a window of low Clb-CDK activity during G1 to 
allow appropriate origin licensing (Lengronne and Schwob, 2002) and it functions in 
parallel with the APC/C to inactivate Clb2-Cdc28 during mitotic exit, when Sic1 
mRNA increases downstream of Ace2 and Swi5 transcription factors (Knapp et al., 
1996, Toyn et al., 1997).  
 
As CDK activity decreases due to cyclin proteolysis during mitotic exit, the protein 
phosphatase Cdc14 dephosphorylates Swi5, promoting Sic1 expression as well as 
reversing CDK-mediated phosphorylation of Sic1, which in turn further inactivates 
CDK (Visintin et al., 1998). These feedback loops ensure mitotic exit is irreversible: 
if cyclin proteolysis is disrupted during mitotic exit, cells can slip back into a mitotic 
state through the re-accumulation of cyclin levels. Sic1 and Cdc14 ensure that 
mitotic exit becomes irreversible and shorten the window in which on-going cyclin 
degradation is required to sustain an interphase state (Lopez-Aviles et al., 2009). 
Unusually, the licensing factor and CDK substrate Cdc6 has been reported to have 
CDK inhibiting activity and cooperates with Sic1 during the inactivation of CDK 
activity at mitotic exit (Elsasser et al., 1996, Calzada et al., 2001). Cdc6 binds 
preferentially to Clbs over Clns (Elsasser et al., 1996) and Cdc6 binding to Clb2-
Cdc28, enhanced by Clb2-Cdc28 phosphorylation of Cdc6, also sequesters Cdc6 
away from the chromatin, providing an additional non-canonical mechanism of 
CDK-mediated inhibition of origin licensing (Mimura et al., 2004).  
 
At G1/S Sic1 protein levels drop precipitously due to the activation of Cln1/2-Cdc28, 
which are insensitive to Sic1 inhibition and target Sic1 for phosphorylation-
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dependent SCFCdc4-mediated ubiquitination (Verma et al., 1997, Nash et al., 2001). 
The inactivation of Sic1 is one of the few critical functions of S. cerevisiae G1-
cyclins, as the lethality the cln1∆ cln2∆ cln3∆ background can be rescued by a 
deletion of sic1 (Tyers, 1996). Another positive feedback loop is involved because 
decreasing Sic1 levels allows the activation of Clb5/6-Cdc28 that also 
phosphorylates Sic1, to promote Sic1 degradation, and thus CDK activation 
(Koivomagi et al., 2011a). Sic1 also integrates signalling pathways into the decision 
to divide or not, for example Sic1 phosphorylation (T173) by the stress-activated 
protein kinase, Hog1, which stabilises Sic1 causing a G1 delay in response to 
osmotic stress (Escote et al., 2004). Sic1 phosphorylation at T173 is also important 
during a rapamycin-dependent cell cycle arrest, suggesting that TOR signalling 
during adequate nutrients conditions supresses T173 phosphorylation to permit cell 
division (Zinzalla et al., 2007). 
 
The only known stoichiometric CDK inhibitor in S. pombe is the non-essential 
protein Rum1, which regulates the G1/S transition. Rum1 is important for G1-arrest 
in response to nitrogen withdrawal but can be complemented by the S. cerevisiae 
Sic1 protein (Moreno and Nurse, 1994, Sanchez-Diaz et al., 1998). Rum1 inhibits 
Cig2-Cdc2 and Cdc13-Cdc2 but not Puc1-Cdc2 or Cig1-Cdc2 complexes and 
promotes Cdc13 degradation during G1 (Martin-Castellanos et al., 2000). Rum1 
levels peak during G1 but are abruptly down-regulated at S-phase by Cig1-Cdc2 
mediated Rum1 phosphorylation (Correa-Bordes et al., 1997, Benito et al., 1998). 
Rum1 inhibition of CDK may also be down regulated by MAP kinase 
phosphorylation of Rum1 (Matsuoka et al., 2002). 
 
Stoichiometric inhibitors of CDK include two families in higher eukaryotes: (i) the 
INK4 family that bind to Cdk4 or Cdk6 as a heterodimer that is incompetent for 
Cyclin D association and (ii) Cip/Kip (p21, p27 & p57) inhibitors that can bind a 
broader range of CDKs and interacts with both the cyclin and CDK subunit (Sherr 
and Roberts, 1999). Crystal structures of CyclinA-Cdk2-p27 indicate that a single 
p27 molecule inhibits CDK activity by binding the cyclin and then interacting with 
and reorganising the N-terminal lobe of CDK, whilst also inserting into CDK ATP 
binding pocket, mimicking ATP to prevent ATP binding (Russo et al., 1996a). Sic1 
has been proposed to inhibit CDK in a similar manner based on functional and 
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structural similarities with p27 (Barberis et al., 2005, Barberis, 2012). p27 
participates in the system level feedback that drives human cells through G1/S. 
The F-box protein Skp2, which specifically recognises CDK phosphorylated p27, 
targets p27 for ubiquitin-mediated proteolysis (Carrano et al., 1999, Montagnoli et 
al., 1999). p27 degradation is limited by Skp2 and Cyclin E/A level which are both 
E2F-dependent transcripts, so as CDK activity rises and induces E2F transcription, 
Skp2 levels increase resulting in reduced p27 levels. This increases CDK activity, 
which in turn induces more Skp2 expression downstream of E2F as well as 
targeting more p27 for Skp2 mediated ubiquitination (Yung et al., 2007).  
 
1.1.4 Spatial dynamics and regulation of CDK activity  
A significant amount of our understanding of CDK regulation and CDK output has 
been elucidated by experiments in soluble extract systems that are unable take 
account of the spatially resolved structures within the cell. Differential localisation of 
Cyclin-CDK complexes could control their accessibility to spatially-restricted 
substrates or regulators in the cell (Moore, 2013). 
 
The most spatially dynamic cyclin is Cyclin B1, which shuttles between the nucleus 
and cytoplasm, in interphase its nuclear export rate dramatically exceeds its 
nuclear import rate resulting in a net cytoplasmic localisation (Hagting et al., 1998, 
Toyoshima et al., 1998, Yang et al., 1998). Towards the end of G2, Cyclin B1 
accumulates at the centrosome where auto-phosphorylation of Cyclin B1’s N-
terminus contributes to the earliest pool of active CyclinB1-Cdk1 at G2/M (Hagting 
et al., 1999, Jackman et al., 2003). Shortly before nuclear envelope breakdown, 
Cyclin B1 dramatically and abruptly relocalises to the nucleus (Pines and Hunter, 
1991, Ookata et al., 1992) which involves a spatial signal amplification mechanism 
in which increasing CDK activity promotes Cyclin B1 nuclear localisation (Gavet 
and Pines, 2010a). Nuclear CyclinB1-Cdk1 is reported to further promote the 
nuclear translocation and activation of CyclinB1-Cdk1 via Cyclin B1 auto-
phosphorylation (Santos et al., 2012). This positive feedback is aborted in Cyclin 
B1 molecules harboring N-terminal phospho-mutants, which also delays the timing 
of the nuclear re-localisation of Cyclin B1 to coincide with, not precede, NEB 
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(Santos et al., 2012). However this conflicts with reports that Cyclin B1 N-terminal 
phosphorylation is not required for nuclear import and instead the dramatic re-
localisation of CyclinB1 is achieved by modulating the nuclear transport apparatus 
to increase Cyclin B1 import rate (Gavet and Pines, 2010a). Regardless of the 
exact mechanism of nuclear import control, the interphase nuclear exclusion of 
Cyclin B1 prevents precocious mitotic entry in higher eukaryotes, suggesting part of 
the role of this carefully orchestrated localisation of CyclinB1-Cdk1 functions to 
spatially control the co-localisation of CDK and its substrates (Moore et al., 2003). 
Cyclin B2 is spatially restricted to the Golgi apparatus and promotes Golgi 
disassembly during mitosis. Switching the localisation determinants between Cyclin 
B1 and Cyclin B2 is sufficient to swap their functions, arguing that there are no 
major differences in biochemical specificity between Cyclin B1 and Cyclin B2 other 
than their spatial co-localisation with sub-pools of substrates (Draviam et al., 2001). 
Cyclin E and A also shuttle between the cytoplasmic and nuclear compartment 
throughout the cell cycle but are predominately nuclear (Pines and Hunter, 1991, 
Ohtsubo et al., 1995) and Cyclin E localisation to the nucleus is essential for its 
ability to promote DNA replication (Moore et al., 2002).  
 
S. pombe CDK, Cdc2, is imported into the nucleus in a cyclin-dependent manner 
throughout the cell cycle, and its nuclear levels accumulate with that of the major 
mitotic cyclin Cdc13 over the cell cycle. Similar to higher eukaryotes Cdc2 and 
Cdc13 are enriched at the SPB before mitosis and decorate the spindle from 
prophase until the onset of anaphase (Decottignies et al., 2001). The synthetic 
forced localisation of active CDK at the S. pombe SPB can advance mitotic entry 
(Grallert et al., 2013b). An appealing model suggests that CDK activity is more 
readily activated at the SPB from where active Cyclin-CDK then disseminates to 
the rest of the cell to promote mitotic commitment via the positive feedback loops 
described above (Pines and Hagan, 2011). This SPB-localised activation feedback 
loop involves Plo1 whose recruitment, by the SPB protein Cut12, promotes mitotic 
commitment and is able to suppress the lethality of temperature-sensitive Cdc25 
alleles (Mulvihill et al., 1999, MacIver et al., 2003).  
 
The centrosome in higher eukaryotes may serve an equivalent function to nucleate 
CDK activation, consistent with the observation that active Cyclin B1-Cdk1 first 
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appears at the centrosome (Jackman et al., 2003). Cdc25B has been reported to 
specifically dephosphorylate centrosomal CyclinB1-Cdk1 and as such may 
participate in this localised initial activation of CDK (Lindqvist et al., 2005). 
Consistent with the need for this CDK activity to propagate from the centrosome, 
the turnover of Cyclin B at the centrosome, measured by FRAP, is rapid. (Pines 
and Hagan, 2011). However, the localised activation of CDK at the centrosome, or 
its equivalent, cannot be considered a universal and essential aspect of mitotic 
commitment given the instances in which spindle assemble and mitotic progression 
can occur in the absence of a centrosome (Khodjakov et al., 2000, Basto et al., 
2006). 
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1.2 Functional outputs of CDK via substrate phosphorylation 
 
The understanding of how CDK coordinates DNA replication and mitosis had 
lagged behind the mechanistic understanding how CDK itself is regulated (Nurse, 
1990), but work over the last two decades has contributed to a rapid rise in the 
knowledge of CDK substrates and how their phosphorylation brings about the 
events of cell cycle. Key examples of CDK substrates will be discussed below to 
highlight the different mechanisms by which CDK phosphorylation can regulate 
multiple cellular functions, as well as examples of CDK substrates in S. pombe as a 
pre-text for their discussion in the subsequent chapter. The functions and 
phosphorylation of dozens of CDK substrates, involved in DNA replication and the 
events of mitosis, has been characterised in budding yeast and higher eukaryotes 
(Enserink and Kolodner, 2010, Errico et al., 2010).  
 
1.2.1 Control over origin licensing and the initiation of DNA synthesis  
The DNA replication of large linear eukaryotic chromosomes occurs by bidirectional 
semi-conservative DNA synthesis, from multiple sites across the genome 
(replication origins). DNA replication occurs only once every cell division cycle and 
this is ensured via the stepwise assembly of replication factors at origins: origins 
are first licensing for replication in G1 before DNA synthesis is initiated at S-phase. 
First of all, the Origin Recognition Complex (ORC; Orc1-6) binds replication origins 
(Bell and Stillman, 1992) and cooperates with Cdc6 (Cdc18 in S. pombe) to load 
the replicative helicase complex Mcm2-7 onto the DNA (Coleman et al., 1996, 
Donovan et al., 1997). ATP hydrolysis by ORC and Cdc6 is necessary to load 
Mcm2-7 (Donovan et al., 1997, Bowers et al., 2004) which is assembled around 
double-stranded DNA as a head-to-head double hexamer (Remus et al., 2009, 
Evrin et al., 2009). The essential licensing factor Cdt1 also cooperates with Cdc6 to 
load inactive Mcm2-7 (Maiorano et al., 2000, Nishitani et al., 2000, Tanaka and 
Diffley, 2002).  
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1.2.1.1 S-phase kinases (CDK and DDK) control origin firing 
CDK cooperates with DDK (Dbf4-Cdc7) to activate the replicative helicase after it is 
loaded onto DNA. The timing of action of CDK and DDK seems to be important, 
given that the most efficient DNA replication is achieved when DDK activity 
precedes CDK addition in Xenopus and yeast lysates (Heller et al., 2011, Walter, 
2000). Activation of the replicative helicase involves the assembly of the CGM 
complex (Cdc45, GINS complex and MCM complex) at licensed origins, resulting in 
pre-initiation complex formation (Siddiqui et al., 2013). CDK phosphorylation of S. 
cerevisiae proteins Sld2 and Sld3 promotes binding to an N-terminal pair of BRCT 
repeats in Dpb11, which is thought to facilitate the recruitment and formation of the 
active CGM helicase complex (Masumoto et al., 2002, Tanaka et al., 2007, 
Zegerman and Diffley, 2007, Labib, 2010). Synthetically forcing these interactions 
with Dpb11 is sufficient to bypass the requirement of CDK for the initiation of DNA 
replication, suggesting that Sld2 and Sld3 constitute the minimal set of CDK 
substrates required for an origin to initiate DNA synthesis (Tanaka et al., 2007, 
Zegerman and Diffley, 2007). However, bypassing Sld2 and Sld3 phosphorylation 
does not result in a physiological S-phase progression indicating that CDK may 
have other, as of yet unidentified, important substrates during S-phase. The 
complete in vitro reconstitution of DNA replication by the sequential addition of 42 
different proteins has recently been reported and demonstrates that CDK 
phosphorylation of Sld2 and Sld3 cooperatively promotes the stable association of 
Cdc45 and the GINs complex with a licenced origin (Yeeles et al., 2015). This 
system is broadly conserved in S. pombe (Fukuura et al., 2011) and the highly 
diverged human orthologs of Sld2 (ReqQL4) and Sld3 (Treslin/Ticrr) are also 
critical for DNA replication (Siddiqui et al., 2013).  
 
DDK phosphorylates the N-terminal tails of multiple MCM subunits and its activity is 
also necessary for DNA replication in vitro and in vivo (Weinreich and Stillman, 
1999, Lei et al., 1997, Heller et al., 2011). It is thought that this phosphorylation 
brings about activating conformational rearrangements in the helicase complex, 
which may serve to stabilise the interaction of the MCM complex with Cdc45 (Sheu 
and Stillman, 2006). A subsection of phosphorylation events in Mcm4 also serve to 
alleviate an intrinsic inhibitory activity in the N-terminal region of Mcm4 (Sheu and 
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Stillman, 2010). In vitro, phosphorylation of the MCM complex is the only necessary 
function for DDK activity in DNA replication (Yeeles et al., 2015).  
 
1.2.1.2 CDK inhibition of origin licensing  
After G1, CDK activity rises to initiate helicase activation, but can only do so at 
origins licenced in the preceding G1 because the CDK activity present in S/G2/M 
inhibits origin re-licencing. The separation of these two mutually exclusive stages of 
DNA replication through inverse dependencies on CDK activity cell ensures DNA 
replication occurs only once per cell cycle. CDK inhibits re-licensing after G1 
through multiple redundant mechanisms (Nguyen et al., 2001). Reconstituted DNA 
synthesis is inhibited if the ORC complex is first phosphorylated by CDK (Yeeles et 
al., 2015) and CDK phosphorylation of S. cerevisiae Orc6 prevents Cdt1 
recruitment to the ORC complex (Chen and Bell, 2011). S. cerevisiae CDK also 
targets MCM for nuclear export (Liku et al., 2005) and Cdc6 for SCFCdc4-mediated 
ubiquitin directed proteolysis in G2 (Perkins et al., 2001). In S. pombe, 
overexpression of Cdc18 (Cdc6 ortholog) can induce re-replication (Nishitani and 
Nurse, 1995). Cdc18 levels drop after G1/S due to CDK phosphorylation that 
targets Cdc18 for SCF mediated degradation (Kominami and Toda, 1997, 
Kominami et al., 1998, Wolf et al., 1999) and consistent with this phospho-mutants 
in Cdc18 have an enhanced ability to re-replicate upon overexpression (Jallepalli et 
al., 1997, Lopez-Girona et al., 1998). CDK dependent phosphorylation of S. pombe 
Orc2 has also been described to play a role in the inhibition of re-licencing. 
Phospho-mutants in Orc2 alone do not induce significant re-replication, but do 
enhance Cdc18 overexpression induced re-replication (Vas et al., 2001). 
 
 In higher eukaryotes CDK also phosphorylates a number of licensing factors but 
the full importance of these as a mechanism to inhibit re-licensing is not presently 
clear (Siddiqui et al., 2013). Two other major mechanisms function in parallel to 
CDK to contribute to the inhibition of origin licensing in eukaryotes. Firstly 
proteolysis of Cdt1 in Xenopus is mediated through the co-recruitment of Cdt1 and 
the Clu4 E3-ubiquitin ligase to the PCNA homo-trimer, in a replication-dependent 
manner (Arias and Walter, 2005, Li and Blow, 2005, Arias and Walter, 2006). This 
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mechanism also exists in fission yeast (Hu and Xiong, 2006, Ralph et al., 2006, 
Guarino et al., 2011) and overexpression of Cdt1 in S. pombe can drive re-
replication when combined with modest Cdc18 overexpression (Gopalakrishnan et 
al., 2001). In higher eukaryotes, Geminin inhibits Cdt1 except in G1 when 
APC/Ccdh1-mediated proteolysis of Geminin alleviates Cdt1 inhibition (McGarry and 
Kirschner, 1998, Tada et al., 2001, Wohlschlegel et al., 2000).  
 
CDK functions via multiple substrates and alongside other mechanisms to prevent 
re-licencing. This probably reflects the selective advantage for incredibly strong 
inhibition of re-replication through multiple redundant mechanisms when duplicating 
the large and complex eukaryotic genome (Diffley, 2011). Whilst the requirements 
for DNA replication are well understood, as illustrated by the complete in vitro 
reconstitution of semi-conservative DNA synthesis, the current knowledge of how 
CDK activity coordinates the more complex process of mitosis is still incompletely 
described.  
 
1.2.2 Initiation and coordination of mitotic progression 
As discussed above (section 1.1.1.4), CDK activity regulates itself through the 
inhibition of Wee1 and activation of Cdc25 activity to drive entry to mitosis, as well 
as the activation of APC/CCdc20 and inactivation of APC/CCdh1 to drive mitotic exit 
and G1/S respectively. In addition to controlling regulatory factors, CDK also 
phosphorylates hundreds of proteins involved in the mechanical execution of 
mitosis including the structural re-organisation of organelles, mitotic spindle 
assembly and re-modeling, chromosome bi-orientation, condensation and 
segregation.  
 
1.2.2.1 Microtubule dynamics and spindle assembly  
Microtubule structures are dynamically remodeled during the cell cycle (Hagan and 
Hyams, 1988, Kirschner and Mitchison, 1986). In fission yeast the cytoplasmic 
interphase microtubule array is disassembled at mitosis when a nuclear mitotic 
spindle forms between two separating SPBs. The spindle elongates, as two 
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daughter nuclei separate, to forms a post-anaphase array and once cell division is 
complete interphase microtubules reassemble (Hagan and Hyams, 1988). Dis1 and 
Alp14 (TOG orthologs) are plus-end microtubule polymerases that promote 
microtubule growth (Al-Bassam and Chang, 2011, Al-Bassam et al., 2012). In S. 
pombe CDK phosphorylates the NLS in Alp7 promoting its association with Cut15 
(α-importin) to drive the net nuclear import of the Alp7-Alp14 dimer, which in turn 
contribute to proper spindle assembly during mitosis (Okada et al., 2014). CDK 
regulation of Dis1 is also important for appropriate spindle formation and 
chromosome segregation (Nakaseko et al., 2001). CDK targets Dis1 to the 
kinetochore during metaphase and the dephosphorylation permits a pool of Dis1 to 
relocalise the spindle at anaphase (Aoki et al., 2006). SPB separation in S. 
cerevisiae requires the kinesin Kip1 that is phosphorylated by Clb2-Cdk28 and 
CDK phosphosites in Kip1 are essential for SPB separation (Chee and Haase, 
2010). In S. cerevisiae the Kar9 protein is important for spindle alignment and it is 
asymmetrically localised to the daughter SPB in a CDK-dependent manner, 
possibly by phosphorylation-dependent disruption of Kar9 interactions with Bim1 
(EB1 ortholog) and/or Stu2 (TOG ortholog) at the mother SPB (Liakopoulos et al., 
2003, Moore and Miller, 2007).  
 
1.2.2.2 Chromosome condensation  
Fission yeast Cut3 is the SMC4 condensin subunit and is necessary for 
chromosome condensation and subsequent chromosome segregation during 
mitosis (Saka et al., 1994). CDK phosphorylates a number of N-terminal sites in 
Cut3 including T19, which is essential for the nuclear localisation of Cut3 and the 
rest of the condensin complex during metaphase (Sutani et al., 1999). In humans, 
CDK phosphorylation of condensin subunits during mitosis, including the condensin 
II subunit CAP-D3, positively controls condensin supercoiling activity in vitro and 
promotes the condensation of chromosome in vivo (Kimura et al., 1998, Abe et al., 
2011).  
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1.2.2.3 Microtubule-kinetochore attachment  
Bi-directional chromosome capture by the spindle in mitosis is regulated by Aurora 
B kinase, part of the chromosome passenger complex (CPC) (Ruchaud et al., 
2007). Bir1 (Survivin), a subunit of the CPC, is phosphorylated in metaphase by 
CDK, facilitating binding of the centromeric shugoshin protein. This directs Ark1 
(Aurora B ortholog) to the kinetochore to ensure chromosome bi-orientation 
(Tsukahara et al., 2010). In humans another CPC subunit (Borealin) binds 
Shugoshin in a CDK phosphorylation-dependent manner (Tsukahara et al., 2010). 
Phosphorylation of Sli15 (INCENP ortholog), another CPC subunit, in S. cerevisiae 
is also involved in CPC localisation to the kinetochore at metaphase (Pereira and 
Schiebel, 2003). Mutation of CDK phosphorylation sites in Sli15 or the DASH 
complex protein Ask1, stabilise microtubules indicating that CDK regulates these 
proteins to increase microtubule dynamics during metaphase (Li and Elledge, 
2003, Higuchi and Uhlmann, 2005).  
 
1.2.2.4 CDK phosphorylation at the metaphase-anaphase transition    
In S. cerevisiae, to prepare the cell for anaphase once chromosome bi-orientation 
is achieved, Cdc28 phosphorylates Pds1 (S. cerevisiae Securin) promoting 
association with Esp1 (S. cerevisiae Seperase) and Pds1 nuclear import (Agarwal 
and Cohen-Fix, 2002). Cdc28 also phosphorylates Pds1 near its destruction box 
preventing ubiquitination by the APC/C. This contributes to a positive feedback that 
sharpens the metaphase-anaphase transition: activation of the CDK-counteracting 
phosphatase Cdc14 promotes Pds1 proteolysis, alleviating Esp1, which functions 
to both further activate Cdc14 as well as cleave the cohesion subunit Scc1, 
permitting chromosome segregation (Holt et al., 2008) (Uhlmann et al., 1999). In a 
similar manner to Pds1 many CDK substrates are dephosphorylated to precisely 
regulate their activity and/or localisation to ensure the timely execution of anaphase 
and cytokinesis (Kuilman et al., 2015). For example Sli15 dephosphorylation by 
Cdc14 allows CPC relocalisation to the spindle to modulate spindle midzone 
assembly during anaphase (Pereira and Schiebel, 2003). As anaphase progresses 
the spindle elongates to further separate chromosomes (anaphase B). Ase1 (S. 
pombe PRC1 ortholog) is an antiparallel microtubule cross-linking factor that binds 
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the kinesin-6 motor Klp9 during anaphase B recruiting it to the spindle mid-zone, 
promoting spindle elongation. This recruitment is inhibited by CDK phosphorylation 
of Ase1 and Klp9 and reversed by Clp1 (S. pombe Cdc14 ortholog) during 
anaphase, to ensure the appropriate regulation of spindle elongation (Fu et al., 
2009). Cdk1 similarly inhibits PRC1 (human Ase1 ortholog) before anaphase (Jiang 
et al., 1998, Mollinari et al., 2002). Cdk1 also phosphorylates the C. elegans 
centralspindlin component ZEN-4 in metaphase, reducing its affinity for 
microtubules and thus its motor activity. As CDK activity declines at anaphase 
ZEN-4 is activated and localises to the central spindle contributing to its timely 
assembly (Mishima et al., 2004). Clp1-mediated dephosphorylation of Nsk1 has 
been reported to allow its localisation to the kinetochore-SPB interphase, which 
helps retain SPB-kinetochore attachments during anaphase B. CDK-mediated 
phosphorylation early in mitosis prevents this but also promotes its release from the 
nucleolus (Buttrick et al., 2011, Chen et al., 2011).  
 
1.2.2.5 Regulation of nuclear remodeling at mitosis  
CDK also regulates nuclear expansion, which accompanies the closed mitosis in S. 
cerevisiae, via the phosphorylation of Lipin (Ned1), a phosphatidate phosphatase. 
During interphase Nem1–Spo7 phosphatase complex antagonises Lipin 
phosphorylation to prevent precocious expansion of the nucleus (Santos-Rosa et 
al., 2005). Higher eukaryotes undergo full NEBD during mitosis, exposing 
chromatin to the full complement of cytoplasmic proteins (Kutay and Hetzer, 2008). 
The closed mitosis of many fungi may explain why they, but not higher eukaryotes, 
regulate the nuclear trafficking of multiple mitotic proteins by CDK phosphorylation. 
CDK phosphorylation also contributes to the processes of NEBD by 
phosphorylating Lamin proteins, promoting disassembly of the karyoskeletal lamina 
network (Peter et al., 1990, Heald and McKeon, 1990). Cytoplasmic Vimentin 
(another intermediate filament) is also disassembled by CDK phosphorylation at 
mitosis (Chou et al., 1990). Organelles besides the nucleus are also re-organised 
during mitosis probably to ensure an even distributive division of the organelle 
components. For example, Golgi cisternae are fragmented during mitosis due to 
CDK phosphorylation of the Golgi membrane receptor GM130, which disrupts the 
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recruitment of the vesicle-docking factor p115 (Lowe et al., 1998). The nucleolus is 
also disassembled in mitosis, and the inhibition of CDK activity during mitosis has 
been reported to increase rDNA transcription and prevent full disassembly of some 
nucleolar proteins (Sirri et al., 2002). In fission yeast other CDK substrates reported 
in the literature involved in mitosis include Mde4, Rap1 and Hcn1 (Choi et al., 2009, 
Fujita et al., 2012, Yoon et al., 2006). 
 
1.2.3 Multisite phosphorylation of CDK substrates  
The examples of CDK-regulated processes at S-phase and mitosis illustrate that 
CDK phosphorylation functions to positively and negatively regulate different 
aspects of different substrates, including enzymatic activity, proteolysis, subcellular 
localisation, multi-protein complex formation etc. Many CDK substrates are 
phosphorylated at multiple resides that often cluster into disordered regions of 
proteins (Holt et al., 2009). However, the logic describing how a CDK substrate 
becomes net phosphorylated is not always straight-forward. 
 
Multisite phosphorylation can proceed via a precise logic that has been proposed to 
function as a ‘signal processor’ for CDK activity, involving the highly conserved 
phosphoadaptor Cks proteins. The first Cks protein identified was S. pombe Suc1, 
a multi-copy suppressor of a temperature-sensitive cdc2 allele (Hayles et al., 
1986). Suc1 orthologs in S. cerevisiae (Cks1) and humans (CksHs1 & CksHs2) 
were first identified as proteins that bind CDK (Hadwiger et al., 1989, Draetta et al., 
1987, Richardson et al., 1990). The ability of Cks proteins from different species to 
complement S. cerevisiae Cks1 and to bind Cyclin-CDK complexes from other 
species illustrates the high level of functional conservation within the Cks protein 
family (Richardson et al., 1990). Cks1 is essential for S-phase and mitosis in S. 
cerevisiae (Tang and Reed, 1993) and ~50% of Cyclin-CDK complexes bind Cks1 
with 1:1 stoichiometry in vivo (Kito et al., 2008). Cks1 functions as a phospho-
adaptor by binding phospho-threonine residues and promotes multisite 
phosphorylation of a number of CDK substrates (Patra et al., 1999, Rudner and 
Murray, 2000, Koivomagi et al., 2011a, Koivomagi et al., 2013). Consistent with this 
model, Cks1 mutants that arrest the cell cycle do not diminish intrinsic CDK activity 
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towards the model substrate H1 (Tang and Reed, 1993). After binding a CDK 
phosphorylated Threonine, Cks1 promotes phosphorylation of secondary sites in a 
N-to-C terminal direction that is optimal when downstream sites are 12-16 residues 
C-terminal to the priming site. This suggests Cks1 positions secondary 
phosphorylation sites, C-terminal to the bound primer phospho-threonine, to 
increase their phosphorylation efficiency (Koivomagi et al., 2013). Consistent with 
this, CyclinA-Cdk2-Cks1 crystal structures show that the phosphate binding site in 
Cks proteins is positioned on the same surface of the Cyclin-CDK-Cks1 complex as 
the substrate binding site (Bourne et al., 1996). In vitro studies of the 
phosphorylation of a model substrate, a Sic1 fragment with a single priming site 
and a single downstream site, indicates that Cks1-dependent phosphorylation 
occurs via a processive reaction with a ~40% probability of the second phosphate 
being added before dissociation of the substrate (Koivomagi et al., 2013). In the 
absence of such a mechanism, multisite phosphorylation would instead be simply 
distributive, that is to say, each site is phosphorylated independently of the 
phosphorylation state of other sites and this does appear to be the case for a 
significant number of tested substrates. Processive or semi-processive 
phosphorylation cascades allows the amplification of substrate phosphorylation and 
could be critical in ensuring abrupt net multisite phosphorylation of CDK substrates 
during cell cycle transitions. Cks1 may also facilitate the phosphorylation of 
secondary sites that otherwise would never be phosphorylated in a distributive 
manner due to their poor phosphorylation efficiency in the absence of Cks1. 
 
Polo-like kinase 1 (Plk1) participates in a different type of multi-site phosphorylation 
cascade. Plk1 contains a C-terminal domain (polo-box domain (PBD)) within which 
there is a charged interface between two polo-boxes that binds phospho-serine or 
phospho-threonine. This recruits Plk1 to specific substrates or sub-cellular 
locations, as well as stimulating Plk1 kinase activity (Elia et al., 2003a, Elia et al., 
2003b). CDK phosphorylation has been shown to recruit Plk1 to Vimentin, BubR1 
and INCENP, resulting in downstream Plk1-mediated phosphorylation at other sites 
within the same protein (Yamaguchi et al., 2005, Wong and Fang, 2007, Goto et al., 
2006). CDK phosphorylation also directly activates Cdc5 (Plk1) in S. cerevisiae 
(Mortensen et al., 2005).  
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It has also been reported that CDK phosphorylation of MCM can promote DDK 
phosphorylation of the same MCM molecules, including sequences where CDK 
phosphorylation might prime phosphorylation at a -1 Serine for DDK-mediated 
phosphorylation (Masai et al., 2000, Montagnoli et al., 2006, Devault et al., 2008). 
DDK also phosphorylates residues in acidic-rich sequences suggesting that the 
local charge provided by CDK-mediated phosphorylation may be what is important 
in promoting DDK phosphorylation on the same molecule (Labib, 2010).  
 
Cks1, Plk1 and DDK are examples the way in which CDK can amplify and diversify 
its phosphorylation outputs. The full nature of the CDK phosphorylation network is 
still mysterious. What proportion of CDK phosphorylation is distributive or 
processive, and how much of it involves crosstalk with other kinases, remains 
unclear.  
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1.3 CDK-counteracting phosphatases and their regulation 
The nature and regulation of CDK-counteracting phosphatases has been the 
subject of intense research over the past decade. Work in S. cerevisiae, and to a 
lesser extent S. pombe, suggests that the major CDK-counteracting phosphatase 
in yeasts, at least during mitotic exit, is the Proline-directed Serine/Threonine 
phosphatase Cdc14 (S. pombe Clp1) (Visintin et al., 1998, Chen et al., 2011, Gray 
et al., 2003). Cdc14 is initially inhibited by sequestration in the nucleolus and then 
the FEAR and MEN pathways act sequentially to alleviate this inactivation during 
mitotic progression from early anaphase onwards (Stegmeier et al., 2002, Queralt 
and Uhlmann, 2008). Cdc14 mutants arrest in mitosis (Culotti and Hartwell, 1971) 
and activation of Cdc14 is nested in a positive feedback loop with Separase 
activation (Holt et al., 2008). In S. pombe, Clp1 is released from the nucleolus early 
in mitosis but is only fully activated once CDK activity declines, permitting Clp1 
auto-dephosphorylation and full Clp1 activation (Trautmann et al., 2001, Wolfe et 
al., 2006). Clp1 has also been implicated in controlling the timing of mitotic entry in 
S. pombe, probably by indirectly antagonising the dephosphorylation of Cdc2-Y15 
(Trautmann et al., 2001).  
 
Cdc14 substrate dephosphorylation follows a temporal sequence as anaphase 
progresses (Bouchoux and Uhlmann, 2011). The order of substrate 
dephosphorylation corresponds to the timing of events during mitotic exit; for 
example, Fin1 is dephosphorylated early and functions in anaphase spindle 
assembly whilst Orc6 dephosphorylation occurs later to ensure that origin re-
licensing only occurs once CDK activity has dropped sufficiently. Bouchoux et al. 
(2011) demonstrated that these small differences in the timing of 
dephosphorylation occur at specific CDK:Cdc14 thresholds. Substrates have 
differential responsiveness to the decreasing CDK:Cdc14 ratio during mitotic exit 
resulting in the temporal ordering of substrate dephosphorylation and the 
respective mitotic exit events. These differences in responsiveness are a function 
of the ratio of the phosphorylation and dephosphorylation rate for any given 
substrate (Bouchoux and Uhlmann, 2011). The biochemical determinants for these 
differences in phosphorylation or dephosphorylation rates are yet to be uncovered.  
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The role of Cdc14 in reversing CDK-mediated phosphorylation does not seem to be 
conserved in higher eukaryotes (Mocciaro and Schiebel, 2010) where PP2A is 
thought to be the major CDK-counteracting phosphatase, which unlike the 
monomeric Cdc14 is a trimer of a structural (A), regulatory (B), and catalytic (C) 
subunit (Xu et al., 2006).  
 
The regulation of PP2A-B55 has been shown to be crucial for the entry into and 
exit from mitosis in Xenopus extracts: PP2A-B55 depletion causes hyper-
phosphorylation of CDK substrates and premature mitotic entry when CDK activity 
is low and then fails to subsequently exit mitosis. Conversely supplementing 
lysates with recombinant PP2A-B55 causes a dose-dependent delay in mitotic 
phosphorylation (Mochida et al., 2009). PP2A-B55 activity drops precipitously 
during mitosis courtesy of the CDK activation of the Greatwall kinase (Gwl), which 
down-regulates dephosphorylation of mitotic substrates by promoting the 
inactivation of PP2A-B55 (Vigneron et al., 2009, Castilho et al., 2009). The 
regulatory circuit was completed with the identification of the Gwl substrate (α-
endosulphine/Arpp19) which when phosphorylated inhibits PP2A-B55 activity 
directly (Gharbi-Ayachi et al., 2010, Mochida et al., 2010). Phosphorylated α-
endosulphine is also a PP2A-B55 substrate, which inhibits PP2A-B55 activity by 
dramatically outcompeting other PP2A-B55 substrates due to its incredibly low Km 
and Kcat (Williams et al., 2014). PP2A-B55 and Gwl participate in multiple arms of 
the auto-regulatory feedback loops that control CDK activity: as CDK activity rises 
Gwl activation reduces PP2A activity, slowing the dephosphorylation of Wee1 and 
Cdc25, facilitating CDK activation and thus further downstream PP2A-B55 
inactivation (Yu et al., 2006, Zhao et al., 2008). This network architecture is called a 
coherent feed forward loop and contributes to the non-linear bistability of the mitotic 
entry network that makes the decision to enter mitosis more irreversible (Domingo-
Sananes et al., 2011) and sets the threshold for CDK activity required for mitotic 
entry (Krasinska et al., 2011). In S. pombe deletion of the major PP2A catalytic 
subunit (ppa2∆) advances cells into mitosis at a small size and is synthetically 
lethal with Wee1 inactivation (wee1-50) or a background harbouring a Cdc2-T14A, 
Y15F mutation, hinting at a possible role for PP2A in antagonising CDK activity in 
fission yeast (Kinoshita et al., 1993, Navarro and Nurse, 2012).  
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In mitotic Xenopus extracts (CSF arrested) depletion of Gwl promotes mitotic exit 
and CDK substrate dephosphorylation even in the absence the auto-regulatory 
feedback loops that act on Cdk1-Y15 (using a Cdk1AF or Wee1 depletion) 
indicating that the function of PP2A-B55 is not just limited to participation in the 
regulation of CDK activity, but more broadly in global CDK substrate 
dephosphorylation (Castilho et al., 2009, Vigneron et al., 2009). The existence of 
the Gwl/α-endosulphine pathway has also been proposed to introduce a time delay 
into the re-activation of PP2A at the metaphase-anaphase transition to ensure that 
CDK substrates, such as PRC1, are always dephosphorylated after full Separase 
activation (Cundell et al., 2013).  
 
Despite the obvious significance of PP2A-B55, Gwl depletion in extracts is not 
sufficient to increase the dephosphorylation rate of all model CDK substrates tested 
(Castilho et al., 2009) and CDK inactivation can still drive mitotic exit when PP2A-
B55 is depleted (Mochida et al., 2009) suggesting that multiple phosphatases co-
operate at mitotic exit to reverse the extensive program of mitotic phosphorylation. 
PP1 is directly inhibited by CDK phosphorylation of a conserved N-terminal 
Threonine (Dohadwala et al., 1994, Yamano et al., 1994) and chemical inhibition or 
depletion of the PP1 also results in cells being unable to exit mitosis (Wu et al., 
2009). Recent work in S. pombe has suggested that PP1 and PP2A participate in a 
dephosphorylation relay where PP1, activated by auto-dephosphorylation as CDK 
activity declines, dephosphorylates and activates PP2A-B55 & B56 as mitotic exit 
proceeds (Grallert et al., 2015).  
 
The precise level of interphase PP2A activity also seems important to permit DNA 
synthesis in interphase: if PP2A is inactivated, DNA replication is prevented even at 
okadaic acid concentrations that are not permissive to mitotic entry. The 
mechanism underlying this inhibition of DNA replication is unclear but may relate to 
the possibility that PP2A dephosphorylates the substrates of other kinases, beside 
CDK, that inhibit DNA replication in interphase (Krasinska et al., 2011).  
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1.4 The differential regulation of CDK outputs  
Different Cyclin-CDK complexes control a plethora of different cellular process via 
phospho-regulation during cell division. Both CDK activity and substrate-specificity 
have been implicated in how Cyclin-CDKs bring about the appropriate ordering of 
cell cycle events. The textbook paradigm describes a model where association of 
S-phase cyclins with CDK directs CDK activity specifically towards substrates 
whose phosphorylation initiate DNA replication. As the cycle progresses and mitotic 
cyclins are synthesised they associate with CDK to impart an altered substrate 
specificity, re-directing CDK activity towards substrates whose phosphorylation is 
required to re-organise the cell to execute the events of mitosis (Morgan, 2007).  
 
1.4.1 Biochemical specificity as a mechanism to order substrate 
phosphorylation 
In 2005 Loog and Morgan illustrated the potential global significance of substrate 
specificity by assaying the relative phosphorylation of substrates by Clb2-Cdc28 or 
Clb5-Cdc28 in budding yeast extracts. 24% of 150 CDK substrates assayed were 
phosphorylated more efficiently by Clb5-Cdc28 than Clb2-Cdc28, normalised to H1 
kinase activity. This specificity is directed towards a number of substrates involved 
in DNA replication and is mediated through a docking interaction between a cyclin 
hydrophobic patch and RxL motif on the substrate (Loog and Morgan, 2005). This 
docking interaction was first identified between Cyclin A2 and its substrate p27, 
illustrating the evolutionary conservation or co-evolution of the use of this motif to 
mediate cyclin-substrate interactions (Russo et al., 1996b, Schulman et al., 1998). 
The RxL motif dramatically decreases the Km of a substrate for the Cyclin-CDK 
complex in vitro whilst leaving the Kcat unaltered (Takeda et al., 2001). Studies on 
the interaction between Cdc6 and Cyclin A2-Cdk2 have shown the RxL motif is 
optimally positioned, at least 15 amino acids, distal to the phosphorylation site(s) 
(Cheng et al., 2006).  
 
G1 cyclin specificity is also conferred by specific motifs in G1 substrates 
(Koivomagi et al., 2011b) (Bhaduri and Pryciak, 2011). For example, Ste5 and 
Ste20 phosphorylation by Cln2-Cdc28 is dependent on a LLPP and a SLDDPIQF 
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motif respectively. These motifs recruit Cln2 to substrates to enhance G1/S 
phosphorylation and can even be switched between Ste5 and Ste20 and still 
maintain Cln2-specific phosphorylation (Bhaduri and Pryciak, 2011). This G1 
cyclin-specific phosphorylation inhibits the pheromone response signalling during 
G1, antagonising mating arrest, and could be important in the phosphorylation of a 
wider range of proteins besides Ste5 and Ste20 (Bhaduri and Pryciak, 2011). For 
example, phosphorylation of Sic1 by Cln2-Cdc28 depends on a VLLPP motif and 
serves to prime Cks1-mediated recruitment of Cln2-Cdc28 and Clb5-cdc28 to drive 
processive phosphorylation of less efficiently phosphorylated sites that serve as a 
Sic1 phospho-degron. Multiple RxL motifs on Sic1 promote phosphorylation by 
Clb5-Cdc28 and are important for this processive phosphorylation reaction 
(Koivomagi et al., 2011a). The region that substrate-docking motifs interact with on 
G1 cyclins is currently unknown.  
 
Recent studies have indicated that the relative positioning of a docking motif with 
respect to the phosphorylation is critical. Clb5 phosphorylation of a model Sic1 
fragment is promoted by an RxL motif but only when the phosphorylation site is 
more than 10 amino acids C-terminal to the RxL motif. In contrast the VLLPP motif 
promotion of Cln2-Cdc28 dependent phosphorylation is less directionally limited but 
does dip as the phosphorylation site and VLLPP motif converge (Koivomagi et al., 
2013). As well as imparting differential substrate specificity, different cyclins 
activate CDK to varying degrees. Cdc28 kinase activity incrementally increases as 
it associates with increasing late cyclins (Cln3 < Cln2 < Clb5 < Clb2) (Loog and 
Morgan, 2005, Koivomagi et al., 2011b). This has been proposed to allow the 
phosphorylation of mitotic substrates later in the cycle, whilst the lower activity 
imparted by earlier cyclins is compensated for by docking interactions to bring 
about phosphorylation of G1/S substrates earlier in the cycle. Clb2 and Cln2 also 
appear to differentially modulate the consensus site specificity of CDK to adjust 
specificity in a site-autonomous manner (Koivomagi et al., 2011b).  
 
Immuno-precipitation of human Cyclin A, B and E has shown that different cyclins 
bind to partially overlapping pools of potential substrates in vivo (Pagliuca et al., 
2011). A significant amount of the cyclin-specific interactions could be due to 
differences in biochemical affinity of a cyclin for its substrates, such as Cyclin A2 
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docking via the RxL motif. However, it is also likely that some specificity is due to 
temporal differences in the in cyclin and/or substrate expression/activation.  
 
Disruption of substrate docking motifs or cyclin hydrophobic patches reduces the 
phosphorylation of model S-phase cyclin substrates in vivo, but does not result in 
the complete collapse of phosphorylation at S-phase (Loog and Morgan, 2005). For 
example, ~100% of the S. cerevisiae protein Fin1 shows a phosphorylation-
dependent mobility shift after release from a G1 arrest, but 60-70% of this is 
maintained when the Fin1-Clb5 docking interaction is disrupted (Loog and Morgan, 
2005). Furthermore Sld3, a critical CDK substrate for the initiation of S-phase 
(Tanaka et al., 2007, Zegerman and Diffley, 2007), is equally well phosphorylated 
by Clb2-Cdc28 or Clb5-Cdc28 (Loog and Morgan, 2005, Uhlmann et al., 2011). 
This suggests specificity could be mediated through other determinants and that 
the timing of substrate phosphorylation is not exclusively, or even predominantly, 
dictated by the biochemical affinity of different cyclins for different substrates.  
 
1.4.2 Quantitative changes in CDK activity as a core organiser for cell cycle 
transitions  
This picture is confounded further by the genetics, which has tested the extent to 
which cells can tolerate the absence of certain cyclins. Deletion of Clb5&6 results in 
an S-phase delay (Schwob and Nasmyth, 1993) which can be rescued by the 
expression of Clb2 from the Clb5 promoter, as long as Swe1 is deleted to allow the 
premature activation of Clb2-cdc28 (Hu and Aparicio, 2005). This is because later 
Cyclin-CDK complexes are more strongly inhibited by Swe1 phosphorylation than 
earlier Cyclin-CDK complexes (Hu and Aparicio, 2005, Keaton et al., 2007, 
Koivomagi et al., 2011b). So S. cerevisiae mitotic cyclins can order S-phase and 
mitosis so long as their expression and activity is wired appropriately. S-phase 
cyclins are not capable of compensating for the mitotic functions of Clb5&6 (Fitch et 
al., 1992) but the requirement for G1 cyclins, Cln1-3, can be bypassed by the 
ectopic expression of Clb5 or the deletion of Sic1 (Schwob and Nasmyth, 1993, 
Tyers, 1996). This again highlights the significant redundancy between cyclins 
when compensating cyclin expression/activitiy is appropriately re-wired.  
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In S. pombe Cdc13 is an essential protein and no attempt to compliment Cdc13 by 
re-wiring the expression of other cyclins has been reported. In the absence of 
Cdc13 cells arrest at G2/M having undergone S-phase in a Cig1/Cig2-dependent 
manner (Hayles et al., 1994) (Fisher and Nurse, 1996). Strikingly S. pombe is able 
to execute all the events of the cell cycle in the absence of G1 or S-phase cyclins 
and only Cdc13 is strictly necessary for cell proliferation (Fisher and Nurse, 1996, 
Martin-Castellanos et al., 2000). Furthermore overexpression of Cdc13 and Cdc2 in 
G1 cells causes precocious mitotic entry resulting in mitotic catastrophe (Hayles et 
al., 1994). Cells running only on Cdc13 are delayed in S-phase initiation upon 
release from nitrogen starvation (Fisher and Nurse, 1996) and spend significantly 
longer in G1 than wild type cells, a delay that is dependent on Rum1. Puc1 and 
Cig1 are insensitive to Rum1 inhibition and phosphorylate Rum1 more efficiently, 
than Cig2 and Cdc13, and thus prevent the Rum1-dependent G1 extension 
observed in their absence (Stern and Nurse, 1998, Martin-Castellanos et al., 2000).  
 
The general outlook is one where mitotic cyclins, with the capacity to impart the 
broadest and highest activity on CDK, are the most non-redundant and able to 
compensate for the absence of earlier cyclins. G1/S cyclins provide a more limited 
activity earlier in the cell cycle, combined with docking interactions to enhance the 
biochemical affinity, and thus the phosphorylation rates, for specific substrates. On 
top of this multiple layers of differential cyclin regulation confounds the 
understanding of the underlying biochemical principles at the core of cell cycle 
organisation. The observations in fission yeast lead to the proposition of the 
quantitative model for cell cycle progression, by Stern and Nurse, which stated that 
the core cell cycle organiser is composed of rising activity of CDK, not temporal 
waves of changing specificity (Stern and Nurse, 1996) (Figure 1.3). In G1 when 
CDK is absent DNA-replication origins are licenced. As CDK reaches a low activity 
threshold early in the cycle this is sufficient to initiate S-phase. As CDK activity 
rises the re-licensing of origins is inhibited in G2 and even higher CDK activity is 
necessary to initiate the events of mitosis. A prediction of the quantitative model is 
that oscillations in CDK activity below and above the S-phase threshold should 
allow rounds of re-replication without intervening mitoses. Early genetic studies 
supported such a model, for example Cdc13 repression or Rum1 overexpression  
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Figure 1.3 | The quantitative model for cell cycle progression 
can induce rounds of re-replication, up to ~32C DNA content (Moreno and Nurse, 
1994, Hayles et al., 1994). In the case of Cdc13 repression, re-replication is 
dependent on Cig1 and Cig2 (Fisher and Nurse, 1996). Overexpression and then 
repression of Sic1 in S. cerevisiae can also drive a single round of origin re-
licensing and then re-firing in cells previously arrested in S-phase or G2/M (Noton 
and Diffley, 2000).  
 
The quantitative model has been recently tested and corroborated by simplifying 
the CDK network in S. pombe and employing chemical genetics to modulate CDK 
activity (Coudreuse and Nurse, 2010). Coudreuse and Nurse (2010) demonstrated 
that a single monomeric fusion protein between Cdc13 and Cdc2 (Cdc13-L-Cdc2) 
is sufficient to drive the cell cycle with near wild type physiology, in the absence of 
all endogenous cyclins and CDK. Specific chemical inhibition (using 1-NmPP1 and 
an ATP analog-sensitised Cdc2 moiety) of this Cdc13-L-Cdc2 construct showed 
that lower 1-NmPP1 concentrations are sufficient to inhibit mitosis than S-phase. 
This is also true of S. cerevisiae when Cdc28 is rendered specifically sensitive to 1-
NmPP1 (Bishop et al., 2000). The removal and subsequent restoration of a low 
level of CDK activity, in a population of G2 cells, initiates a single round of DNA 
replication in the absence of an intervening mitosis. Similarly exposing G1-arrested 
cells to precociously high levels of CDK activity can drive the simultaneous initiation 
of S-phase and a premature mitosis. Coudreuse and Nurse (2010) were also able 
to drive progression through an entire cell cycle, under the control of a non-
degradable Cdc13-L-Cdc2 protein, simply by sequentially chemically setting its 
activity at these distinct thresholds. The ability to decouple the natural order of cell 
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Figure 1.03 | The quantitative 
model for cell cycle progression 
CDK activity rises as cells 
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cycle progression only via the manipulation of CDK activity strongly argues that cell 
cycle events lack major intrinsic directionality. It also argues that the sequential 
passage through different activity thresholds functions as a coarse organising 
mechanism for cell cycle transitions, at least in fission yeast.  
 
1.4.3 CDK and cyclin requirements and redundancies in higher eukaryotes  
Various strands of evidence from work in higher eukaryotes, that have reported 
redundancies between the multiple CDKs and cyclins, are consistent with this 
model. Unlike the yeasts, higher eukaryotes have multiple CDKs that are thought to 
be required for distinct stages of the cell cycle: Cdk1, Cdk2, Cdk4 and Cdk6 
(Malumbres and Barbacid, 2005, Satyanarayana and Kaldis, 2009). Cdk1 is 
essential for early embryogenesis but the combined deletion of all cell cycle CDKs 
in mice, besides Cdk1, permits development until mid-gestation and can give rise 
to mouse embryonic fibroblasts (MEFs) that can proliferate in vitro. In these 
conditions Cdk1 associates with all cell cycle cyclins but is inefficient at 
phosphorylating Rb causing a slowing in cell cycle time (Santamaria et al., 2007).  
 
The redundancy between higher eukaryotic cyclins is less straightforward. In the 
early Xenopus embryos Cyclin E promotes S-phase, but Cyclin A is also capable of 
initiating S-phase (Strausfeld et al., 1996). Murine Cyclin E is dispensable for cell 
division, Cyclin E null embryos develop with surprising normality and Cyclin E 
genes are only necessary for specialised developmental programs involving 
endoreplication (Geng et al., 2003). Similarly embryos deleted for all three Cyclin D 
genes can give rise to proliferating fibroblasts and Cyclin D null embryos have 
specific developmental defects that result in embryo lethality at mid-to-late 
gestation (Kozar et al., 2004). Finally deletion of Cyclin A in mice is lethal early 
during embryogenesis but Cyclin A1 Cyclin A2 null MEFs can still be isolated and 
are competent for the basic process of cell division (Murphy et al., 1997, 
Kalaszczynska et al., 2009). In early Xenopus embryo lysates, addition of high 
concentrations of Cyclin A, but not Cyclin E, is also able to bring about the initiation 
of mitosis (Strausfeld et al., 1996) and Cyclin A2 knockdown cells delay Cyclin B1 
accumulation in the nucleus and delay NEBD onset (Gong et al., 2007).  
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What is less clear from these studies is whether all but one higher eukaryotic cyclin 
is sufficient to initiate S-phase and mitosis. Cyclin A null MEFs cell division is 
dependent on Cyclin E, indicating that the system may not be able to be reduced 
further to run on only the single most essential cyclin; Cyclin B1, the deletion of 
which is lethal very early during embryogenesis (Brandeis et al., 1998). Consistent 
with this Cyclin E-Cdk1 and Cyclin A-Cdk1/2, but not CyclinB-Cdk1, can provide S-
phase promoting activity in Xenopus extracts (Jackson et al., 1995, Strausfeld et al., 
1996). The ability of Cyclin E and Cyclin A to cross compensate is consistent with 
the observation that there are striking structural similarities between Cyclin E-Cdk2 
and Cyclin A-Cdk2 (Honda et al., 2005) and that the vast majority (81%) of putative 
substrates that interact with Cyclin E in vivo are also bound by Cyclin A (Pagliuca 
et al., 2011).  
 
As described above (section 1.1.4) an important aspect of Cyclin B1 regulation is 
the control over its nuclear import at mitotic entry. Moore et al. (2003) re-
engineered Cyclin B1, by replacing its NES-containing N-terminus region with the 
Cyclin E-NLS (Cyclin E/B1) or SV40 large T-antigen NLS. These constructs were 
able to initiate semi-conservative DNA replication after cyclin E depletion whilst 
wild-type Cyclin B1 could not, thus unmasking a cryptic S-phase promoting activity 
in Cyclin B1-CDK. However Cyclin E/B1 eventually aborts DNA replication as it 
also initiates mitosis (Moore et al., 2003). This inability to temporally separate S-
phase and mitosis is probably in part because it transverses the two activity 
thresholds too rapidly, as bypassing the positive feedback loops that accelerates 
Cyclin B1-Cdk1 activity results in greater Cyclin B1 S-phase promoting activity.  
 
These data are consistent with the idea that surpassing sequential CDK activity 
thresholds orders S-phase and mitosis in higher eukaryotes, and that a significant 
amount of the requirement for different cyclins is due to their differential expression 
and upstream regulation, not their intrinsic ability to promote specific cell cycle 
stages. Cyclin B1 is capable of initiating S-phase and mitosis but the use of Cyclin 
E or Cyclin A for the initiation of S-phase in a physiological cell cycle may allow 
greater temporal resolution between the attainment of the S-phase and mitotic 
activity thresholds and, as such, a more robust separation of S-phase and mitosis.  
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1.4.4 The requirement of different cyclins during developmental cell cycle 
programs 
Clearly an important aspect to having multiple cyclins is their contribution to specific 
developmental situations. This could be because of two non-mutually exclusive 
reasons. Firstly, cyclins may target CDKs to cyclin-specific substrates, only 
required for certain developmental fates. Alternatively, differential developmental 
expression/regulation of cyclins may reduce the ability of one cyclin to compensate 
for another. For example despite being viable, male Cyclin A1 null mice are infertile 
due to failure of the first meiotic division during spermatogenesis (Liu et al., 1998) 
and ~50% of Cyclin E2 null male mice are infertile (Geng et al., 2003). Cyclin E is 
specifically important for the development of tissues that undergo endoreplication 
and Cyclin E embryonic lethality is due to defects in trophoectodermal 
endoreplicaiton and can be rescued if the extra-embryonic tissues, which includes 
the trophoectoderm, are wild type (Geng et al., 2003). Whilst Cyclin A1 and Cyclin 
A2 are dispensable for cell division, they are required for embryonic and 
hematopoietic stem cell division (Kalaszczynska et al., 2009).  
 
Sexual differentiation is one of the most distinctive developmental fates and 
involves passage through the specialised cell division program of meiosis, which 
constitutes a single round of DNA replication (pre-meiotic S-phase) followed by a 
reductional (MI) and then equational (MII) nuclear division (Ohkura, 2015). The 
requirement of different kinase activities in meiosis as opposed to mitosis has been 
studied in more depth in the yeasts. S. cerevisiae Cln proteins are not required for 
the progression into the meiotic division cycle, which is initiated by the meiosis 
specific kinase Ime2, which inactivates Sic1 and inhibits APC/CCdh1. This allows the 
expression and activation of S-phase cyclin Clb5&6 that drive progression through 
pre-meiotic S-phase (Foiani et al., 1996, Dirick et al., 1998, Bolte et al., 2002, 
Stuart and Wittenberg, 1998, Benjamin et al., 2003). Clb1,4&5 complex with Cdc28 
to initiate M1, whilst MII is orchestrated by the Clb3/5-Cdc28 complexes (Dahmann 
and Futcher, 1995, Carlile and Amon, 2008). These data from S. cerevisiae 
suggest that cyclin specificity may be of heightened significance during meiosis. In 
S. pombe, two additional cyclins (Crs1 and Rem1) are specifically expressed in 
meiosis (Malapeira et al., 2005). Cdc13 is essential for progression beyond pre-
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meiotic S-phase in S. pombe, but five other mitotic or meiotic cyclins (Crs1, Rem1, 
Puc1, Cig1, Cig2) have no or very minor effects on meiotic cycle progression when 
individually deleted. However, Cdc13 alone is unable to drive progression through 
meiosis. Despite this, overexpression of the cdc13-L-cdc2 module constructed by 
Coudreuse and Nurse (2010) allows progression through an azygotic meiosis in the 
absence of all endogenous cyclins and CDK (Gutierrez-Escribano and Nurse, 
2015). This suggests that the principle of activity-dependent organisation of the 
mitotic cell cycle also applies to progression from pre-meiotic S-phase through MI 
and then MII. Minor azygotic meiotic defects and more pronounced problems 
during zygotic meiosis suggest that cyclin specific expression profiles or cyclin 
specific substrate interactions are important for the full physiology of the sexual 
cycle in S. pombe (Gutierrez-Escribano and Nurse, 2015).  
 
This raises the question as to how CDK activity is coordinated from MI and MII 
without initiating an intervening round of DNA replication. Mes1 regulates the 
APC/C, specifically during meiosis, to prevent complete degradation of Cdc13 
between the two meiotic divisions (Izawa et al., 2005, Kimata et al., 2011). This 
may allow CDK activity to drop low enough to permit exit from MI without dropping 
so low as to cause origin re-licencing. In S. cerevisiae, the Ime2 kinase, which 
phosphorylates overlapping substrates to CDK but at distinct sites (R-P-X-S/T 
consensus), compensates for reduced CDK phosphorylation between MI and MII to 
inhibit DNA replication (Holt et al., 2007). Holt et al. (2007) propose Ime2 
phosphorylation is not removed between MI and MII because it is resistant to the 
mitotic exit phosphatase Cdc14 and that Ime2, unlike CDK, is not inactivated after 
MI. 
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1.5 Global Dynamics of CDK substrate phosphorylation in a 
simplified CDK network  
The observations discussed above point to a model where rising CDK activity 
orders cell cycle events via the sequential passage through specific activity 
thresholds and this coarse organising mechanism is refined by multiple Cyclin-CDK 
complexes with alternate regulatory inputs and substrate preferences. However, 
the nature of the output of CDK activity at these transitions is not understood. The 
output of CDK, i.e. substrate phosphorylation and its dynamics, and how such 
dynamics are achieved are the subject matter of this thesis. To provide a global 
perspective, phosphoproteomics was adopted to detect and quantify thousands of 
phosphorylation events in vivo. In the second chapter I describe the definition of 
hundreds of CDK substrate sites in S. pombe and their phosphorylation dynamics 
during the cell cycle. Different CDK substrates are first phosphorylated at different 
times during the cell cycle but are only net dephosphorylated at mitotic exit. In the 
third chapter I present data that argues that the timing of cell cycle events is 
organised by differential substrate sensitivity to in vivo CDK activity, as well as 
presenting data that suggests that the progression through the G2/M transition is 
also ordered by differential substrate sensitivity to CDK activity thresholds. In the 
fourth chapter I briefly discuss the possible contribution of G1/S-phase cyclins in S. 
pombe towards CDK substrate phosphorylation. In the final results chapter, I 
present an analysis of the dynamics of cell cycle phosphorylation mediated by 
kinases other than CDK, which suggests that mitotic phosphorylation is temporally 
coordinated to bring about the amplification and diversification of CDK signalling. 
Chapter 2 - Results 
 
50 
 
Chapter 2. CDK dependent phosphorylation and its 
cell cycle dynamics 
A combination of biochemical and proteomic approaches have been used over the 
last two decades to define the CDK consensus site and identify CDK substrates. 
The CDK consensus site was determined as S/T-P-X-K/R, with a minimal 
requirement for S/T-P (Songyang et al., 1994) and more recently a modest 
preference for an expanded motif has been proposed: P/C/X-X-S/T-P-X-K/R-K 
(Alexander et al., 2011). The strong bias for a +1 Proline is because Proline is 
incapable of forming an unfavourable hydrogen bond within the CDK active site, 
unlike all other amino acids (Brown et al., 1999). The preference for a basic residue 
at +3 is due a favourable ionic interaction between +3 K/R and phospho-
threonine160 (in Cdk2), which helps position the S/T within the active site (Brown 
et al., 1999) (Holmes and Solomon, 2001). The first systematic attempt to define 
mitotic phosphorylation in Xenopus egg lysates suggested that the majority of 
proteins, specifically phosphorylated in mitosis, are CDK substrates (Stukenberg et 
al., 1997). More recently, specific covalent tagging of CDK substrates in vitro, and 
subsequent capture of phosphorylated peptides, has been used to define 68 Cdk1 
substrates and 180 Cdk2 substrates in human cell lysates, many of which are also 
phosphorylated in vivo (Blethrow et al., 2008) (Chi et al., 2008). The two most 
extensive studies of CDK substrates have been undertaken in S. cerevisiae. 
Ubersax et al. (2003) identified 181 potential Cdc28 substrates, from a screen of 
11% of the S. cerevisiae proteome, for proteins directly phosphorylated by Cdc28 
in budding yeast cell lysates. More recently Holt et al. (2009) identified 547 CDK 
dependent phosphorylation events on 308 proteins, by combining in vivo chemical 
inhibition of Cdc28 with phosphoproteomics. Cdc28 substrate sites cluster in 
disordered regions of protein and are enriched at the consensus motif: S/T-P-X-K/R. 
Furthermore, a significant proportion (80/122) of substrates defined in vitro, that 
were detected as phosphorylated in vivo at the minimal CDK consensus site (S/T-
P), are phosphorylated in a Cdc28-dependent manner in vivo (Holt et al., 2009).  
 
Despite an increasing repertoire of bona fide and putative CDK substrates there 
has been no large-scale description of how CDK substrate phosphorylation 
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behaves during the cell cycle. Understanding how kinases, such as CDK, 
coordinate progression through the cell cycle requires more information than a 
simple list of substrates. Phosphorylation, in general, is very dynamic during the 
cell cycle. In the most extensive cell cycle phosphoproteomics study to date more 
than half of detected phosphorylation shows at least a twofold change between 
different cell cycle stages and the stoichiometry of phosphorylation approaches full 
site-occupancy at a significant proportion of phosphorylation sites during mitosis 
(Olsen et al., 2010). However, understanding if and how CDKs order these global 
phosphorylation changes in vivo is confounded by the presence of multiple Cyclin-
CDK complexes in vertebrate systems as well as the lack of a large-scale in vivo 
definition of bona fide CDK substrates, outside of budding yeast. 
 
In this chapter I describe, for the first time, the definition of hundreds of CDK 
substrates in S. pombe and the quantification of their phosphorylation dynamics 
during the mitotic cell cycle. SILAC was used to quantify protein levels and site 
resolved phosphorylation. A Shokat kinase allele (Cdc2F84G) that is rendered 
specifically sensitive to inhibition by bulky ATP analogs (e.g. 1-NmPP1) was used 
to control CDK activity in vivo (Coudreuse and Nurse, 2010) (Bishop et al., 2000, 
Dischinger et al., 2008). All experiments were performed in the simplified CDK 
network (cdc13-L-cdc2 ∆2 ∆13 ∆CCP), in which only a single Cyclin-CDK activity 
can direct phosphorylation and drive a physiologically normal cell cycle (Coudreuse 
and Nurse, 2010).  
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2.1 Using SILAC to analyse the phosphoproteome and 
proteome in S. pombe  
Stable isotope labelling by amino acids in cell culture (SILAC) is a well-established 
method for comparative quantification of the proteome and involves metabolically 
labelling cultures with stable lysine and arginine isotopes (de Godoy et al., 2008, 
Ong et al., 2002, Ong and Mann, 2005). Protein samples from differentially labelled 
cultures are combined, digested into peptides and analysed by tandem mass 
spectrometry (LC-MS/MS). A given peptide from cultures labelled with heavy or 
light (i.e. unlabelled) amino acid isotopes will give the same spectra, with the 
exception that the heavy labelled peptide has a conserved six Dalton shift in its 
mass-to-charge (m/z) ratio (Figure 2.01a). The ratio of the heavy versus light peak 
intensity is used to quantify, for any given peptide, the difference in abundance 
between the heavy and light labelled samples. To metabolically label fission yeast 
lysine and arginine synthesis was disrupted (arg1-230, lys3-37). In S. pombe 
arginine is readily converted to other amino acids especially proline, confounding 
SILAC analysis, but this can be prevented by disrupting Arginine catabolism 
(car2∆) (Bicho et al., 2010). As such all metabolic labelling of cultures was 
conducted in an arg1-230 lys3-37 car2∆ background. The linearity and dynamic 
range of this quantification was tested by constructing a dilution series between a 
heavy (H) and a light (L) protein extract and plotting the theoretical H:L ratio against 
the observed H:L. Figure 2.01b shows that the relationship between the observed 
and theoretical ratio is linear within an approximately eightfold range in either 
direction. Phospho-enrichment of peptides followed by LC-MS/MS allows large-
scale quantification of the phosphoproteome (Holt et al., 2009, Olsen et al., 2006, 
Olsen et al., 2010, Sharma et al., 2014). It is worth noting a few advantages of 
using a SILAC-phosphoproteomics platform to study phosphorylation: i) detection 
of site resolved phosphorylation events, ii) detection of thousands of 
phosphorylation events simultaneously in the same samples, and iii) quantitative 
measurement of the relative differences in phosphorylation level.  
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Figure 2.1 | SILAC provides linear quantitative measurements  
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Figure 2.01 | SILAC provides linear and 
quantitative measurements  
a Schematic of SILAC workflow to quantify 
relative site phosphorylation or protein levels. 
m/z = mass/charge.  
b Plot of theoretical versus observed mean 
protein H:L ratios of proteins (527) quantified 
in all 19 mixes of protein samples from 
labelled (heavy) and unlabelled (light) 
cultures. Theoretical H:L ratios span a >2500-
fold range. Error bars = standard deviation. 
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2.2 CDK-dependent phosphorylation 
To define CDK substrates throughout the cell cycle, a heavy labelled culture was 
released from a G2 arrest and CDK was inactivated in mitosis (i.e. 10 minutes after 
release from G2 arrest) or S-phase (i.e. 65 minutes after release from G2 arrest) by 
the addition of 10 µM 1-NmPP1 (Figure 2.02a). The timing of S-phase and mitosis 
were determined by FACS (Figure 2.02b&f-h) and binucleation index respectively 
(Figure 2.02c-e). Protein extracts were recovered between 0 and 24 minutes after 
CDK inactivation. Each heavy sample was mixed with a common unlabelled 
reference sample, which was collected in the same conditions as the sample 
recovered 0 minutes from CDK inactivation in mitosis (this time point is named M00 
minutes) (figure 2.02a). The unlabelled M00 min sample was used as a reference 
as it had the largest amount of detected phosphorylation and as such allows the 
detection of the most number of phosphorylation sites.  
 
2.2.1 Global dephosphorylation in response to CDK inactivation  
Both direct CDK substrates and downstream phosphorylation events dependent on 
CDK should eventually become dephosphorylated after CDK inactivation. Figure 
2.03a shows a cumulative frequency plot of the relative changes in all detected 
phosphorylation after CDK inactivation in mitosis and illustrates that global 
phosphorylation progressively decreases as the time after CDK inactivation 
increases. The smaller differences between 12 and 24 min suggest that most CDK 
dependent phosphorylation approaches a plateau by 24 minutes. A large cross-
section of the phosphoproteome is dependent on CDK activity: by 12 or 24 minutes 
a significant proportion of the phosphoproteome is at least twofold less 
phosphorylated (13.2% and 16.9% respectively) (Figure 2.03c&d), despite only a 
tiny fraction of the proteome having decreased similarly (1.25% and 0.78% 
respectively) (Figure 2.03e&f). This compares to 0.94% of the phosphoproteome 
and 0.53% of the proteome behaving similar, before CDK inactivation (M00 min). 
M00 min is a null distribution (i.e. heavy and light samples should be identical and  
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Figure 2.02 | CDK inactivation in mitosis and S-phase 
a Schematic of experimental design: a labelled (H) culture (MS230) was arrested in G2 and released into 
mitosis, when the culture was split into two. One was treated with 10 µM 1-NmPP1 in mitosis (10 min after 
release from G2 arrest) and the other was untreated and split (60 min after release from G2 arrest) again 
were derived cultures treated with 10 µM 1-NmPP1 in S-phase (65 min after release from G2 arrest) or left 
untreated. Protein samples were recovered at 0, 1, 3, 6, 9, 12 and 24 min after addition of 10 µM 1-
NmPP1. Protein samples from all 14 time points were mixed with a common unlabelled reference (L) 
(MS230, 10 min after release from a G2 arrest). 
b & f-h, DNA content profiles determined by FACS and quantification. Peak in > 2C DNA content 
corresponds to S-phase (65-80 min).  
c-e Chromosome and cell division quantified from DAPI and calcofluor stained cells. Treatment with 10 µM 
1-NmPP1 in mitosis results in aberrant mitotic divisions and cut cells.  
c-h Dashed lines correspond to 10 and 65 min after wash and release.  
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Figure 2.03 | CDK-dependent phosphorylation 
a Cumulative frequency plot of the H:L ratio of all phosphorylation sites detected (loc. prob. > 0.9) at each 
time point after CDK inactivation in mitosis. 
b 2D annotation enrichment, of gene ontology terms, comparing time points 12 min and 24 min after CDK 
inactivation in mitosis. Significantly depleted terms are shown. 
c-f Scatter plot of before (0 min) against after (12 min or 24 min) CDK inactivation in mitosis for c&d 
phosphorylation of all detected phosphosites (loc. prob. > 0.9) (c: n=3397,  d: n=3400) or e&f protein 
levels (e: n=3140,  f: n=3158).  
 
therefore theoretical H:L=1, Log2(H:L)=0) and as such provides a good 
approximation of the inherent technical noise in the data. The fact that less than 1% 
falls outside a two fold change from the expected value of H:L=1 means the vast 
majority of changes in phosphorylation observed must be due to changes in the 
site phosphorylation occupancy, not technical noise or an indirect artefact of 
changes in protein level. Such a large proportion of the phosphoproteome being 
dependent on CDK is consistent with previous work in budding yeast (Holt et al., 
2009). A 2D annotation enrichment analysis of gene ontology categories was used 
to analyse the entire detected phosphoproteome at 12 and 24 minutes after CDK 
inactivation. 2D annotation enrichment is a rank based statistical analysis that 
quantifies enrichment score: the more negative a categories enrichment score the 
greater the reduction in phosphorylation at sites annotated to a given category, in 
that sample (Cox and Mann, 2012). Figure 2.03b shows a strong quantitative 
relationship between the term enrichment scores for these two samples and 
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Figure 2.04 | Candidate substrate dephosphorylation during mitosis 
Western blot analysis of CDK substrate (Orc2, Sld3 and Dis2) phosphorylation in mitosis. 
A culture (MS212) was synchronised in mitosis and split. Each culture was treated (10 min after G2 
release) with either (i) DMSO or (ii) 10 µM 1-NmPP1 (as described in Figure2.02a, lower panel). Samples 
were taken between 0 and 15 min after 1-NmPP1 or DMSO addition. CDK substrates are phosphorylated 
in mitosis and start to become dephosphorylated between 10 and 15 min without 1-NmPP1 treatment.  
 
includes cell cycle related process. This indicates that the same classes of proteins 
continue to be dephosphorylated during the time course, after CDK inactivation. 
2.2.2 Site resolved CDK substrate phosphorylation  
Unlike previous studies, time-resolved dephosphorylation kinetics after kinase 
inactivation was quantified, and this was used to define CDK substrates (Figure 
2.05a). Briefly, sites that fitted an exponential decay, occurred at a minimal CDK 
consensus site (S/T-P) and decreased at least twofold by 12 minutes after CDK 
inactivation, were defined as CDK substrates (see Material & Methods for details). 
12 minutes after CDK inactivation was chosen because in the absence of 1-
NmPP1 treatment, DNA segregation initiates and candidate CDK substrates 
(previously identified in the literature) start to be dephosphorylated between 10-15 
min (Figure 2.02c & 2.04). Phosphorylation sites whose ratios deviated more than 
twofold from the expected H:L=1 at 0 minutes from CDK inactivation in mitosis 
(M00 min) were disregarded. The time point before CDK inactivation in S-phase 
(S00 min) is not a null distribution and so phosphorylation events that were only 
identified in the reference (unlabelled) and not the S-phase sample (S00 min, 
heavy) were disregarded. Using these combined criteria, 275 phosphorylation 
events were defined as CDK substrate sites.  
 
Numerous properties of these sites corroborate the conclusion that they are direct 
CDK substrates. Firstly, they are significantly enriched on proteins annotated to  
Dis2
Orc2-3pk
Sld3-5flag
Dis2-T316-P
Time after CDK inactivation (min) 0 .75 1.5 2.5 3.5 5 8 10 15
+DMSO
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Figure 2.05 | CDK substrates and their properties 
a Workflow used to to define CDK substrates (see Materials and methods section 7.4.1) 
b Consensus sequences surrounding phosphorylation events (phospho STY) (loc. prob. > 0.9) and CDK 
substrate sites.  
c Proportion of sites with predicted disordered secondary structure for STY (all potential phosphorylation 
sites n=437752), Phospho STY (all detected phosphorylation events, n=11407) and CDK substrate sites (n 
=275). Phospho STY and CDK substrates were compared to STY using a one tailed binomial test (p 
<0.0001) (see Materials and methods). 
d Cumulative frequency of protein copies per cell (Marguerat et al., 2012) for all proteins, Phospho STY 
(all detected phosphorylated proteins) and CDK substrates. CDK substrates are lower in abundance than 
all detected phosphorylated proteins (two-tailed student t-test, p = 0.0348) (see Materials and methods). 
 
a number of cell cycle related gene ontology terms and are enriched on orthologs 
of CDK substrates defined in S. cerevisiae (Table 2-1) (Sheet02) (Holt et al., 2009). 
Secondly, the majority of S. pombe CDK substrates reported in the literature to 
date are identified as CDK substrates here: Orc2, Sld3, Drc1, Cut3, Bir1, Nsk1, 
Alp7, Dis1, Klp9, Alp14, Ase1, Cdc25, Clp1 and Mde4. Thirdly, arginine and lysine 
are enriched at the +3 position, as has been described for CDK specificity in vitro 
and in vivo (Figure 2.05b) (Songyang et al., 1994, Alexander et al., 2011, Holt et al., 
2009). Furthermore, phosphorylation at other kinases’ substrate sites, that are 
expected to be downstream of CDK but not direct CDK substrates, are stable for a 
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Table 2-1 | CDK substrate enrichment analysis 
CDK substrates are enriched in gene ontologies groups involved in cell cycle processes. CDK substrate 
phosphorylation is enriched on orthologs of proteins defined as having CDK dependent phosphorylation in 
S. cerevisiae. E.g. the annotation category phosphoS/T-P <0.25 (Holt et al. 2009) contains all S/T-P sites 
on orthologs of proteins that contained at least one S/TP sites that decreased at least 4x upon CDK 
(Cdc28) inactivation in S. cerevisiae (Holt et al., 2009). 
 
period following CDK inactivation, suggesting downstream effects are unlikely to be 
miss-annotated as direct CDK substrates (see Chapter 5, Figure 5.04).  
 
It is occasionally assumed in the literature that CDK substrates are low abundant 
proteins (Blethrow et al., 2008). To actually test this the protein copy number per 
cell, quantified by Marguerat et al. (2012), of CDK substrates was compared to all 
proteins with detected phosphorylation. CDK substrates are indeed significantly 
less abundant than the total pool of phosphorylated proteins, as well as the entire S. 
pombe proteome (Figure 2.05d) (Marguerat et al., 2012). Additionally, consistent 
with previous studies, CDK substrate sites and all detected phosphorylated sites 
are enriched in disordered regions of proteins when compared to all Serine, 
Threonine and Tyrosine residues in the fission yeast proteome (Figure 2.05c) 
(Iakoucheva et al., 2004). 
 
In Figure 2.06 the dephosphorylation of individual sites is shown after CDK 
inactivation in mitosis (Figure 2.06a&b) and S-phase (Figure 2.06c&d). To assess 
the reproducibility of these measurements, phosphorylation half live values were 
also calculated from a repeat experiment (from a preliminary study) after CDK 
inactivation in mitosis. The repeat experiment only extended to 12 minutes after 
CDK inactivation, so both datasets have half lives calculated with values truncated  
Category value 
 
Total size 
(PhosphoSTY) 
Selection 
size 
Category 
size 
Intersection 
size 
Enrichment 
factor 
P value 
 
Benj. Hoch.  
FDR 
regulation of cell cycle 6300 275 782 63 1.8456 3.03E-07 1.35E-05 
chromosome organization 6300 275 586 48 1.8765 5.84E-06 0.00014468 
regulation of mitotic cell cycle 6300 275 596 52 1.9988 3.57E-07 1.33E-05 
cell division 6300 275 339 36 2.4328 2.97E-07 1.66E-05 
DNA metabolic process 6300 275 366 41 2.5663 9.43E-09 7.01E-07 
kinetochore 6300 275 84 10 2.7273 0.0024022 0.017616 
microtubule organizing center 6300 275 99 12 2.7769 0.00082962 0.014601 
chromosome segregation 6300 275 185 24 2.972 9.56E-07 2.67E-05 
nuclear pore 6300 275 99 13 3.0083 0.00024586 0.007212 
DNA packaging 6300 275 83 13 3.5882 4.19E-05 0.00093444 
chromosome 6300 275 31 6 4.434 0.0016181 0.012945 
origin recognition complex 6300 275 11 4 8.3306 0.00086211 0.010838 
condensin complex 6300 275 11 4 8.3306 0.00086211 0.012644 
Annotation 
 
Total size  
(S/T-P) 
Selection 
size 
Category 
size 
Intersection 
size 
Enrichment 
factor 
P value 
 
Benj. Hoch.  
FDR 
phosphoS/T-P <0.25 (Holt et al. 2009) 1950 275 137 51 2.6397 1.18E-12 1.18E-12 
phosphoS/T-P <0.5 (Holt et al. 2009)  1950 275 308 68 1.5655 1.09E-05 1.09E-05 
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Figure 2.06 | CDK substrate dephosphorylation after CDK inactivation 
a-d Examples of individual CDK substrate sites' relative phosphorylation (H:L) after CDK inactivation in 
a&b mitosis and c&d S-phase. Curves are a one phase exponential decay fit to the data.  
e Plot of the calculated half lives against the half lives calculated from a biological repeat (MS122). Each 
point corresponds to a unique phosphorylation site. Biological repeat only extended to 12 min so half lives 
were re-calculated for both experiments truncated at 12 min. Only sites that satisfy the criteria in Figure 
2.05a in both experiments and that had one phase decay fit R squared >0.95 are plotted (n=85). Linear 
regression line: Y = 1.069*X + 0.6062 (R squared = 0.682). 
 
at 12 minutes. There is a strong linear correlation between biological repeats 
supporting the notion that this SILAC phosphoproteomics workflow generates 
quantitatively reproducible data (Figure 2.06e). This is further supported by the fact 
that there is a clear correlation between the phosphorylation half live after CDK 
inactivation in mitosis and the phosphorylation half live after CDK inactivation in S-
phase, of the same site (see Chapter 3, Figure 3.13e). Figure 2.07a&b shows a  
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Figure 2.07 | CDK substrates and the CDK consensus site 
Heat map after hierarchical clustering of a CDK substrate site phosphorylation, b CDK substrate protein 
levels and c&d all CDK consensus site phosphorylation (S/T-P-X-K/R). Each row corresponds to a single 
phosphorylation site and each column corresponds to a different time point after CDK inhibition. Rows are 
ordered by hierarchical clustering according to Euclidian distance. Values outside the display range (3 > 
Log2(L:H) > -3) are set to the respective extreme. 
 
heat map of CDK substrate site phosphorylation and protein level quantification 
after CDK inactivation respectively and confirms that the disappearance of detected 
phosphorylation on CDK substrates is due to a change in phosphorylation site 
stoichiometry and not an indirect effect of protein level changes. Despite the 
existence of a strong CDK consensus sequence (S/T-P-X-K/R), less than half 
(42.5%) of CDK substrate sites in vivo occur at this full CDK consensus site. Holt et 
al. (2009) found that only 29% of sites that decreased twofold after CDK 
inactivation are full CDK consensus sites in S. cerevisiae. Furthermore, only 52.6% 
of S/T-P-X-K/R sites had changed at least twofold by 12 minutes, similar to the 
58.5% of S/T-P-X-K/R sites that decrease twofold after CDK inactivation in S. 
cerevisiae (Holt et al., 2009). Figure 2.07c shows the phosphorylation of all S/T-P-
X-K/R sites defined as CDK consensus sites, and Figure 2.07d shows all S/T-P-X-
K/R sites not defined as CDK substrates. Of the latter there is a significant 
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proportion that show no significant decrease in phosphorylation after CDK 
inactivation, and those that do were likely omitted as CDK substrates due to a lack 
of data points (before data imputation required for clustering) or anomalous decay 
kinetics. 
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2.3 Phosphorylation dynamics during the cell cycle 
Characterising how CDK organises the phosphorylation of different substrates in 
time is critical to understanding the way in which CDK organises sequential cell 
 
 
Figure 2.08 | Cell cycle synchronised culture 
a Schematic of experimental design: an unlabelled (L) culture (MS230) was released from a G2 arrest and 
protein samples were recovered at 20 time points over the first and second cell division cycle. Protein 
samples were mixed with a common heavy labeled (H) reference (MS230, synchronised in mitosis).  
b Chromosome and cell division quantified from DAPI and calcofluor stained cells. Corresponding cell 
cycle stages assigned are annotated above the graph. Peak in binucleation 20-25 min corresponds to G1 
and follows mitosis.  
c&d quantification and profiles of DNA content, determined by FACS, after release from G2 arrest. 
e Western blot analysis of Cdc13-L-Cdc2 levels after release from G2 arrest.  
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cycle transitions. To describe the behaviour of phosphorylation across the cell cycle 
the phosphoproteome was analysed over two sequential synchronised cell division 
cycles, after release from a G2 arrest (Figure 2.08a). Cell cycle progression was 
monitored by imaging chromosome division (i.e. binucleation), cell division (Figure 
2.08b) and measuring DNA content, by FACS (Figure 2.08d&c). Synchrony is high 
in the first cycle (>80%) but drops in the subsequent cycle (<50%). Western blot 
analysis shows high levels of Cdc13-L-Cdc2 protein in the G2 arrest (0 min) and 
first mitosis (8-16 min). Cdc13-L-Cdc2 is then degraded, coincident with 
chromosome division (16-20 min), and rises from G1 levels (20-30 min) through S-
phase (30-50 min) and G2 until the next mitosis (90-110 min), which precedes the 
second of round of chromosome division (Figure 2.08e). 
 
 
Figure 2.09 | CDK substrates have different phosphorylation dynamics during the cell cycle 
a-d Examples of the relative phosphorylation (L:H) (after smoothing, see material and methods) of CDK 
substrate sites after release from a G2 arrest. Corresponding cell cycle stages are annotated above the 
graph. Spline (smoothed line) connects points. 
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2.3.1 CDK substrates have different phosphorylation dynamics during the 
cell cycle 
The profiles of the relative phosphorylation, of example CDK substrate sites, are 
shown in Figure 2.09a-d. Substrates involved in mitotic functions (e.g. Cut3, Alp14 
& Ask1) dramatically increase in phosphorylation at mitosis, after release from the 
G2 arrest. Phosphorylation then decreases as cells exit mitosis and only rises 
again as cell re-enter mitosis (90-110 min) during the second less synchronous 
cycle. The peak in phosphorylation at the second mitosis is half the size of the first, 
which is proportional to the difference in binucleation synchrony between the two 
mitoses. In contrast, substrates involved in S-phase (e.g. Orc2, Rad2, and Drc1) 
are already phosphorylated in G2 and mitosis and are then dephosphorylated 
during mitotic exit and G1. As cells initiate S-phase they become re-phosphorylated 
and their phosphorylation is maintained or increases, after S-phase completion, 
into the subsequent G2 and mitosis.  
 
Figure 2.10a shows a heat map of all the CDK substrate sites detected in this 
experiment. Hierarchical clustering by Euclidian distance was used to identify three 
distinct and consistent behaviours across the time course. Firstly, the majority of 
sites fall into a single large cluster (black bar) and behave as, and include, mitotic 
proteins peaking specifically in mitosis (e.g. Cut3, Bir1, Plo1, Pic1, Dis1, Alp14 & 
Ask1). These 169 sites were defined as mitotic substrates. Two small clusters (light 
grey) show a major increase in phosphorylation at G1/S and include proteins 
known to be involved in DNA replication (e.g. Orc2, Orc1, Sld3 and Drc1) and, as 
such, were defined as S-phase phosphorylation sites (n=16). Finally, another 
cluster (dark grey) shows a small jump in phosphorylation at G1/S and a 
subsequent increase in phosphorylation at G2/M (e.g. Mis4, Rad2 and Mcm10). 
These substrate sites were defined as biphasic substrates (n=8). Besides these 
three behaviours there are a small number of sites that are broadly unchanged or 
that behave sporadically, likely due to technical noise, that were disregarded. The 
median relative phosphorylation of S-phase, biphasic and mitotic sites is plotted in 
Figure 2.10b, and Figure 2.10c shows the first derivative of the median relative 
phosphorylation with respect to time (i.e. the rate of change of phosphorylation). 
There is a sharp positive rate change in phosphorylation for mitotic substrate sites 
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Figure 2.10 | Global dynamics of CDK substrate phosphorylation during the cell cycle  
a Heat map of CDK substrate site phosphorylation and CDK substrate protein levels. Each row 
corresponds to a single phosphorylation site or protein and each column corresponds to a single time point 
after release from G2 arrest. Rows are ordered by hierarchical clustering according to Euclidian distance. 
Hierarchical clustering was applied after imputation to replace missing values (see method and materials). 
Values outside the display range (3 > Log2(L:H) > -3) are set to the respective extreme.  
b Median relative phosphorylation (L:H), and c the first derivative of median relative phosphorylation, of 
mitotic, biphasic and S-phase substrates after release from a G2 arrest. Corresponding cell cycle stages 
are annotated above the graph. Spline (smoothed line) connects points.  
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at G2/M, and for S-phase substrate sites at S-phase initiation. Biphasic substrates 
have a clear but smaller rate change at both transitions. In the second cycle 
biphasic substrate sites peak just before mitotic substrates, in late G2 after DNA 
replication is completed. All three classes show a significant negative rate change 
in phosphorylation during mitotic exit, i.e. rapid dephosphorylation. It is worth noting 
that the breadth of distribution of phosphorylation level around the second mitotic 
peak (~100 min) is not the same for all mitotic substrates, indicating that some 
substrates are phosphorylated earlier in the progression from G2 to mitosis than 
others (figure 2.10a). This will be discussed further in Chapter 3.  
 
2.3.2 Changes in candidate substrate phosphorylation recapitulate global 
CDK phosphorylation dynamics  
Four CDK substrates involved in S-phase functions (Sld3 and Orc2) or mitotic 
functions (Dis2 and Bir1), described in the literature, were also analysed by 
Western blotting to corroborate the phosphoproteomics data. Sld3, Orc2 and Bir1 
phosphorylation was assayed by reduced band mobility on Phos-tag supplemented 
gels. Dis2 phosphorylation was detected using a site-specific anti-T316-P antibody. 
To monitor phosphorylation dynamics during the cell cycle, a culture was 
synchronised at G2/M (Figure 2.08a) and DNA content, nuclear division and cell 
division were monitored (Figure 2.11a&b). CDK substrate phosphorylation was 
assayed over the subsequent mitosis, G1, S-phase and G2 (Figure 2.11c). Total 
Cdc13-L-Cdc2 protein levels drop significantly at mitotic exit, followed by a gradual 
re-synthesis as cell progress from G1, through S-phase, to G2. Both Orc2 and Sld3 
are highly phosphorylated in G2 and mitosis, become dephosphorylated in G1 and 
then re-phosphorylated as cells enter S-phase and their phosphorylation is 
maintained after the completion of S-phase. Dis2-T316 and Bir1 are specifically 
phosphorylated at mitotic entry and then dephosphorylated as cells progress out of 
mitosis. Net phosphorylation of Bir1 does fully not decrease until after mitotic exit, 
possibly due to Bir1 phosphorylation by other kinases. Consists with this possibility, 
site resolved Bir1 phosphorylation at CDK sites (S244, S278) does show a sharp 
and full dephosphorylation at mitotic exit. To confirm these mobility shifts (Orc2, 
Sld3 & Bir1) or antibody signal (Dis2-T316-P) are dependent on both 
Chapter 2 - Results 
 
68 
 
phosphorylation and CDK activity, three conditions with different CDK activity levels 
(high, intermediate & low) were tested and protein extracts were dephosphorylated 
with lambda phosphatase (Figure 2.11d). These behaviours are consistent with the 
phosphorylation dynamics observed for more than a hundred CDK substrates using 
phosphoproteomics and the conclusion that different CDK substrates are first 
phosphorylated at different times during the cell cycle. A limitation of 
phosphoproteomics is it is difficult to calculate stoichiometry of phosphorylation 
events. However, for the three candidate substrates where phosphorylation has 
been assayed by mobility band shifts (Orc2, Sld3 & Bir1) the vast majority of the 
protein undergoes a change in net phosphorylation at the respective cell cycle 
transitions.  
 
Figure 2.11 | Candidate CDK substrate phosphorylation dynamics during the cell cycle 
Cells (MS132) were synchronised, as in Figure 2.08a. 
a Quantification of DAPI and calcofluor stained cells after release from G2 arrest. 
b Quantification of DNA content, determined by FACS. 
c Western blot of Cdc13-L-Cdc2, α tubulin and four CDK substrates: Orc2, Sld3, Bir1 and Dis2 after 
release from a G2 arrest. Phosphorylation is monitored by mobility shift for Orc2, Sld3 and Bir1. Dis2 
phosphorylation is detected directly with anit-T316-P. Asterisk (*) marks non-specific bands.  
d Dis2-T316-P signal and band shifts are CDK and phosphorylation dependent. Low CDK activity = 20min 
10 µM 1-NmPP1 treatment (MS132), intermediate CDK activity = G2 arrest (1 generation in 1 µM NmPP1) 
(MS132) and high CDK activity = mitosis (10 min after release from G2 arrest) (MS132). Each sample was 
treated with: (i) mock, (ii) lambda phosphates + phosphatase inhibitors or (iii) lambda phosphatase. 
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2.4 Discussion 
The main conclusions of this chapter are as follows. Firstly, hundreds of CDK 
substrate sites have been defined in S. pombe for the first time. Secondly the cell 
cycle dynamics of the proteome and phosphoproteome have been analysed and 
indicate that different CDK substrates have dramatically different behaviours in the 
dynamics of their phosphorylation during the cell cycle. S-phase substrates, first 
phosphorylated at G1/S are not dephosphorylated after S-phase but their 
phosphorylation is sustained across the rest of the cycle until cyclin degradation at 
mitotic exit. Mitotic substrates do not show an increase in phosphorylation at G1/S 
but instead show a dramatic increase at G2/M. The behaviour of S-phase and 
mitotic substrates starts to explain how a single CDK temporally separates the 
initiation of S-phase and mitosis: substrates required at S-phase are first 
phosphorylated earlier in the cell cycle than mitotic substrates and everything is 
reset as the cell cycle is completed. This progresses the question from how a 
single CDK orders cell cycle events to how does a single CDK temporally order the 
initial increase in phosphorylation of different classes of CDK substrates? How 
CDK activity contributes to this differential behaviour is the topic of chapter 3. 
Finally, there is a third class of substrates whose phosphorylation changes at both 
the G1/S and G2/M transitions (biphasic substrates). The significance of these 
phosphorylation events is not clear but may have a role in the completion of S-
phase or the preparation of replicated chromosomes for mitosis, given that they 
peak before mitotic substrates at G2/M.  
 
The majority of previously described fission yeast CDK substrates have been 
identified here, often with multiple phosphorylation events detected per protein. 
Proteins described as important for the execution of S-phase and mitosis are 
phosphorylated at the respective cell cycle stages. The identification of multiple 
conserved and essential CDK substrates, for example the critical DNA initiation 
proteins Sld3 and Drc1 (Sld2 ortholog), supports the classification of other 
identified sites as bona fide CDK substrates. Furthermore, a number of novel CDK 
substrates in S. pombe are orthologs of CDK substrates described in other systems. 
For example, phosphorylation of multiple ORC proteins has been reported in 
budding yeast and higher eukaryotes and here we identify phosphorylation events 
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on Orc1 (S320, T292) that increase at S-phase initiation, in addition to 
phosphorylation in the previously described substrate Orc2. Numerous orthologs of 
budding yeast Cdc28 substrates are also novel fission yeast Cdc2 substrates as 
discussed further in Chapter 6. These examples and the fact the CDK substrates 
described here are enriched in orthologs of Cdc28 dependent phosphorylation 
described by Holt et al. (2009), suggest that numerous regulatory outputs of CDK 
have been conserved over, at least, the 330–420 million of years of evolution 
between budding and fission yeast (Sipiczki, 2000). Possible functions of as yet 
uncharacterised CDK regulation on certain substrates will be explored in the 
general discussion. Less than 10% of CDK substrates with consistent dynamics 
over the cell cycle are S-phase substrates, suggesting the CDK regulation of S-
phase is significantly simpler than that for mitosis, consistent with the fact that the 
initiation of eukaryotic DNA replication, and the inhibition of licensing by CDK, can 
be fully reconstituted in vitro (Yeeles et al., 2015). It also hints that when 
considering the differences between mitotic and S-phase substrates, that S-phase 
substrates can be considered the exception to the rule and that determinants to 
increase S-phase substrate phosphorylation earlier in the cycle may have been 
easier to evolve than a mechanism to decrease the phosphorylation of ten-times 
more mitotic substrates.  
 
Not all CDK substrate sites in vivo reside at the optimal consensus sequence (S/T-
P-X-K/R). Both in fission yeast and budding yeast the majority of defined substrates 
are phosphorylated at only the minimal consensus site (S/T-P). Ubersax et al. 
(2003) also failed to detect any CDK phosphorylation on 123 proteins that 
contained S/T-P-X-K/R sites. This could of course be because these sites are not 
appropriately exposed for phosphorylation. However, Figure 2.07 shows examples 
of S/T-P-X-K/R site that are phosphorylated in vivo but are not dependent on CDK 
activity. Its possible that CDK is capable of phosphorylating these sites but other 
kinases may phosphorylate these sites with such high stoichiometry that CDK has 
no net contribution to phosphorylation. Alternatively, CDK may be unable to 
phosphorylate these sites because some other constraints or requirements are 
imposed on the CDK-substrate interaction.  
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CDK substrates are lower abundance than the average phospho-protein, 
consistent with the view that regulatory proteins tend to be lower abundance. The 
“futility” of phosphorylation-dephosphorylation cycles between a kinase and 
phosphatase has been discussed in terms of energy (ATP) wastage (Mochida and 
Hunt, 2012). At first sight the energy wastage of futile cycles on CDK substrates 
might seem significant given the large number CDK substrates and the rapid 
dephosphorylation rates they are subjected to (median half life = 2.21 min). 
However, this fails to consider the absolute abundance of phosphorylation sites 
that CDK regulates. Ultradeep phosphoproteomics analysis, which mapped 
>50,000 phosphorylation events in human cell lines, concluded that 
phosphorylation adheres to a Paerto-like principle, where 80% of total 
phosphorylation occurs at 11% of unique phosphosites (Sharma et al., 2014). This 
means the vast majority of unique phosphorylation sites (89%) in humans account 
for only a small fraction of cellular ATP used on protein phosphorylation reactions 
(20%). The CDK substrates defined here are low abundant proteins and as such 
the phosphorylation-dephosphorylation cycle can probably be considered minimal 
in terms of energy expenditure within a cell.  
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Chapter 3. Differential sensitivity to CDK activity 
orders substrate phosphorylation to temporally 
organise cell cycle events 
The data presented in Chapter 2 demonstrates there are hundreds sites 
phosphorylated by CDK that, despite being phosphorylated by the same kinase, 
have different phosphorylation dynamics during the cell cycle. CDK activity rises 
during the cell cycle and is higher in mitosis than in S-phase, in both S. pombe 
(Moreno et al., 1989) and higher eukaryotes (Arion et al., 1988, Draetta and Beach, 
1988, Labbe et al., 1988b). The observation that a single Cyclin-CDK complex is 
capable of ordering S-phase and mitosis in S. pombe lead to the proposal of the 
quantitative model for cell cycle progression; where S-phase is initiated at a low 
CDK activity threshold and high CDK activity is required to initiate mitotic entry 
(Stern and Nurse, 1996). This model has gained strong support from recent work, 
discussed at length in the Introduction (Coudreuse and Nurse, 2010). If S-phase 
substrates are more sensitive to CDK activity than mitotic substrates, rising CDK 
activity during the cycle could then order substrate phosphorylation to organise cell 
cycle events. In this chapter I will describe the quantification of in vivo substrate 
sensitivity to CDK activity and experiments to test if changes in activity-dependent 
substrate phosphorylation are sufficient to explain the ordering of cell cycle events. 
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3.1 CDK substrates phosphorylation sensitivity to CDK activity 
in vivo 
To quantify the relative sensitivity of substrates to CDK activity, CDK activity was 
titrated in vivo and the phosphoproteome was assayed to monitor CDK substrate 
phosphorylation. A range of titres of CDK activity were achieved by arresting cells, 
to accumulate Cdc13-L-Cdc2, eliminating all CDK activity with 10 µM 1-NmPP1 (30 
min) and then washing and releasing cells into a range of 1-NmPP1 concentrations 
() (Figure 3.01a). The phosphoproteome was analysed at a fixed time after release 
(10min) to assess CDK substrate phosphorylation across a range of CDK activities. 
CDK activation is highly non-linear due to positive and double negative feedback 
loops (Solomon et al., 1990, Pomerening et al., 2005). Bypassing the auto-
regulatory feedback loops that act on the inhibitory T14/Y15 phosphorylation on 
CDK can linearise the CDK activation profile (Pomerening et al., 2005). As such, 
mutations in the Cdc2 moiety (T14A Y15F, referred to as AF, (Coudreuse and 
Nurse, 2010)) that bypass this feedback were used to ensure a more linear output 
of CDK activity in response to 1-NmPP1 concentrations. Protein samples were also 
extracted from cells with a wild type Cdc2 moiety at the extremes of the titration  
 
 
Figure 3.01 | Titration of in vivo CDK activity  
a Schematic of experimental design: cultures were arrested for 4.5 h (3 h (1 µM 1-NmPP1) + 1.5 h (2 µM 
1-NmPP1)) and then CDK activity was eliminated by the addition of 10 µM 1-NmPP1. Cultures were then 
washed & released into media containing 2% DMSO or 1-NmPP1 (5 nM, 15 nM, 50 nM, 150 nM, 300 nM, 
1 µM, 2.5 µM, 5 µM, 7.5 µM, 10 µM, 20 µM). Protein samples were taken 10 min after the wash was 
started and were mixed with a common heavy labelled (H) reference (MS230, synchronised in mitosis). An 
AF strain (MS86: cdc13-L-cdc2AF ∆2 ∆13 ∆CCP (T14A, Y15F mutations in cdc2 moiety)) was used to 
bypass positive feedback on CDK activity. Samples were also recovered from a rad3∆ (MS87: cdc13-L-
cdc2 rad3∆ ∆2 ∆13 ∆CCP) in DMSO and 20 µM 1-NmPP1.  
b Cumulative frequency of CDK substrate phosphorylation (L:H) in rad3∆ and AF after release into DMSO 
or 20 µM 1-NmPP1. AF (DMSO): n=236, AF (20 µM 1-NmPP1): n=218, rad3∆ (DMSO): n=242, rad3∆ (20 
µM 1-NmPP1): n=220. 
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series (DMSO and 20 µM 1-NmPP1). To ensure that activation of the DNA 
damage/replication checkpoint did not feed into CDK activity, a rad3∆ was 
introduced into this background. This was not necessary in the AF background, as 
checkpoint dependent inactivation of Cdc2 works through T14Y15 phosphorylation 
(Rhind and Russell, 1998, Coudreuse and Nurse, 2010). Figure 3.01b shows the 
cumulative frequency of the relative phosphorylation for all CDK substrates in 
DMSO or 20 µM 1-NmPP1 for the rad3∆ or AF strains. The vast majority of CDK 
substrates are dephosphorylated in 20 µM 1-NmPP1 in both backgrounds and 
there is a massive global increase in CDK substrate phosphorylation between 20 
µM 1-NmPP1 and DMSO for both strains, despite the fact that the AF strain does 
not achieve the maximal phosphorylation of all substrates in DMSO that is 
observed in rad3∆. 
 
3.1.1 S-phase substrates are more sensitive to CDK activity than mitotic 
substrates  
Figure 3.02a-d shows examples of the relative phosphorylation for CDK substrates. 
Substrates involved in S-phase (e.g. Drc1, Orc1 & Rad2) are dephosphorylated up 
to 7.5 µM 1-NmPP1 and become phosphorylated between 1-5 µM 1-NmPP1. In 
contrast CDK substrates involved in mitotic functions (e.g. Cut2, Dis1, Alp14 & 
Ask1) are not phosphorylated below 1 µM 1-NmPP1 and become maximally 
phosphorylated between 15 nM and 50 nM 1-NmPP1. The dose response to 1-
NmPP1 of most CDK sites can be fitted to a four parameter sigmoid function, which 
was used to calculate an IC50 value (nM) of phosphorylation to 1-NmPP1 for more 
than a hundred CDK substrate sites. The median IC50 values are 215nM, 1726 nM 
and 3658 nM for mitotic, biphasic and S-phase substrates respectively. Figure 
3.02e shows the cumulative frequency of IC50 values for each category of 
substrates. Figure 3.02f shows the cumulative frequency of the sigmoidal curve Hill 
slope values for each category. The Hill slope is a measure of how abrupt or steep 
the rise in phosphorylation is between maximal and minimal phosphorylation. The 
median hill slopes are -1.4, -1.3 and -3.6 for mitotic, biphasic and S-phase 
substrates respectively. In conclusion, mitotic CDK substrate phosphorylation is  
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Figure 3.02 | Mitotic and S-phase CDK substrates have different sensitivities to CDK activity 
a-d Examples of individual CDK substrate sites' relative phosphorylation (L:H) over a range of 1-NmPP1 
concentrations. Relative phosphorylation was normalised so phosphorylation in DMSO = 1. Curves are a 
sigmoidal fit to the data.  
e Cumulative frequency of the IC50 to 1-NmPP1 of mitotic, biphasic and S-phase CDK substrates.  
f Cumulative frequency of the hill coefficient of mitotic, biphasic and S-phase CDK substrates. 
 
more sensitive to 1-NmPP1 inhibition and conversely less sensitive to CDK activity 
than biphasic substrates, which are in turn more sensitive to CDK activity than S-
phase substrates. S-phase substrate phosphorylation is also more ultrasensitive to 
CDK as the rise in S-phase phosphorylation is more step-like and less gradual than 
that of mitotic or biphasic substrates (i.e. more negative Hill slope).  
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As well the significant differences between S-phase, biphasic and mitotic CDK 
substrates, there are also small differences between the phosphorylation sensitivity 
of different mitotic substrates. Figure 3.03a shows examples of sites on three 
different mitotic substrates: Plo1, Pic1 and Bir1. Bir1 phosphorylation is more 
sensitive to CDK activity than Pic1 and Plo1, with Plo1 the least sensitive of the 
three. Sites within the same protein appear to behave more similarly to each other 
than sites between different proteins. To test if this is a global trend the IC50 was 
calculated for 48 CDK sites that reside on substrates with more than one mitotic 
CDK substrate site (n=19). The absolute difference between the IC50 of two sites 
(∆IC50) was calculated for every pair of mitotic CDK sites in the same protein 
(intra-protein comparisons) and between all possible pairs of the 48 sites 
irrespective of which protein they resided in (all comparisons). Figure 3.03c is a 
cumulative frequency plot of these two ∆IC50 populations and shows that the 
differences between sites in the same protein are smaller than all differences 
between all sites, illustrating that sites on the same protein tend to behave similarly 
to each other.  
 
3.1.2 Substrate sensitivity correlates with the timing of phosphorylation at 
the G2/M transition  
As noted in Chapter 2 (section 2.3.1) the timing of phosphorylation during the G2/M 
transition is not identical for all mitotic substrates (Figure 2.10a). Figure 3.03b 
shows Bir1 is phosphorylated a little earlier during G2/M than Pic1, which in turn is 
phosphorylated before Plo1. To test if these small differences in the sensitivity to 
CDK are relevant to the dynamics of phosphorylation during a physiological cell 
cycle, the extent/timing of mitotic substrate phosphorylation was quantified during 
the G2/M transition. This was done by taking the integral (Area Under Curve 
(AUC)) of phosphorylation between 50 and 100 minutes after release from G2 
arrest. The second mitotic division (50-100 minutes) was used, as the dynamics of 
CDK activity accumulation are likely to be more physiological than immediately 
after release from a G2 arrest. Sites that are phosphorylated early in the G2/M 
transition will be phosphorylated for a longer proportion of the time course and as a 
consequence will also have a higher peak in quantified relative phosphorylation. 
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Figure 3.03 | Differences between mitotic phosphorylation sensitivity are smaller between sites in 
the same protein and correlate with their timing of phosphorylation at G2/M   
a Examples of individual CDK substrate sites' relative phosphorylation (L:H) over a range of 1-NmPP1 
concentrations (only sigmoidal fit plotted for presentation).  
b Examples of individual CDK substrate sites' relative phosphorylation (L:H) during G2/M: 50-100 min after 
release from a G2 arrest (only Spline (smoothed line) plotted for presentation) (missing values imputed). 
c Cumulative frequency plot of the ∆IC50 between all sites in multi-phosphorylated mitotic substrates (all 
comparisons) and between sites in the same mitotic substrate (intra-protein comparisons). 
d-e Plot of the CDK substrate site sensitivity to CDK activity (i.e. 1-NmPP1 IC50) against the extent/timing 
of phosphorylation during G2/M (i.e. AUC (50-100 min), calculated from imputed and smoothed data) for d 
all quantified sites (i.e. R squared > 0.9), e all mitotic sites (two data points outside the axis).  
 f Plot of the example mitotic CDK substrate site sensitivity to CDK activity (i.e. 1-NmPP1 IC50) against the 
(i.e. AUC (50-100 min), calculated from imputed data).  
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This is because a larger proportion of cells, in an imperfectly synchronised culture 
(<50% synchrony), will be in a stage of the G2/M transition where such a site is 
phosphorylated. The AUC of sites correlates with the sensitivity of a site to CDK 
activity (1-NmPP1 IC50), therefore sites that are less sensitive to CDK activity are 
phosphorylated later during G2/M. This relationship holds true within mitotic 
substrates (Figure3.03e). Examples of mitotic substrates involved in different 
mitotic processes/functions are labelled in Figure 3.03f. These data are consistent 
with a model in which, as CDK activity rises during the G2/M transition, substrates 
are phosphorylated in an ordered manner according to their sensitivity to CDK 
activity.  
 
In some multi-phosphorylated proteins there are significant differences between the 
IC50s of different sites, in contrast to the global tendency for site in the same 
protein to behave similarly. For example Cut3 has numerous CDK substrate sites in 
its N-terminus, of which Cut3-T19 phosphorylation has previously been shown to 
be essential for Cut3 nuclear import during mitosis (Sutani et al., 1999). 
Comparison of three of these sites (T19, S36 & T86) shows that they span a range 
of sensitivities to CDK activity, which correlates with the timing/extent of 
phosphorylation (AUC) during the G2/M transition (Figure 3.04a-c). The fact that 
these differences in sensitivity are recapitulated in a physiological cell cycle 
transition suggests they may be of biological significance in determining the timing 
of condensin related mitotic events. 
 
Figure 3.04 | Stepwise phosphorylation in the N-terminus of Cut3 
a Cut3 phosphosites’ relative phosphorylation (L:H) over a range of 1-NmPP1 concentrations (only 
sigmoidal fit plotted for presentation) (as in Figure 3.02).  
b Cut3 phosphosites’ relative phosphorylation (L:H) during the G2/M transition: 50-100 min after release 
from a G2 arrest (only Spline (smoothed line) plotted for presentation) (as in Figure 2.09)). 
c Plot of Cut3 phosphosites’ sensitivity to CDK activity (i.e. 1-NmPP1 IC50) against the extent/timing of 
phosphorylation during G2/M (i.e. AUC (50-100 min), calculated from imputed data). 
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3.2 Testing the causal relationship between CDK substrate 
phosphorylation and the organisation of cell cycle events 
The observation that S-phase substrates are phosphorylated at lower CDK 
activities than mitotic substrates strongly suggests that the quantitative model for 
cell cycle progression works though differential sensitivity of substrate 
phosphorylation to CDK activity, but does not formally demonstrate it. Manipulating 
CDK activity to alter CDK substrate phosphorylation should allow the 
reorganisation of the cell cycle, if it is true that cell cycle events are ordered by 
differential substrate phosphorylation. There are two main predictions of a 
substrate phosphorylation threshold quantitative model for cell cycle progression: 
 
(i) Premature high CDK activity in G1 cells should result in mitotic and S-
phase substrate phosphorylation and initiate S-phase and mitosis 
simultaneously.  
 
(ii) Removal of CDK activity should result in the dephosphorylation of S-
phase substrates in G2 and re-phosphorylation of exclusively S-phase 
substrates at low CDK activity should initiate a second single round of 
DNA replication in the absence of mitosis.  
 
It has been shown that modulating CDK activity can reorganise cell cycle events 
(Coudreuse and Nurse, 2010). To test how CDK substrate phosphorylation 
behaves in these reordered cycles, phosphorylation was quantified during six 
different cell cycle paths (reordered cycle A-C, released into (i) high or (ii) low CDK 
activity). A schematic of the experimental design for each of these reordered cycles 
is shown in Figure 3.05a. Reordered cycle A starts in a G2 arrest, cells are then 
treated with to 10 µM 1-NmPP1 (90 min) to remove CDK activity, after which cells 
are then release into high CDK activity (DMSO) or low CDK activity (1 µM 1-
NmPP1). Reordered cycle B is the same as A, except cells are not treated with the 
10 µM 1-NmPP1 and instead are maintained in a 1 µM 1-NmPP1 arrest. Finally 
reordered cycle C involves arresting cells in G1 for 150 minutes, by adding 10 µM 
1-NmPP1 at anaphase after which cells are release into high CDK activity (DMSO) 
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Figure 3.05 | Reordering of cell cycle events  
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Figure 3.05 | Reordering of cell cycle events (continued) 
a Schematic of experimental design: unlabelled cultures (L) were reset in G1 (reordered cycle A (MS230)), 
arrested in G2 (reordered cycle B (MS230)) or arrested in G1 (reordered cycle C (MS108)). Cultures were 
then washed and released into DMSO or 1 µM 1-NmPP1 to direct cell cycle fate via six routes. Protein 
samples were recovered during the arrests/reset and 10 and 15 min after release. Protein samples were 
mixed with a common heavy labelled (H) reference (MS230, synchronised in mitosis). MS108 was used in 
reordered cycle C because of low synchrony in the release from G1 arrest in MS230. 
Cell cycle fates are monitored in b-g. 
b-d Chromosome and cell division quantified from DAPI and calcofluor stained cells during reordered cycle 
A-C (images of cells in Figure 3.06).  
e-g DNA content, determined by FACS, during reordered cycle A-C.  
 
______________________________________________________________________________________________________________________________  
 
 
 
 
 
Figure 3.06 | Nuclear and cell division during reordered cell cycles 
a-c DAPI (DNA) and calcofluor (cell septum) stained cells after wash & release (into 1 µM 1-NmPP1 or 
DMSO) for reordered cell cycle A-C. Time and wash & release conditions are labelled on each image. 
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or low CDK activity (1 µM 1-NmPP1). DNA content, chromosome division and cell 
division were monitored throughout (Figure 3.05b-g) (representative images of 
DAPI and calcofluor stained cells are shown in Figure 3.06). Protein extracts were 
taken during the reordered cycles (before and after release) and compared to a 
reference sample from cells synchronised in mitosis (Figure 3.05a).  
 
3.2.1 Global CDK-mediated phosphorylation during reordered cell cycles 
Figure 3.07 shows the median relative phosphorylation of S-phase and mitotic CDK 
substrates during these reordered cycles. In cells arrested in G1 (10 µM 1-NmPP1) 
S-phase and mitotic substrates are dephosphorylated (Figure 3.07c). Upon release 
into low CDK activity (1 µM 1-NmPP1) only S-phase substrates become fully 
phosphorylated and this initiates a single round of replication (Figure 3.05g, left 
panel (reordered cycle C)). When CDK activity is removed from G2 cells (10 µM of 
1-NmPP1), S-phase substrates become dephosphorylated (G1-reset) and if low 
levels of CDK activity are restored (i.e. released into 1 µM 1-NmPP1) S-phase 
substrates become re-phosphorylated but mitotic substrates do not (Figure 3.07a, 
(reordered cycle A)). As S-phase substrates are re-phosphorylated, a single round 
of DNA replication is initiated and the G2 DNA content is re-replicated (Figure 
3.05e). In contrast, when S-phase substrate phosphorylation is maintained at a 
high level throughout the experiment (Figure 3.07b) cells do not re-replicate 
(Figure3.05e, left panel (reordered cycle B)). This demonstrates that S-phase 
substrate phosphorylation controls the initiation of S-phase as long as cells have 
experienced a preceding G1-like state (G1-arrest or G1-rest) of low CDK activity to 
dephosphorylate S-phase substrates. This is consistent with an extensive body of 
work concerning the mechanisms of origin firing and licensing as discussed in the 
Introduction. If cells in a G1-like state (G1-arrest or G1-reset) are release into high 
CDK activity (DMSO), instead of low CDK activity (1 µM 1-NmPP1), S-phase 
substrates are still re-phosphorylated (Figure 3.07d&f (reordered cycle A&C)) and 
cells still undergo a round of DNA replication (Figure 3.05e&g right hand panel). 
This demonstrates that it is not only at a specific level of CDK activity at which S-
phase is initiated, it is simply the net phosphorylation of S-phase substrates, at or 
above a specific CDK activity threshold. 
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Figure 3.07 | Modulating CDK activity can direct differential mitotic/S-phase phosphorylation to 
reorder the cell cycle I 
a-f Median phosphorylation (L:H) of mitotic and S-phase substrates during reordered cell cycle A-C. 
Corresponding cell cycle state (as defined in Figure 3.06) and 1-NmPP1 concentrations are annotated 
above the graph.  
 
Cells re-set in a G1-like state released into high CDK activity (DMSO) also results 
in high mitotic substrate phosphorylation (Figure 3.07d), which drives cells into a 
mitotic-like state. Because cells are also undergoing a round of re-replication the 
overlap in S-phase and mitosis causes the majority of cells to present with aberrant 
mitotic phenotypes including mis-segregated chromosomes, stretched 
unsegregated chromosomes and mitotic catastrophe (i.e. cut) (Figure 3.05b) 
(Coudreuse and Nurse, 2010). If G2 cells that are not reset in G1 with 10 µM 1-
NmPP1, and as such cannot re-replicate, are released into high CDK activity 
(DMSO) mitotic substrates become phosphorylated (Figure 3.07f) and normal 
chromosome segregation is initiated (Figure 3.05c upper panel). In contrast, when 
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Figure 3.08 | Modulating CDK activity can direct differential mitotic/S-phase phosphorylation to 
reorder the cell cycle II  
a-f Examples of individual CDK substrate sites' relative phosphorylation (L:H) during reordered cell cycles 
A-C. Corresponding cell cycle fates are annotated above the graph. Two left hand columns are examples 
of protein with mitotic functions. Two right hand columns are examples of proteins with S-phase functions.  
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mitotic substrates are not fully phosphorylated (Figure 3.07a&b), due to low CDK 
activity, cells do not enter mitosis (Figure 3.05b&c lower panel). Cells arrested in 
G1 (10 µM 1-NmPP1) that are released into high CDK activity (DMSO) also 
simultaneously fully phosphorylate S-phase and mitotic substrates (Figure 3.07f) 
resulting in the concurrence of S-phase and mitosis (figure 3.05d upper panel). The 
behaviours of S-phase and mitotic substrates are recapitulated at the level of 
individual substrates as can be seen by example of mitotic (Cut3, Ask1, Alp14 & 
Dis1) and S-phase related substrates (Orc1, Cdc10, Rad2 & Drc1) during these six 
conditions (figure 3.08).  
.  
3.2.2 Candidate substrate phosphorylation during reordered cell cycles 
These six re-ordered cycles were repeated using a strain harbouring tagged 
candidate substrates (Orc2 and Sid3) and candidate CDK substrate (Sld3, Orc2, 
Dis2 and Bir1) phosphorylation was assayed by Western blotting. The experimental 
outline is as in figure 3.05a. Chromosome division, cell division and DNA content 
are shown in figure 3.09, whilst figure 3.10 shows Orc2, Sld3, Bir1 and Dis2 
phosphorylation as well as Cdc13-L-Cdc2 levels. When G2 cells are reset in G1 
(10 µM 1-NmPP1) Orc2 and Sld3 are dephosphorylated and then re-
phosphorylated as cells are released into 1 µM 1-NmPP1 (Figure 3.10a, left panel) 
resulting in cells undergoing DNA replication. When Sld3 and Orc2 phosphorylation 
is maintained high throughout the experiment (i.e. no G1-reset) re-replication does 
not occur. Bir1 and Dis2 are not maximally phosphorylated and cells do not enter 
mitosis in these conditions and Cdc13-L-Cdc2 continuously accumulates. When 
G1-arrested cells are released into 1 µM 1-NmPP1 only Sld3 and Orc2 are 
maximally phosphorylated and cells initiate S-phase (Figure 3.10c). When G1-
arrested or G1-reset cells are released into high CDK activity (DMSO), Bir1, Dis2 
Orc2 and Sld3 all become highly phosphorylated and S-phase and mitosis occur 
simultaneously (Figure 3.10c&b). After Bir1 and Dis2 phosphorylation Cdc13-L-
Cdc2 levels drop precipitously indicating that the APC/C is activated. As Cdc13-L-
Cdc2 is degraded all CDK substrates are dephosphorylated (Figure 3.10b, right 
panel) as in a normal mitotic exit (Figure 3.10a, right panel). 
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Figure 3.09 | Reordering of cell cycles events with epitope tagged substrates 
Experimental design as in Figure 3.05a. Reordered cycle A&B were performed in YE4S (MS212) due to 
orc2-3pk dependent retardation of re-replication in EMM4S. Reordered cycle C was performed in EMM4S 
(MS132). 
a-c DAPI and calcofluor stained cells quantification after release for reordered cycle A-C (images not 
shown). 
d-f DNA content determined by FACS during reordered cycle A-C. 
 
Interestingly Cdc13-L-Cdc2 levels are still able to start to rise after degradation 
resulting in rephosphorylation of Sld3 and Orc2 after the aberrant mitosis (Figure 
3.10a, right panel). The phosphoproteomics describes the behaviour of site 
resolved phosphorylation on hundreds of CDK substrates (but often only one site 
per protein). Phosphorylation dependent band shifts have the benefit of assaying 
the net phosphorylation of an entire protein and demonstrates that Orc2, Sld3 and 
Bir1 exhibit stoichiometric changes in phosphorylation during these re-ordered 
cycles that are consistent with the observations from the phosphoproteomics data.  
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Figure 3.10 | Candidate CDK substrates phosphorylation dynamics during reordered cell cycles 
Together these data demonstrate that CDK can be manipulated to alter the profile 
of differential CDK substrate phosphorylation. In these reordered cell cycles the 
differential phosphorylation of CDK substrates determines cell cycle fate. This 
supports the conclusion that there is a causal relationship between CDK activity, 
substrate phosphorylation and cell cycle fate and that there is no inherent 
directionality to the ordering of CDK substrate phosphorylation.  
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Dis2 during reordered cycle A-C 
respectively. Phosphorylation is 
monitored by mobility shift except for 
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Chapter 3 - Results 
 
88 
 
Interestingly some mitotic substrates become partially phosphorylated upon release 
into low CDK activity despite mitosis not being initiated. For example, a small 
increase in Dis2-T316 phosphorylation, and Bir1 mobility retardation, can be 
detected during the release from a G1-reset or G1-arrest into 1 µM 1-NmPP1. 
Looking at site resolved phosphorylation events in Figure 3.08, Cut3-T86 and Cut3-
19 phosphorylation is maintained at a basal level in cells released into 1 µM 1-
NmPP1, whereas Cut3-S36 phosphorylation (a site more sensitive to CDK activity) 
shows a small but significant increase. Furthermore, as cells grow during the G2 
arrest and Cdc13-L-Cdc2 accumulates, mitotic phosphorylation sites rise 
significantly (including T19 in cut3 which is necessary for its nuclear import during 
mitosis) despite the fact that cells do not undergo nuclear division (Figure 3.8d). It 
is only when cells are released into DMSO and these sites phosphorylation hits 
maximal levels that mitosis is undertake. This may suggest that cells are robust in 
their ability to only undergo mitosis when the entire critical pool of CDK substrates 
is fully phosphorylated. This maybe because only specific less sensitive sites are 
critical for the full initiation of mitosis and a number of CDK phosphorylation events, 
normally phosphorylated during mitosis, are necessary but not sufficient to activate 
the machinery of mitotic division. 
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3.3 How flexible is the cell cycle machinery to alterations to the 
profile of CDK activity? 
CDK inactivation has been show to be sufficient to relicense origin in S. cerevisiae 
(Noton and Diffley, 2000) consistent with the observation that transient inhibition of 
CDK permits re-replication (Coudreuse and Nurse, 2010). A transient CDK 
inhibition (10 µM 1-NmPP1) pulse of 90 minutes was used when Coudreuse and 
Nurse (2010) reported synchronous re-replication in G2 S. pombe cells. However, 
the dephosphorylation half lives of CDK substrates, including critical substrates for 
S-phase are almost all less than 10 minutes (Chapter 2). To investigate this further 
CDK activity was removed in G2 cells with 10 µM 1-NmPP1 pulses of varying 
length (30-90 min) and then released into 1 µM 1-NmPP1. The progression though 
the subsequent S-phase was determined by FACS analysis (Figure 3.11a). The 
final proportion of re-replicated cells is not dramatically different between the three 
pulse lengths (90 min: 81% >2C, 60 min: 80.7% >2C, 30 min: 71.4% >2C, 0 min 
3.9% >2C) consistent with the conclusion that S-phase substrate 
dephosphorylation is sufficient to permit origin licencing. However shorter pulses 
result in slower replication perhaps indicating that factors downstream of CDK 
phosphorylation might be limiting. Numerous initiation factors besides CDK have 
been described in other systems as limiting the timing and/or progression though 
S-phase (Wu and Nurse, 2009, Mantiero et al., 2011, Collart et al., 2013).  
 
Furthermore, when cells undergo a round of DNA replication after mitosis and a 
short G1, or after an extended G1-arrest, the majority of DNA synthesis is 
completed in a matter of 10-20 minutes, dramatically faster than after G2 cells are 
reset in G1 and released into 1 µM 1-NmPP1 (Figure 2.09d-f) (Coudreuse and 
Nurse, 2010). The differences in S-phase completion rate, may be due to one of 
two things: slower DNA synthesis rate (i.e. fork speed/processivity) or a lower 
number of origins being fired, probably due to reduced licensing efficiency. These 
differences may be due to a factor(s) that is regulated by progression through 
mitosis. In Xenopus, mitotic “conditioning” of the chromosomes is important for the 
subsequent cycle and involves increased replication factor recruitment to 
chromosomes and a shortening of the inter-origin distance during S-phase 
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(Lemaitre et al., 2005). Extending 
 
 
Figure 3.11 | Flexibility/robustness of the cell cycle to reorganisation by CDK activity 
a DNA content determined by FACS after release from 10 µM 1-NmPP1 G1-reset into 1 µM 1-NmPP1. 
Experimental design for 90 min pulse is as in Figure 3.05a (re-ordered cycle A) (MS108). 10 µM pulse was 
delayed to shorten it (but not the timescale of the whole experiment) to 60, 30 or 0 min. Quantification of 
>2C DNA content:  90 min pulse: 81%, 60 min pulse: 80.7%, 30 min pulse: 71.4%, no pulse: 3.9%. 90 min 
after release into 1-NmPP1 cells exposed to a 90min 10 µM pulse or no 1-NmPP1 pulse were washed and 
released into media lacking 1-NmPP1. 
b Representative images of DAPI and calcofluor stained cells 30 min after release into media lacking 1-
NmPP1. Top panel: cells previously exposed to a 10 µM pulse (i.e. re-replicated) or no 10 µM pulse (i.e. 
no re-replication). 
c Serial dilution (on YE4S plates) of cells plated one hours after release into 1-NmPP1 free media. No 
arrest: cells in exponential growth.  
 
mitosis in S. pombe allows more, and less efficient, origins to accumulate ORC and 
alters the pattern of origin usage in the subsequent S-phase, indicating that 
passage though mitosis play a role in origin licensing (Wu and Nurse, 2009). For 
example, Cdc13 proteolysis might serve as such a requirement, given that Cdc13 
transiently dissociates from chromatin at anaphase, coincident with when the MCM 
complex associates (Wuarin et al., 2002).  
 
During the program of re-replication reported by Coudreuse and Nurse (2010) it 
appears that a single round of bulk DNA synthesis is completed but it is not clear if 
all aspects of the program of S-phase are completed appropriately and the post-
replication chromosomes are competent for subsequent mitotic division as a diploid. 
To test this; cells in 1 µM 1-NmPP1 that had either been subjected to a preceding 
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90 min 10 µM pulse or no (0 min) 10 µM pulse, that did and did not re-replicate 
respectively, were released into media lacking 1-NmPP1. Cells that had not re-
replicated segregated their chromosomes normally with a modest septation defect 
(Figure 3.11b). In contrast, cells that had re-replicated showed defects in 
chromosome segregation, and have a significant reduction in cell viability when 
plated as a serial dilution one hour after release (Figure 3.11b&c). This suggests 
that this program of re-replication is not as permissive to a subsequent mitosis as a 
normal S-phase. It is unclear why this is, but it could be due to failure to properly 
complete aspects of the DNA replication program, such as replication termination. 
 
These two examples illustrate that despite CDK substrate phosphorylation being 
the major critical determinate for cell cycle progression, other aspects of the cell 
cycle machinery are optimally tuned to align with the physiological normality of the 
alternation of S-phase and mitosis. 
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3.4 Testing possible determinants of CDK sensitivity  
As discussed in Chapter 2 given there are so few S-phase compared to mitotic 
substrates it is reasonable to consider then the exception to the rule with regards to 
phosphorylation timing. As such a few hypotheses regarding what determines the 
increased sensitivity of S-phase substrates were tested. 
 
3.4.1 Consensus sites and distal short linear motifs  
Figure 3.12a shows amino acid distribution around all S-phase, biphasic or mitotic 
phosphorylation sites and illustrates that S-phase substrates do not conform to the 
full CDK consensus site (S/T-P-X-K/R), but that there is a significant enrichment of 
the +3 lysine/arginine in the biphasic substrates compared to mitotic substrates. To 
test if any other global differences in CDK sensitivity require the full CDK 
consensus motif, the cumulative frequencies of all S/T-P-X-K/R site and all other 
CDK substrate sites were plotted (Figure 3.12b). This shows that there is no 
significant difference between the full and minimal CDK consensus site and 
furthermore there are also no significant differences between Threonine and Serine 
as the phosphorylated residue (Figure 3.12c).  
 
To search for short linear motifs that may play a role in increasing S-phase 
substrate association with CDK, the protein sequences of five S-phase substrates 
(Orc1, Orc2, Sld3, Drc1 & Fkh2) were analysed using SLiMFinder, a bioinfomatic 
tool designed to identify short linear motifs enriched in a query list of proteins 
(Davey et al., 2010). All significantly over-represented motifs were related either to 
the CDK consensus site or a four amino acid motif: N-G-I/L/F-D/E. This motif was 
mutated to A-G-G-A in ectopically expressed and 5pk tagged Drc1, Sld3 and Orc2 
constructs. Partial motifs lacking a position 4 Glutamate or Aspartate were mutated 
to A-G-G. Phosphorylation of the wild type and mutant (A-G-G-A) proteins was 
assayed by mobility shift in extracts from asynchronous cultures. Asynchronous 
cultures were analysed as S. pombe spend ~80% of the cell cycle during 
exponential growth, in S-phase and G2, when S-phase substrates are 
phosphorylated but mitotic substrates are not. Figure 3.12d shows that Drc1 and 
Sld3 have CDK dependent mobility shifts in the wild type and A-G-G-A mutant 
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Figure 3.12 | Consensus sites and distal short linear motifs   
a Consensus sites for S-phase, biphasic and mitotic substrates.  
b&c cumulative frequency plot of CDK sensitivity (IC50 to 1-NmPP1) for the fully or minimal CDK 
consensus sites and Threonine or Serines phosphosites.  
d Western blot of wild type (N-G-I/L/F-D/E) and mutant (A-G-G-A) Drc1-5pk, Sld3-5pk and Orc2-5pk with 
(10 µM 1-NmPP1, 20 min) and without (DMSO 1-NmPP1, 20 min) CDK inactivation in asynchronous 
exponential cultures. Ectopic constructs expressing wild type or mutant nmt41-drc1-5pk, nmt41-orc2-5pk 
and nmt41-sld3-5pk (de-repressed in minimal media – thiamine, >48 h, 32 °C) (all partial motifs (N-G-I/L/F) 
were also mutated to A-G-G). 
e Phosphorylation dependent band shift of endogenously expressed Orc2-3pk and ectopically (nmt41) 
expressed Orc2-5pk with (10 µM 1-NmPP1, 20 min) and without (DMSO 1-NmPP1, 20 min) CDK 
inactivation in asynchronous exponential cultures + thiamine.  
 
proteins, indicating that the N-G-I/L/F-D/E motif is not an essential determinate for 
Drc1 or Sld3 substrate phosphorylation. Surprisingly, ectopically expressed Orc2-
5pk did not show any significant CDK dependent mobility shifts, even at sub-
endogenous levels (Figure 3.12e).  
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3.4.2 Mitotic and S-phase substrates have similar dephosphorylation rates  
It has been proposed that mitotic substrates might have faster dephosphorylation 
rates thus decreasing their net phosphorylation at interphase CDK activities 
(Coudreuse and Nurse, 2010, Uhlmann et al., 2011, Fisher et al., 2012). A 
prediction of this model is that mitotic substrates should be dephosphorylated with 
shorter half lives upon CDK inactivation. Figure 3.13a shows a cumulative 
frequency distribution of the phosphorylation half lives for S-phase and mitotic 
substrates after CDK inactivation in mitosis. There is no significant difference 
between the dephosphorylation rates of S-phase and mitotic substrates in these 
 
Figure 3.13 | CDK substrate dephosphorylation rates 
a Histogram of phosphosite half life in mitosis after CDK inactivation for S-phase and mitotic substrates. 
b Plot of CDK substrate phosphosite half lives after CDK inactivation in mitosis, against IC50 to 1-NmPP1. 
Sites with a one phase decay fit R squared > 0.95 and a sigmoidal fit R squared > 0.95 are plotted. Linear 
regression line: Y = -30.10*X + 856.9 (R squared = 0.005).  
c Plot of CDK substrate site half lives, after CDK inactivation in mitosis, against hill slope from sigmoidal fit. 
(12 hill slope values lie below -5 and are not plotted) 
d Plot of the phosphorylation half life during S-phase against half life calculated in mitosis. Sites with a 
one-phase decay fit R squared > 0.95 i after CDK inactivation n both S-phase and mitosis are plotted. 
Linear regression line: Y = 0.8710*X + 0.2361 (R squared = 0.954). 
d Plot of the phosphorylation half life after CDK inactivation in mitosis and hill slope to CDK activity (i.e. 
IC50 to 1-NmPP1). Sites with a one phase decay fit R squared > 0.95 and a sigmoidal fit R squared > 0.95 
are plotted. Linear regression line: Y = -30.10*X + 856.9 (R squared = 0.005).  
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experimental conditions. Consistent with this, phosphorylation half life does not 
correlate with the 1-NmPP1 IC50, or the hill slope for a given site (Figure 3.13b&c). 
These data indicate that differences between substrates in their sensitivity to CDK 
activity, or the abruptness of a sites response to CDK, cannot be explained 
exclusively by differential dephosphorylation rates of substrates by CDK-
counteracting phosphatase(s) activity. S-phase substrate dephosphorylation rates 
are also unchanged between S-phase and mitosis, suggesting they are 
dephosphorylated by the same phosphatase throughout the cell cycle (Figure 
3.13d). There is also a small general tendency for phospho-threonine residues to 
be dephosphorylated faster than phospho-serines (Figure 3.13e).  
 
3.4.3 ORC stability influences Orc1 and Orc2, but not Sld3, phosphorylation 
Fission yeast Orc2 is one of nine proteins that were identified as binding Cdc2 by 
yeast-2-hybrid (Leatherwood et al., 1996). CDK also associates with origins of 
replication in a Cdc13 dependent manner and can be displaced from origins using 
an Orc1 temperature sensitive (ts) mutant (Wuarin et al., 2002). Localisation to 
origins could increase the local concentration of CDK, resulting in preferential 
phosphorylation of S-phase substrates at origins. To test this, the phosphorylation 
state of three tagged endogenous S-phase substrates (Orc1, Orc2 and Sld3) was 
assayed in two ORC ts backgrounds: orc1-4 (cdc30-4) and orc2-2 (Figure 3.14a). 
ORC ts strains show a major 1C DNA content peak after shifting to the restrictive 
temperature indicating that there is a significant disruption of the ORC function in 
DNA replication (Figure 3.14b). Figure 3.14c shows that CDK dependent 
phosphorylation of Orc1 is significantly reduced in an orc2-2 backgrounds at the 
restrictive temperature and Orc2 phosphorylation is modestly reduced in an orc1-1 
background, however Sld3 phosphorylation is unaffected by temperature shift in 
either ORC ts allele. Y15 phosphorylation in the Cdc2 moiety was also detected, 
quantified and normalised to Cdc13-L-Cdc2 levels and showed a small but 
consistent increase in Y15 phosphorylation upon shift to the restrictive temperature 
(Figure 3.13c&d). This could be because of the temperature shift itself or the ORC 
ts alleles resulting in DNA damage dependent checkpoint activation, and may 
indirectly influence substrate phosphorylation. To control for this, strains with and 
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Figure 3.14 | Origin recognition complex stability is required for ORC protein phosphorylation but 
not Sld3 phosphorylation 
a Schematic of experimental design: strains with temperature sensitive (ts) ORC alleles (orc1-4 or orc2-2) 
and expressing tagged S-phase CDK substrates (orc1-HA, orc2-3pk, sld3-5flag) were grown at 25 °C. 
Asynchronous exponential cultures were either kept at the 25 °C (permissive temperature) (upper panel) 
or shifted to 36.5 °C (restrictive temperature) (middle panel). 10 min after temperature shift DMSO or 10 
µM 1-NmPP1 was added and cell were recovered for protein samples 30 min after temperature shift.  
b DNA content of cells 2 hours after shift to 25 °C or 36.5 °C.  
c Western blots to detect CDK substrate phosphorylation by mobility shift of orc1-HA, orc2-3pk, sld3-5flag 
at 25 °C or 36.5 °C after DMSO or 10 µM 1-NmPP1 treatment. c also contains Western blots to detect Y15 
phosphorylation of the cdc2 moiety and Cdc13-L-Cdc2 protein quantified in d  
a Cells with and without ORC ts alleles in genes were either arrested in G2 or kept in asynchronous 
growth and shifted to 36.5 °C, protein samples were taken 30 min after shift (lower panel). 
e Western blots to detect CDK substrate phosphorylation by mobility shift of Orc1-HA, Orc2-3pk, Sld3-
5flag at 36.5 °C in asynchronous exponential cultures or cultures arrested in G2.  
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without the ORC ts background were shifted to the restrictive temperature from 
exponential growth or a G2 arrest (Figure 3.14, lower panel). Tagged strains 
without the ORC ts background showed normal phosphorylation at the restrictive 
temperature indicating that temperature shift per se does not affect phosphorylation. 
G2 arrested cells (where S-phase associated DNA damage will not occur) still 
showed a significant reduction in Orc1 phosphorylation in an orc2-2 background, 
and a modest reduction in Orc2 phosphorylation in an orc1-4 background, whilst 
Sld3 phosphorylation was unaffected (Figure 3.14e).  
 
The fact that Sld3 phosphorylation is not influenced by the disruption of the ORC 
suggest that co-localisation of CDK and S-phase substrates at the ORC cannot be 
a universal mechanism to increase S-phase substrate sensitivity to CDK. The 
observation that the stability of different ORC components affects the 
phosphorylation of each other suggests that some of the determinates for ORC 
subunit phosphorylation exist at the level of the whole complex. The fact that an 
ectopic 5pk tagged version of Orc2 could not be phosphorylated by CDK but an 
endogenous 3pk tagged version could be because the larger 5pk tag disrupts 
incorporation of Orc2-5pk into the ORC complex, preventing it from being 
appropriately presented to CDK. Orc2-5pk phosphorylation is still not detected at 
sub-endogenous levels indicating that the lack of Orc2-5pk phosphorylation is not 
because it is ectopically expressed in excess of the endogenous ORC subunits 
(Figure 3.12e). 
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3.5 Discussion 
The data presented in this chapter demonstrates that the timing of CDK substrate 
phosphorylation is determined by differential sensitivity to CDK activity with S-
phase substrates more sensitive to CDK activity than mitotic substrates. The fact 
that the correlation between CDK activity, substrate phosphorylation and cell cycle 
fate is maintained outside of the physiological cell cycle, in re-ordered cell cycles, is 
consistent with two causal relationships. Firstly, low CDK activity results in S-phase 
substrate phosphorylation and thus bringing about DNA replication. Secondly, high 
CDK activity brings about mitotic substrate phosphorylation initiating mitosis. The 
ability of CDK activity to control substrate phosphorylation, and in turn, cell cycle 
events, is not contingent on the cell cycle history of the cell and argues that there is 
no inherent directionality to the order of substrate phosphorylation of the S. pombe 
cell cycle. S-phase substrates are also more ultrasensitive to CDK activity than 
mitotic substrates. S-phase substrates may have more abrupt response to CDK 
activity to ensure the transition from G1 to S-phase is switch like. This may not be 
required in mitotic substrates as the rise in CDK activity from G2 to M is thought to 
be significantly greater and more abrupt. So the switch like commitment to mitosis 
may be achieved via the non-linear dynamics of CDK activity, as opposed to the 
non-linear response of all substrates to CDK activity.  
 
There is also a third category of CDK substrates that have an intermediate 
sensitivity to CDK activity and increase in phosphorylation significantly at both S-
phase and mitosis. These biphasic substrates peak in G2 just before mitosis, 
indicating that they are sensitive to changes at a third threshold of CDK activity 
during G2. The exact significant of the timing of these biphasic substrates is not 
clear but may be involved in the completion of S-phase or the preparation of 
chromosomes for mitosis. Rad2 (Flap endonuclease, involved in Okazaki fragment 
maturation), Mis4 (the Cohesin loader) and Mcm10 (DNA initiation factor) all have 
phosphorylation events that show this biphasic behaviour, suggesting that the 
termination of DNA replication and/or remodelling of Cohesin or Cohesin loading 
machinery may be controlled by this G2 phosphorylation. Consistent with this, the 
human Flap endonuclease (Fen1) is phosphorylated by Cdk2 to inactivate it and 
disrupt its interaction with PCNA (Henneke et al., 2003). In S. pombe Rad2, the 
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PCNA interaction peptide (336-344) sits seven amino acids N-terminal to the 
detected CDK site (S351), suggesting it may also function to disrupt the Fen1-
PCNA interaction. It might be the case that cells that are manipulated to re-
replicate, as described above, simultaneously phosphorylate S-phase and biphasic 
substrates preventing the completion/termination of S-phase in some respects. 
This could explain why they are not all able to undergo a physiological mitosis as a 
diploid following re-replication.  
 
3.5.1 Possible determinates of sensitivity to CDK activity 
How these important differences in sensitivity are biochemically determined is 
unclear. The fact that sites with the same protein tend to have more similar CDK 
sensitivities to each other suggests that the determinants for sensitivity are more 
likely to be due to protein-wide properties, not site autonomous properties. This 
could require ancillary factors (such as Cks1) that promote processive 
phosphorylation reactions on multisite substrates. The inter-dependency of ORC 
subunit phosphorylation also indicates that multiple proteins within the same multi-
protein complex can function together to determine complex-wide properties and 
that one subunit of a complex can directly contribute to the phosphorylation status 
of another. There are multiple mechanisms by which such differences in sensitivity 
could be achieved.  
 
Differential specificity for residues surrounding the phosphorylation site or 
increased biochemical affinity due to a docking interaction with a substrate are the 
simplest determinants to envisage. A simple hypothesis would be that early 
substrates conform to full CDK consensus site (S/T-P-X-K/R) whilst mitotic 
substrates only adhere to the minimal site (S/T-P) (Koivomagi et al., 2011b). 
However, this is not the case, and in fact the full CDK consensus sequence is 
under represented in S-phase substrate sites. Biphasic substrate sites are strongly 
enriched in the +3 K/R, suggesting that the full consensus site may be necessary 
for their increased sensitivity compared to mitotic substrates, but cannot be 
considered sufficient given many mitotic substrates also conform to the S/T-P-X-
K/R consensus.  
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Kinase-substrate docking interactions are often distal to the phosphorylation site 
and have been described for a wide range of regulatory kinases (e.g. ERK, MEK, 
JNKs, PHK, GSK3 and PDK1) (Ubersax and Ferrell, 2007). In its simplest form a 
docking reaction would increase the local concentration of a substrate around a 
kinase, reducing the Km of a substrate. Docking motifs could also position 
substrate sites with respect to the active site, to decreasing a substrates Kcat or 
function to allosterically stimulate kinase activity, as has been reported for MAPK 
and ERK (Chang et al., 2002) (Lee et al., 2004). The only candidate docking motif 
identified amongst S-phase substrates (N-G-I/L/F-D/E) was dispensable for 
substrate phosphorylation. An as of yet unidentified docking motif seems like the 
most likely determinant for differences in sensitivity to CDK activity. In an 
analogous manner binding to a common scaffold or platform could perform a 
similar function as a motif that directly docks a kinase to a substrate (Ubersax and 
Ferrell, 2007). The possible role of the ORC complex as a platform to increase the 
local concentration of CDK and S-phase substrates to enhance S-phase substrate 
phosphorylation was tested but was not important for the phosphorylation of a 
major S-phase substrate: Sld3. 
 
As discussed in the Introduction Cyclin-CDK localisation changes dynamically 
during the cell cycle and the spatial restriction of a cyclin can limit is ability to 
phosphorylate sub-pools of substrates. During mitosis in S. pombe CDK is 
localised across the nucleus and enriched on the spindle and chromatin 
(Decottignies et al., 2001). CyclinB1-Cdk1 auto-phosphorylates Cyclin B1 at 
multiple N-terminal Serine residues, which is important for the association of Cyclin 
B1 with chromatin and the spindle (Santos et al., 2012). A hypothesis for how the 
timing of mitotic substrates could be achieved is as follows. Outside of mitosis 
Cyclin-CDK does not see mitotic substrates, then once CDK activity surpasses a 
specific threshold it auto-phosphorylates directing itself to the chromatin and 
spindle to co-localise with mitotic substrates resulting in their phosphorylation. 
However, there are numerous examples of mitotic substrates that are cytoplasmic 
or nucleolar and the majority of S-phase substrates also interact with chromatin. It 
is equally plausible to speculate that subcellular co-localisation of CDK and its 
substrates could be of little significance: if the exchange cycle of CDK or CDK 
substrates on/off specific subcellular structures is dynamic enough then the 
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transient association of CDK and a substrate when off those structures may be 
sufficient to permit net substrate phosphorylation, especially if the 
dephosphorylation rate is slow comparative to the phosphorylation rate or if 
phosphatase activity were also spatial regulated. This raises the question as to 
whether all the dynamic changes in the local concentration of Cyclin-CDK actually 
have any meaningful impact on the phosphorylation of substrates specifically at 
those subcellular locations. The fact that a CDK activity reporter in human cell lines 
does not seem to show an increased read-out at locations where CyclinB1 
becomes enriched during early mitosis hints this may not be the case (Gavet and 
Pines, 2010a). The experimental tethering of CDK and CDK-counteracting 
phosphatases to certain subcellular locations should allow the contribution of the 
subcellular localisation of CDK substrates to be probed more systematically.  
 
Which phosphatase(s) counteract CDK phosphorylation in fission yeast is not yet 
fully clear. Clp1 certainly plays a significant role, although it possible this is 
predominantly during mitotic exit. It has been reported that phospho-threonine is 
dephosphorylated significantly slower by S. cerevisiae Cdc14 (Clp1 ortholog) than 
phospho-serine (Bremmer et al., 2012). However, CDK substrate sites that are 
phospho-threonines are dephosphorylated slightly faster than phospho-serines 
after CDK inactivation. This suggests that other phosphatases besides Clp1 are 
also operating to antagonise CDK activity in S. pombe. It has been hypothesised 
that a difference in timing of S-phase and mitotic substrate phosphorylation could 
be due to specific phosphatase activities that antagonises CDK phosphorylation on 
mitotic but not S-phase substrates (Coudreuse and Nurse, 2010, Uhlmann et al., 
2011, Fisher et al., 2012). However, the dephosphorylation rate of mitotic 
substrates is no faster than that of S-phase substrates, arguing against this 
hypothesis. An important caveat to this conclusion is that phosphatases are down 
regulated in mitosis (see Introduction (section 1.3)), which is when the 
dephosphorylation rates are measured. It is plausible that the dephosphorylation 
rate of mitotic substrates in interphase is dramatically higher and imparts a 
threshold for greater CDK sensitivity until cells commit to mitosis, when 
phosphatases are inactivated and dephosphorylation rates drop. However, 
phosphate turnover is measured after CDK inactivation, when CDK regulated 
phosphatases should become de-repressed. If mitotic substrates are completely 
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refractory to interphase phosphatase activities in these experimental conditions, 
then interphase phosphatase activity could be the exclusive determinant for the 
timing of mitosis substrates, as long as mitotic substrates were dephosphorylated 
with half lives significantly shorter than the least stable S-phase substrate (< 1 
minute). Especially given that dephosphorylation rates of S-phase substrates does 
not change between S-phase and mitosis. The fact that S-phase sites are 
dephosphorylated with the same rate in mitosis and S-phase suggests that 
whichever phosphatase(s) is dephosphorylating S-phase substrates is not 
differentially regulated between S-phase and mitosis. Given the span of 
dephosphorylation rates quantified here it is also important to consider different 
substrates may be able to achieve the same net phosphorylation with different 
dephosphorylation and phosphorylation rates as long as the ratio between the two 
rates (or some parameters related to them) are kept at a constant ratio.  
 
Substrate competition could also play a role in resolving the phosphorylation of 
different substrate apart from one another. Substrate competition has been shown 
to contribute in vitro to the dynamics of Wee1 inactivation by CDK phosphorylation 
at T150 (Kim and Ferrell, 2007). The phosphorylation of reconstituted Wee1 by 
CDK is more ultrasensitive when co-incubated with cell lysates or other 
recombinant CDK substrates. It also significantly increases the concentration of 
CDK required to reach half maximal Wee1 T105 phosphorylation (Kim and Ferrell, 
2007). This demonstrates that more sensitive substrates with a lower Km could 
control both the timing and the non-linear dynamics of the phosphorylation of less 
sensitive CDK substrates via competition. Interestingly phosphorylated α-
endosolphine, the inhibitor of PP2A-B55, has recently been shown to also be a 
substrate of PP2A-B55 and function via an “unfair competition” mechanism. 
Phosphorylated α-endosolphine has a very low Km and Kcat meaning it binds 
PP2A-B55 very well and is dephosphorylated slowly preventing the enzyme 
working on other substrates. The main consequence of this is that PP2A-B55 does 
not dephosphorylate its wide range of other substrates until α-endosulphine is 
dephosphorylated and displaced from the PP2A-B55 active site (Williams et al., 
2014). A similar situation could be envisaged in which S-phase substrates compete 
for CDK to prevent phosphorylation of mitotic substrates at low CDK activity levels. 
The constant turn-over of S-phase substrate phosphorylation could allow a steady-
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state in which S-phase substrates are continuously being phosphorylated and 
occupy the small number of active CDK molecules early in the cycle, although it 
seems unlikely that S-phase substrates will have Michaelis-Menten parameters as 
extreme as that of phosphorylated α-endosulphine.  
 
Given that a molecular precedent exists for all of these mechanisms in regulating 
kinase-substrate specificity, it is plausible that different substrates use different 
mechanisms, possibly combinations of alternate mechanisms, to hone their specific 
sensitivity to CDK activity in the cell. Such a scenario would make it incredibly 
challenging to assess globally how CDK-substrate dynamics are determined in 
anything other than a case-by-case basis.  
 
3.5.2 Staggered substrate phosphorylation during the G2/M transition 
In addition to the ordering of CDK substrate phosphorylation across the cycle, CDK 
substrates are progressively phosphorylated during the G2/M transition. The 
extent/timing of phosphorylation during G2/M, of a mitotic substrate site, correlates 
with its sensitivity to CDK indicating that rising CDK activity may also order the 
progression through G2/M as well as between S-phase and mitosis. What 
determines these smaller differences in sensitivity may come down to subtle 
structural and sequence differences that impact the affinity and reaction kinetics of 
CDK and CDK-counteracting phosphatases towards specific substrates. There is 
no significant difference in the sensitivity to CDK between the full and minimal 
consensus site or between Serine or Threonine indicating that these 
phosphorylation site proximal factors cannot be generally responsible for these 
small differences. 
 
The ordered phosphorylation of CDK substrates during the G2/M transition has 
been previously reported in somatic extracts, where Wee1 is phosphorylated at low 
Cyclin B1 concentrations, followed by Securin, Cdc25, and finally Cdc27, the 
APC/C subunit. The ordered phosphorylation of Wee1 and Ccd25 is thought to 
contribute to the non-linear dynamics of CDK activation (Deibler and Kirschner, 
2010). This graded phosphorylation of CDK substrate is far less pronounced in 
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Xenopus egg extracts (Georgi et al., 2002). Furthermore, CDK activity, measured 
in single cells by the net phosphorylation of a CDK activity biosensor rises 
progressively as cells transverse the G2/M transition until after NEBD. As the 
biosensor phosphorylation increases cells undergo sequential mitotic events 
(Gavet and Pines, 2010b). In cells unable to attain the highest mitotic levels of 
biosensor phosphorylation, later mitotic events (e.g. NEBD, chromosome alignment 
and cytokinesis) fail to occur, while earlier events (e.g. cell rounding and Cyclin B1 
nuclear import) do occur (Gavet and Pines, 2010b). These data are consistent with 
a model where CDK substrates are phosphorylated in an orderly manner during 
G2/M at specific CDK activity thresholds, due to differential sensitivity to CDK 
activity, and that this ordering of substrate phosphorylation is important in ordering 
the events of mitosis. Alternatively, early G2/M phosphorylation could be necessary 
but not sufficient for the associated mitotic event if there were no physiological 
consequence to it being phosphorylated slightly earlier than required, whereas 
phosphorylation of other substrates may have to be precisely timed to ensure the 
timely progression through mitotic events. In the former scenario, there may be no 
selection for a precise sensitivity to CDK activity, only a pressure to evolve 
phosphorylation that occurs at or before the corresponding mitotic event.  
 
Figure 3.03f shows examples of mitotic substrates that span the range of 
sensitivities to CDK activity. For example, phosphorylation that function to inhibit 
proteins before anaphase onset (e.g. Nsk1) are phosphorylated earlier than protein 
involved in mitotic spindle assembly (e.g. Alp14 and Dis1) or chromosome 
condensation (e.g. Cut3). These timing differences could function to ensure that 
factors involved in anaphase are fully inhibited first so that they cannot disrupt the 
events of early mitosis. SPB proteins (Sad1, & Ppc89) are also phosphorylated 
earlier and at lower CDK activities, which may implicate them in the very early 
mitotic event of nuclear SPB insertion (Ding et al., 1997, McCully and Robinow, 
1971). Consistent with this Kms2 phosphorylation has an AUC of 16, similar to that 
of Sad1 and Ppc89, although no IC50 could be adequately calculated. Kms2 is an 
essential SPB-localised protein and its depletion results in aberrant SPB nuclear 
insertion (Walde and King, 2014). In contrast, other SPB proteins (Sid2 and Spo15) 
involved in the later events of cytokinesis are phosphorylated significantly later.  
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One, initially counter-intuitive, observation is that phosphorylation of Plo1 by CDK 
occurs later than most of the above proteins, despite the fact that Plo1 localisation 
to the SPB is thought to be one of the earliest mitotic events (Mulvihill et al., 1999). 
Plo1 recruitment to the SPB is dependent on its polo-box domain (PBD) (Reynolds 
and Ohkura, 2003) likely via the binding to SPB phospho-epitopes. As such the 
early phosphorylation of SPB proteins, as opposed to Plo1 itself, is probably what 
targets Plo1 to the SPB. Consistent with this, phosphorylation of Cut12 has been 
heavily implicated in Plo1 recruitment to the SPB (Grallert et al., 2013a) and Kms2 
depletion has been shown to slow the rate of Cut12 and Plo1 accumulation at the 
SPB (Walde and King, 2014). The later phosphorylation of Plo1 may specifically 
function to further activate/regulate Plo1 for the later events of cytokinesis, in which 
Plo1 is also involved (Almonacid et al., 2011, Mulvihill and Hyams, 2002, Ohkura et 
al., 1995). The separation of the dual functions of Plo1 in chromosome segregation 
and septation was uncovered by the overexpression of mutations in the PBD that 
cause septation defects, but not the mitotic arrest observed when wild type Plo1 is 
overexpressed (Reynolds and Ohkura, 2003). Aurora kinase (part of the CPC) is 
involved in ensuring the proper bi-orientation of chromosome attachments at a 
kinetochore (Ruchaud et al., 2007) and the phosphorylation of Pic1 and Bir1 (CPC 
subunits) controls its localisation to the kinetochore (Pereira and Schiebel, 2003, 
Tsukahara et al., 2010)). Pic1 and Bir1 phosphorylation precedes the 
phosphorylation of substrates involved in spindle assembly and attachment, 
possibly to ensure that Ark1 is at the kinetochore before the spindle starts to be 
constructed, and the first spindle attachments forms, to allowing it to monitor and 
remodel all spindle attachments throughout mitosis. The exact significance of the 
timing of these phosphorylation events at present is speculative, but a surprising 
amount of sense can be made of them in light of what is known about their 
involvement in the various events of mitosis.  
 
Early G2/M phosphorylation, which is more sensitive to CDK activity, could also 
function to inhibit phosphorylation of later events via substrate competition to buffer 
the timing of later mitotic events. Some CDK phosphorylation may not functionally 
regulate the target substrate and could simply function to compete with other 
substrates to buffer and delay their phosphorylation until later in the cycle. CDK 
phosphorylates a large number of substrates, and it is conceivable that some 
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proteins have “accidentally” or “passively” evolved CDK phosphorylation sites, in 
the absence of negative selective pressure. Recent work in S. cerevisiae has 
shown that a significant expansion of the Ime2 kinase’s specificity has no major 
dominant consequences indicating that cells are able to tolerate a significant 
amount of promiscuous phosphorylation (Howard et al., 2014). If there were a 
sufficient pool of such “passenger” CDK substrates, lacking any actual CDK 
regulated functions, they may have been maintained as substrates to regulate the 
phosphorylation of other substrates, through substrate competition. 
 
Sites within the same protein are more likely to behave like each other but there 
are exceptions to this general tendency. For example, three sites in the N-terminus 
of Cut3 are phosphorylated sequentially at rising CDK activity thresholds. This 
strikes a notable resemblance to the description of CDK dependent 
phosphorylation of Xenopus Wee1. Wee1 phosphorylation occurs at five N-terminal 
sites; T104 and T150 are highly conserved and are required for Wee1 inactivation 
at mitotic entry (Kim et al., 2005). Three other sites, S38, T53 and S62, are poorly 
conserved, non-essential for Wee1 inactivation and are phosphorylated before 
T150 (Kim et al., 2005). Kim et al. (2007) demonstrated that these non-essential 
sites act as decoy targets for CDK, competing with and delaying T150 
phosphorylation and also generate a more ultrasensitive output of T150 
phosphorylation. An equivalent mechanism could be responsible for the ordered 
phosphorylation of sites in Cut3. The exact significant of multisite phosphorylation 
in Cut3 has not been investigated but could be significant in the exact dynamics of 
CDK regulated Cut3 nuclear influx during mitosis (Sutani et al., 1999). 
Unfortunately, Wee1 phosphorylation was not detected in this dataset so the 
potential conservation of this behaviour between Xenopus Wee1 and S. pombe 
Wee1 could not be assessed. 
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Chapter 4. The contribution of G1/S-phase cyclins  
All the experiments described in Chapter 2 and 3 were preformed using strains with 
a genetic background lacking endogenous cyclins (cdc13-L-cdc2 ∆2 ∆13 ∆CCP). S. 
pombe has three cyclins besides Cdc13 that associate with CDK during the cell 
cycle and contribute to progression through G1 and S-phase: Puc1, Cig1 Cig2 
(Booher and Beach, 1988, Bueno et al., 1991, Bueno and Russell, 1993, Connolly 
and Beach, 1994, Martin-Castellanos et al., 2000). As discussed during the 
Introduction, G1 and S-phase cyclins in S. cerevisiae have enhanced biochemical 
affinity towards a subset of CDK substrates. However, the global contribution of 
these associations to in vivo phosphorylation has not been extensively studied, and 
there is very little work on S. pombe cyclin specificity. In this chapter I present the 
quantification of CDK substrates during a S-phase arrest in the absence and 
presence of S-phase cyclins.  
 
4.1 Testing the role of Cig1, Cig2 and Puc1 
To test the differential contribution of the S. pombe cyclins to CDK substrate 
phosphorylation, the phosphoproteome was analysed in three backgrounds: wt 
(cig1+ cig2+ puc1+), ∆CCP (cig1∆ cig2∆ puc1∆) and cdc13-L-cdc2 ∆2 ∆13 ∆CCP. 
In asynchronous exponential growth wild-type S. pombe shows no G1 DNA content 
peak (1C) because in nutrient rich conditions cytokinesis occurs after DNA 
replication. In contrast, ∆CCP shows a pronounced G1 peak whilst cdc13-L-cdc2 
∆2 ∆13 ∆CCP shows a small G1 population (Figure 4.01a). In all three strains Cdc2 
has the F84G mutant so 1-NmPP1 could be used to synchronise cells in G2. 
Because endogenous Cdc2 does not fully tolerate the F84G mutant, an additional 
mutation was used that recues the associated defects (Aoi et al., 2014). This is not 
required in the Cdc13-L-Cdc2 construct, which does not present with F84G 
associated defects (Coudreuse and Nurse, 2010). Light labelled cultures (wt, ∆CCP 
and cdc13-L-cdc2 ∆2 ∆13 ∆CCP) were released from G2 into hydroxyurea (HU) in 
order to deplete nucleotide pools and arrest cells in S-phase (Figure 4.01b). In the 
absence of HU, wt cells undergo bulk DNA synthesis 30-40 min after release,  
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Figure 4.01 | Contribution of S-phase cyclins to the timing of S-phase 
a DNA content during asynchronous exponential growth, determined by FACS, for wt (MS131) ∆CCP 
(MS200) and cdc13-L-cdc2 ∆2 ∆13 ∆CCP (MS213).  
b schematic of experimental design. Unlabelled MS131, MS200 and MS213 were released from a G2 
arrest and then Hydroxyurea (HU) or H20 was added to all three cultures. Samples for proteomics were 
taken 60 min after release. Reference samples were taken from heavy labelled cultures in the same 
conditions (HU arrest) or released from a G2 arrest into mitosis.  
c DNA content determined by FACS. 
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whilst ∆CCP and cdc13-L-cdc2 ∆2 ∆13 ∆CCP undergo bulk DNA synthesis 5-10 
minutes later (35-50 min) (Figure 4.01c, upper panel) consistent with previous 
observations that Cig1 and Cig2 contribute to the timing of S-phase (Fisher and 
Nurse, 1996). The absence of a discrete 4C peak during S-phase for ∆CCP and 
cdc13-L-cdc2 ∆2 ∆13 ∆CCP is because the delay in DNA replication results in it 
coinciding with cell division, which splits the S-phase population either side of the 
2C DNA content peak before S-phase has completed. When HU is added after the 
G2 arrest and release, cells arrest with a G1 DNA content (Figure 4.01c, lower 
panel). Protein extracts were recovered at 60 min, i.e. after the time at which cells 
would have completed S-phase if HU had not been added. Samples were mixed 
with one of two references as follows. Firstly, a heavy sample recovered in mitosis 
(i.e. cells 10 min after a G2 arrest and release), to allow the comparison with 
maximal phosphorylation. Secondly, an extracts from a heavy labelled wild type 
culture also arrested in HU to allow the quantification of the relative 
phosphorylation changes with and without S-phase cyclins.  
 
4.2 The contribution of G1/S-phase cyclins to CDK substrate 
phosphorylation  
Figure 4.02a shows the median phosphorylation of S-phase, biphasic and Mitotic 
CDK substrates, as well as the quantification of Cdc2-T167 phosphorylation in 
these three strains relative to maximal phosphorylation in mitosis. S-phase 
phosphorylation is greater than biphasic substrate phosphorylation, which is 
greater than mitotic substrate phosphorylation in all three backgrounds. This is 
consistent with cells arrested in S-phase being unable to attain sufficient CDK 
activity to majorly phosphorylate mitotic substrates. T167 phosphorylation is 
thought to occur after Cyclin-CDK complex formation (see Introduction, section 
1.1.1) and as such can be use as a proxy for the amount of Cyclin-CDK complex 
formed. In the absence of S-phase cyclins there is significantly less T167 (~60%) 
suggesting that in these conditions Cyclin-CDK complex formation is limited by the 
availability of cyclin not CDK. In the wild-type background where CDK-complex 
formation has increased specifically due to Cig1, Cig2 and/or Puc1 there is a  
corresponding increase in S-phase substrate phosphorylation, but also in the 
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Figure 4.02 | Contribution of S-phase cyclins to CDK substrate phosphorylation 
a&b Median phosphorylation of CDK substrates (S-phase, biphasic and mitotic) and the quantification of 
Cdc2-T167 phosphorylation, in wt (MS131) ∆CCP (MS200) and cdc13-L-cdc2 ∆2 ∆13 ∆CCP (MS213) 
when compared to a mitotic (a) or S-phase arrest (b) reference.  
c-e The cumulative frequency of relative phosphorylation for CDK substrates (S-phase, biphasic and 
mitotic) in in wt (MS131) ∆CCP (MS200) and cdc13-L-cdc2 ∆2 ∆13 ∆CCP (MS213). 
f Relative phosphorylation of CDK substrate sites plotted against each site sensitivity to CDK activity (i.e. 
IC50 to 1-NmPP1).  
 
relative phosphorylation of biphasic substrates and mitotic substrates (Figure 
4.02a). The increase in S-phase and biphasic substrate phosphorylation, as a 
proportion of maximal phosphorylation (i.e. L:H =1), is larger compared to mitotic 
substrates. This demonstrates that G1/S-phase cyclins contribute more to total 
phosphorylation of S-phase related substrates. This could be for one of two 
reasons. S-phase and biphasic substrates could be more sensitive to specific 
G1/S-phase cyclins and as such are more phosphorylated. Alternatively, S-phase 
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and biphasic substrates could be more responsive to the range of CDK activities in 
the cell to which S-phase cyclins are contributing in the HU arrest.  
 
To attempt to distinguish between these two possibilities, the relative differences in 
S-phase, biphasic and mitotic phosphorylation was quantified when comparing 
these three samples to a heavy reference that was also arrested in HU. Figure 
4.02b shows the median phosphorylation of the S-phase, biphasic and mitotic 
substrates in the wt, ∆CCP and cdc13-L-Cdc2 ∆2 ∆13 ∆CCP background in an HU 
arrest compared to wt in an HU arrest. Figures 4.02c-e show the cumulative 
frequency of phosphorylation in each of the three backgrounds for each class of 
substrate. Both mitotic and S-phase substrate phosphorylation increases in the 
presence of Cig1, Cig2 and Puc1 by 10-15%. This suggests that when S-phase 
cyclins are associated with CDK, they activate the kinase but do not restrict the 
activity towards S-phase substrates. Mitotic substrates remain hypo-
phosphorylated because CDK activity is too low to cause significant net mitotic 
substrate phosphorylation. Biphasic substrates show a greater difference 
with/without cyclins and are more sensitive to greater CDK activities than S-phase 
substrates but lower activities than mitotic substrates. The greater enhancement of 
biphasic substrate phosphorylation by Cig1, Cig2 and/or Puc1, could be because 
the presence of the S-phase cyclins tips total CDK activity over a third intermediate 
threshold for biphasic substrate phosphorylation or it could be because of cyclin 
specificity towards these substrates. Figure 4.02f shows the relative 
phosphorylation of CDK substrate sites in these three genetic backgrounds plotted 
against the site’s sensitivity to CDK activity in vivo (i.e. 1-NmPP1 IC50). This 
suggests that the presence of S-phase cyclin, in these experimental conditions, 
increases the phosphorylation of substrates with the most intermediate sensitivity 
to CDK activity the most. This supports a model where the presence of Cig1, Cig2 
and/or Puc1 simply increases the total CDK activity, and thus promotes the 
phosphorylation of substrate that are most sensitive to an increase in activity over 
this range.  
 
If the amount of CDK substrate phosphorylation is used as a proxy for CDK activity 
the absence of S-phase cyclins seems to reduce CDK activity by ~15%. However, 
there is a >40% reduction in the amount of Cyclin-CDK complex formation (T167 
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phosphorylation). This indicates that Puc1, Cig1 and/or Cig2 do not contribute as 
much to total kinase activity per complex as Cdc13-Cdc2. Cd13-L-Cdc2 has a 
modest increase in T167 phosphorylation compared to ∆CCP. This could be 
because there is slightly more Cdc13 in the cell or the fact that the fusion between 
Cdc13 and Cdc2 promotes complex formation. Despite this, Cd13-L-Cdc2 is 
slightly less proficient at phosphorylating mitotic substrates than Cdc13 freely 
associating with Cdc2 (i.e. ∆CCP) (Figure 4.02a&b). This may be an artefact 
related to the fact that Cdc2 in the ∆CCP strain has an additional mutation to 
stabilise the F84G mutation, which is not necessary in the cdc13-L-cdc2 ∆2 ∆13 
∆CCP background. 
 
4.3 Cig1, Cig2 or Puc1 unique phosphorylation events 
If there where substrates that are truly unique to a S-phase cyclin(s) these would 
not have been defined as CDK substrates in Chapter 2, given that the definition of 
CDK substrates was done in the simplified CDK network background in which Cig1 
Cig2 and Puc1 are absent. Figure 4.03 shows the quantification of all detected 
phosphorylation in the ∆CCP and cdc13-L-Cdc2 ∆2 ∆13 ∆CCP samples, relative to 
wt, plotted against each other. Putative Puc1, Cig1 and/or Cig2 unique substrates 
were defined as phosphorylation events that were fivefold less phosphorylated in in 
both ∆CCP and cdc13-L-cdc2 ∆2 ∆13 ∆CCP as compared to the heavy wt  
 
Figure 4.3  | S-phase cyclin unique phosphorylation events 
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phosphorylation events 
Scatter plot of the quantification of all 
detected phosphorylation events (one point 
= one site) in ∆CCP and cdc13-L-cdc2 ∆2 
∆13 ∆CCP compared to wild-type when 
cells where arrested in S-phase with HU. 
Four sites (labelled yellow) had a >fivefold 
depletion in the absence of S-phase cyclins 
in both backgrounds.  
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reference. Only four phosphorylation events were more than fivefold depleted in 
∆CCP and cdc13-L-cdc2 ∆2 ∆13 ∆CCP compared to wt: Oca2-T38, Cig1-S96, 
Cig1-S108, Cig2-S76. Oca2T38 is not at a T-P site and is also low in the null 
distribution (wt(L) : wt (H)) ruling it out as a possible G1/S-phase cyclin specific 
CDK substrate. The presence of substrates being phosphorylated exclusively by 
G1/S-phase Cyclin-CDK cannot be formally ruled out because phosphoproteomics 
coverage is not comprehensive. This analysis involves <5000 phospho-sites whilst 
all previously published phospho-proteomics studies have identified more than 
18,000 phosphorylation events in S. pombe between them (Kettenbach et al., 
2015). As such 18,000 can be considered a very conservative, but empirical, lower 
limit on the number of phosphorylation events in vivo. Despite this the detection of 
four sites on the G1/S cyclins that are significantly decreased serves as a good 
positive control and suggested if G1/S cyclin-unique substrates where prevalent 
they would have been detected here.  
 
4.4 Discussion  
These data demonstrate that S-phase cyclins can contribute to the phosphorylation 
of all types of CDK substrates and does not provide any convincing evidence that 
S-phase cyclins have dramatic specificity restricting them to early CDK substrates. 
Instead it points to a model where S-phase cyclins contribute to the profile of 
increasing CDK activity involved in the initiation of S-phase. The conclusion that S-
phase cyclins contribute to the timing of S-phase, and do so predominantly by 
increasing CDK activity, as opposed to specificity, early in the cycle is consistent 
with the observation that cig1∆ cig2∆ cells initiate DNA replication after release 
from nitrogen starvation later than wild type cells (Fisher and Nurse, 1996). This 
delay corresponds to a delay in the accumulation of Cdc2 associated H1 kinase 
activity but not a significant delay in the rise in Cdc13 associated H1 kinase activity, 
indicating that Cig1 and Cig2 do not contribute to CDK activity indirectly upstream 
of Cdc13-Cdc2 activity (e.g. by regulating Cdc13-Cdc2 expression or activation) 
(Fisher and Nurse, 1996). The fact that Puc1, Cig1 and/or Cig2 binding to CDK 
does not increase CDK activity as much as Cdc13 binding is consistent with reports 
in S. cerevisiae that earlier cyclins have lower intrinsic CDK H1 kinase activity 
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(Loog and Morgan, 2005, Koivomagi et al., 2011b). A decrease in CDK activity per 
Cyclin-CDK complex could make it easier for rising CDK activity to resolve the S-
phase activity threshold from the mitotic threshold by using a large number of less 
active complexes, as opposed to a smaller number of more active Cdc13-Cdc2 
complexes. An alternative explanation for the data presented here is that Puc1, 
Cig1 and Cig2 are specific to S-phase substrates but by targeting CDK to them for 
phosphorylation a pool of Cdc13-Cdc2 is alleviated and able to now increase 
phosphorylation of mitotic substrates, such a mechanism would require S-phase 
substrates to function as competitive inhibitors of mitotic substrate phosphorylation 
as discussed in Chapter 3. The possible specificity of S. pombe S-phase cyclin 
should not be formally ruled out until cyclin specific CDK phosphorylation rates are 
quantified for a number of critical CDK substrates using different S. pombe Cyclin-
CDK complexes.  
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Chapter 5. Beyond CDK: global phosphorylation 
dynamics of cell cycle kinases 
In addition to CDK, multiple other kinases have been implicated in the processes of 
cell division and growth. The most notable examples involved in mitotic functions 
are the Polo-like kinases (Plk), Aurora Kinases and NIMA kinase. Fission yeast has 
a version of each: Plo1, Ark1 and Fin1 respectively. It is not obvious how and why 
mitotic phosphorylation is divided up between multiple regulatory kinases and a 
well resolved description of the phosphorylation dynamics downstream of these 
different kinases should further inform this question. 
 
Plk1 is critical for bi-polar spindle assembly and is also involved in the auto-
regulatory feedback loops that control CDK activity at mitotic entry, the regulation of 
chromosome cohesion and cytokinesis (Archambault and Glover, 2009). S. pombe 
Plo1 is necessary for bi-polar spindle formation and promotes septation (Mulvihill et 
al., 1999, Tanaka et al., 2001). Plo1 localises to the SPB early in mitosis and to the 
site of septation later (Mulvihill et al., 1999, Bahler et al., 1998a). Plo1’s localisation 
to the SPB as well as its association with bona fide substrates such as Mid1 
requires its Polo-box domain (PBD) (Reynolds and Ohkura, 2003, Almonacid et al., 
2011). Higher eukaryotic Aurora B is part of the chromosome passenger complex 
(CPC) which promotes chromosome condensation, appropriate kinetochore 
microtubule attachment and spindle mid-zone formation, whilst also antagonising 
chromosome sister chromatid cohesion and regulating some aspects of cytokinesis 
(Vader and Lens, 2008, Carmena et al., 2012). The only S. pombe Aurora kinase, 
Ark1, concentrates at the kinetochore during early mitosis and distributes along the 
spindle during anaphase (Petersen et al., 2001). Ark1 is required for chromosome 
condensation, segregation and spindle assembly checkpoint function (Leverson et 
al., 2002, Petersen and Hagan, 2003) and Ark1 phosphorylation of the kleisin 
condensin subunit, Cnd2, promotes condensin recruitment to the chromosomes 
(Nakazawa et al., 2011, Tada et al., 2011). NIMA kinase was first identified as a 
protein essential for mitotic commitment in the filamentous fungus Aspergillus 
nidulans (Morris, 1975). The S. pombe ortholog is important for chromosome 
condensation and spindle assembly as well as participating in the activation and 
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recruitment of Plo1 to the SPB (Grallert et al., 2013a, Grallert and Hagan, 2002, 
Krien et al., 1998, Krien et al., 2002).  
 
A combination of biochemical and phospho-proteomics approaches have been 
used to define phosphorylation consensus sequences for these kinases, across 
eukaryotic systems (Koch et al., 2011, Cheeseman et al., 2002, Nakajima et al., 
2003, Grosstessner-Hain et al., 2011). Positional scanning oriented peptide library 
screening has corroborated these consensus sites and highlights the fact that 
human Plk1, Aurora A&B and Nek2 (NIMA-related kinase) have a strong 
preference for any residue besides Proline in the +1 position. This means that the 
CDK consensus site is mutually exclusive with that of other mitotic kinases. This 
may form the basics of a “division of labour” between CDK and other mitotic 
kinases, despite the overlap in their spatial distributions during mitosis (Alexander 
et al., 2011).  
 
In this chapter I present an analysis of cell cycle dependent phosphorylation 
(quantified in Chapter 2), besides that directly mediated by CDK (Cdc2). This 
analysis identifies a number of trends that seem to allow the amplification and 
diversification of the cell cycle dependent phosphorylation beyond CDK signalling. 
It also hints at possible mechanisms by which cell cycle kinase cascades are 
coordinated. 
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5.1 Global phosphorylation is highly dynamic during the cell 
cycle 
The global behaviours of the phosphoproteome were analysed during two 
sequential cell cycles to investigate the contributions of, and the connectivity 
between, different kinases over the cell cycle. Cells were synchronised after 
release from a G2 arrest imposed by chemical inhibition of Cdc2 (by 1 µM 1-
NmPP1) (Figure 2.08). Compared to previous cell cycle phosphoproteomics 
studies this analysis involves significantly more time points (20) and also analyses 
two sequential synchronous divisions (Olsen et al., 2010, Carpy et al., 2014). The 
ability to define behaviours that are reproduced over two sequential divisions is 
important as it allows the discrimination of cell cycle dependent phenomena from 
possible artefacts of cell cycle perturbation used for synchronisation, that would be 
seen only during the first cycle after release, such as the temperature shifts to 
synchronise cell in previous S. pombe proteomics studies (Bicho et al., 2010, 
Carpy et al., 2014).  
 
5.1.1 Global phosphorylation is highly dynamic and synchronised during 
the cell cycle  
Hierarchal clustering and principal component analysis (PCA) were used to assess 
the global changes in, and variance between, the phosphoproteome and proteome 
across the synchronised cycles. PCA is a powerful statistical approach used to 
describe the proximity of different conditions (i.e. time points) within a multi-
dimensional dataset (i.e. thousands of different phosphorylation events). It defines 
the first (principal) component as an orthogonal coordinate axis that describes the 
direction of the maximal variance between all samples through multi-dimensional 
space. It then defines a second component that accounts for the next most 
maximal variance, orthogonal to the first component, and so on. The relative 
distance between any two conditions on a component reflects the relative 
differences between those two samples, in the direction for which that axis 
accounts for variance. PCA of the phosphoproteome clusters samples from the 
same cell cycle stages demonstrating that the phosphoproteome is less different 
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Figure 5.01 | Global dynamics and synchrony of the phosphoproteome and proteome during the 
cell cycle  
a&b Plot of component one and two from principle component analysis of the phosphoproteome and proteome. Each 
point corresponds to a single time point during over two sequential cell cycles. Points closer together are more similar in 
the respective component.  
c Heat map of total phosphorylation and protein levels, after hierarchical clustering by Euclidian distance. Each row 
corresponds to a single phosphorylation event or protein and each column corresponds to a different time point after 
release from a G2 arrest. Values outside the display range (3 > Log2(L:H) > -3) are set to the closest extreme. 
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between samples taken from the same cell cycle stage (Figure 5.01a). The first 
component accounts for 35.1% of the variance whilst the second component 
accounts for 14.5% of the variance. In the second division cycle (90-130 min) the 
variance between samples is less, due to the reduced synchrony of the culture 
which is why time points spiral toward the origin on the plot of component 1 v 
component 2. The largest differences (component 1) in the phosphoproteome 
occur between interphase and mitosis. This is not true for the proteome, for which 
PCA is unable to draw out differences between time points that cluster cell cycle 
states together (Figure5.01b). This demonstrates a global synchrony to the 
phosphoproteome that corresponds to cell cycle progression, but is absent at the 
level of the proteome. The degree and direction of global change in 
phosphorylation and protein can be seen in Figure 5.01c, a heat map of all 
phosphosites relative phosphorylation values after hierarchical clustering. This 
shows a wide dynamic range in the changes in phosphorylation during the cell 
cycle with a large number of sites peaking in mitosis, whilst the proteome is broadly 
unchanged. 33.7% of the phosphosites in Figure5.01c show a threefold change 
during the cell cycle.  
 
5.1.2 Defining dynamic phosphorylation at non-CDK substrate sites  
To dissect the contributions to specific behaviours all subsequent analysis was 
restricted to singly phosphorylated peptides. This should eliminate artefacts where 
quantification of phosphorylation at a particular site is influenced by changes in 
phosphorylation of adjacent sites on the same peptide. As discussed in Chapter 2, 
hundreds of S/T-P sites are regulated by CDK, and 42.0% (629/1497) of the S/T-P 
on singly phosphorylated peptides change more than threefold across the cell cycle, 
whilst 24.3% (685/2814) of sites not at a S/T-P sites changed similarly. Sites that 
change threefold were considered to be dynamic. The consensus motifs of mitotic 
cell cycle kinases (Sheet03) were analysed. This shows that dynamic S/T-P sites 
are enriched in the CDK consensus site (S/T-P-X-K/R). In contrast dynamic non-
S/T-P are enriched at the Plk1 sequence consensus motifs and at Ark1-dependent 
phosphorylation sites, previously identified in a phospho-proteomics screen (Koch 
et al., 2011). They are also enriched on proteins phosphorylated by CDK at other 
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residues (defined in Chapter 2) suggesting co-regulation of substrates between 
CDK and other kinases is commonplace.  
 
 
Figure 5.02 | Dynamics of non-CDK substrate phosphorylation during the cell cycle 
a Heat map of phosphorylation after release from G2 arrest, of all non S/T-P sites that changed more than threefold 
during the cell cycle. Each row corresponds to a single phosphorylation event and each column corresponds to a 
different time point after releaser from a G2 arrest. Rows are ordered by hierarchical clustering according to Euclidian 
distance. Different clusters (A-H) represent a number of cell cycle dependent behaviours that are consistent over the 
two sequential cell cycles. 
b Median phosphorylation of all sites in clusters A-H, after release from a G2 arrest. 
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To get a sense of the differing outputs of the kinases besides CDK, these 685 
dynamic non S/T-P sites were hierarchically clustered by Euclidean distance and a 
number of discrete behaviours, which showed consistent changes over the two cell  
cycles, were defined in cluster A-H (Figure 5.02a). Figure 5.02b shows the median 
profile for all sites in a given cluster and Figure 5.03 shows the distribution of amino 
acids around the phosphorylation site for all phosphorylation events in each cluster.  
 
Cluster A defines a significant portion of the phosphoproteome that increases 
during mitosis. These mitotic sites are enriched in Ark1 substrate sites described by 
Koche et al. (2011) as well as all three Polo-like kinase (Plk1) consensus motifs. 
Cluster A is the only cluster enriched on proteins with CDK-dependent 
phosphorylation events at S/T-P residues elsewhere in the protein. Cluster A is 
also enriched in cell cycle related GO-terms such as chromosome segregation, cell 
division and the kinetochore. Cluster B phosphorylation peaks later in mitosis and 
is sustained until S-phase/cytokinesis when these sites are dephosphorylated until 
the next mitosis. Cluster B was also enriched in previously defined Ark1 dependent 
phosphorylation sites as well as sites on proteins involved in chromosome 
organisation.  
 
A smaller number of sites do not peak in mitosis but still have a dynamic and 
consistent behaviour over the two cell cycles (clusters C-H) (Figure 5.02). Of these, 
clusters C and D both decline during nuclear and cell division, when the majority of  
 
 
Figure 5.03 | Phosphorylation site consensus sequence  
Amino acid distribution around the phosphorylation site for all phosphorylation sites in clusters A to H, as 
well as all non-S/T-P phosphorylation sites and dynamic non S/T-P phosphorylation. 
Cluster A (n=292)
Cluster B  (n=22) Cluster F  (n=12)
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Cluster C  (n=24) Cluster G  (n=18)
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the dynamic phosphoproteome is maximally phosphorylated, peak during G2 and 
decline as cells enter the second mitosis. The sequences, surrounding these 
phosphorylation sites in cluster C&D, have a significant enrichment of a -5 histidine 
and -3 arginine (Figure 5.03). In terms of protein function, cluster D is enriched in 
proteins annotated to secretion and lipid metabolism gene ontologies. Clusters E 
and G show the opposite behaviour and peak during G1/S, are low through the rest 
of G2, and start to rise again at the end of the next mitosis. Both of these clusters 
are heavily enriched for a -3 arginine with respect to the phosphorylation site. All 
dynamic non-S/TP sites, clusters A-H, and the enrichments are listed in 
supplementary Sheet03. 
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5.2 Mitotic Kinase substrate phosphorylation and their 
dependency on CDK activity   
The evolution of more than one kinases to control the progression through mitosis 
may have been driven by the need for different substrates to be phosphorylated 
with precisely resolved differences in timings/dynamics, i.e. diversifying the range 
of substrate phosphorylation profiles. Because there has been no systematic 
analysis of all mitotic kinase’s targets in S. pombe, putative Ark1 (Aurora), Plo1 
(Plk) and Fin1 (NIMA kinase) substrates were defined in the dataset and were 
compared to the phosphorylation dynamics of CDK substrates. Although putative 
substrates are not direct substrates, the average behaviour of their phosphorylation 
should reflect the collective dynamics of true substrates. 
 
Putative Ark1, Plo1 and Fin1 substrates were defined using the dataset of 685 
dynamic phosphorylation events (quantified only from singly phosphorylated 
peptides). This dataset contained 84 Aurora, 114 Plk and 54 NIMA kinase 
consensus sites (consensus sequences listed in Sheet03) and 30 Aurora, 80 Plk 
and 26 NIMA kinase consensus sites that fall with in the mitotic clusters (A&B). 
Given these three kinases are known to function during mitosis these mitotic sites 
were defined as putative substrates. Examples of these sites are shown in Figure 
5.04a-c. Putative Ark1 substrate sites are enriched in previously describe Ark1 
dependent phosphorylation events whilst Fin1 and Plo1 sites are enriched on 
proteins phosphorylated by CDK at other residues, suggesting a significant amount 
of cross talk may exist between these kinases and Cdc2. The examples in 
 
 
Figure 5.04 | Mitotic kinases: putative Ark1, Plo1 and Fin1 kinase substrate phosphorylation during 
the cell cycle  
a-c Examples of the relative phosphorylation (after smoothing) of Ark1 and putative Plo1 and Fin1 
substrates after release from a G2 arrest (A smoothed line, Spline, connects values). 
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figure 5.04a-c show that Ark1 substrates peak at the end of mitosis and during G1 
whilst putative Plo1 and Fin1 substrates peak in mitosis, and that Plo1 
phosphorylation persist slightly longer than Fin1 substrate phosphorylation.  
 
As an approximation of the phosphorylation output of these kinase the median 
phosphorylation of Cdc2, Ark1 and putative Plo1 and Fin1 substrates during the 
first mitotic exit and second mitotic entry are shown in Figure 5.05a&b. The first 
mitotic exit was analysed because it is the most synchronous. The second mitotic 
entry was analysed as it is more physiological than the abrupt release from 
Cdc2 inhibition after G2 arrest at the first mitotic entry. Putative Fin1 and Plo1 
substrates are as described above, Cdc2 substrates were defined in Chapter 2 and 
Ark1 substrates are defined as the overlap between putative Ark1 substrates and 
Ark1 dependent phosphorylation sites defined by Koch et al. (2011). During mitotic 
exit the substrates of different mitotic kinase are dephosphorylated in sequential 
waves with Cdc2 substrates dephosphorylated first, followed almost immediately by 
Fin1 substrates then Plo1 and finally Ark1 substrates. During mitotic entry Cdc2 
substrates are phosphorylated first followed by Fin1 then Plo1 substrates. Ark1 
substrate phosphorylation peaks last, about ten minutes after Cdc2 substrate 
phosphorylation. These timing intervals may represent an important aspect of the 
ordering of the temporal progression through mitosis and the timely completion of 
cytokinesis. There are also differences between putative substrates of the same 
kinase, for example some of the Ark1 substrate sites peak at the beginning of G1 
and then immediately start to be dephosphorylated, whilst phosphorylation on 
others substrates, such as the non-SMC condensin subunit Cnd2, only start to be 
removed in the middle of S-phase/cytokinesis (figure 5.04c). 
 
Cells arrested in G2 by Cdc2 inhibition (1 µM 1-NmPP1) do not have Ark1, Plk1 or 
Fin1 substrate phosphorylation until the 1-NmPP1 is washed out, indicating that the 
phosphorylation of these kinases’ substrate is down-stream of Cdc2 either directly, 
or indirectly in response to the initiation of mitotic events. To asses these 
dependencies, the phosphorylation of these substrates was analysed after 
complete chemical inhibition of Cdc2 during mitosis (10 µM 1-NmPP1). Figure 
5.05c shows the median relative phosphorylation of Cdc2 and Ark1 substrates and  
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Figure 5.05 | Ark1, Plo1 and Fin1 substrate phosphorylation dependencies on CDK activity  
a-c Median phosphorylation of Akr1 and Cdc2 substrate sites and putative Plo1 and Fin1 substrate sites during  
(a) mitotic exit, (b) mitotic entry or (c) after CDK inactivation in mitosis with 10 µM 1-NmPP1. 
d Relative phosphorylation of all putative Ark1, Plo1 and Fin1 substrates after CDK inactivation in mitosis (see Figure 
2.02a for experimental design. Putative substrate sites were split across two graphs (upper and lower panel) showing 
two distinct behaviours. Ark1 dependent phosphorylation events defined by Koch et al. (2011) are shown in blue. One 
putative Fin1 site is not shown as it falls outside the axis limit.  
 
putative Plo1 and Fin1 substrates after Cdc2 inhibition, whilst Figure 5.05d shows 
individual profiles of putative Ark1, Plo1 and Fin1 kinase substrates after Cdc2 
inhibition. Cdc2 substrates start to be dephosphorylated immediately after Cdc2 
inhibition whilst putative Fin1 substrates show a small delay of 3-6 min before they 
start to be dephosphorylated. Plo1 substrates rise slightly or are stable up to 
approximately 6 min after Cdc2 inhibition, when the majority start to be 
dephosphorylated. In contrast putative Ark1 substrate phosphorylation is refractory 
to CDK inhibition and is either stable (Figure 5.05d lower panel) or continues to 
increase (Figure 5.05d upper panel) in phosphorylation, even after Cdc2 has been 
inhibited for 24 min.  
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The dependencies of these kinases on Cdc2 activity suggest that Cdc2 may 
directly positively regulate Fin1 and Plo1 activity, whereas Ark1 does not require 
the continued presence of Cdc2 activity, once mitosis is initiated. These differential 
dependencies on Cdc2 would be sufficient to explain the progressive ordering of 
phosphorylation during mitotic entry and exit. Cdc2 activation results in the 
phosphorylation of its substrates that then initiates the activation of Fin1 and Plo1 
substrate phosphorylation, which rise shortly after Cdc2 substrate phosphorylation 
in mitosis.  
 
When Cdc2 is inactivated, or when cells progress through mitotic exit, putative Fin1 
substrate are dephosphorylated faster than those of Plo1, suggesting that Plo1 
activity or substrate phosphorylation is more stable than that of Fin1. This may be 
because Plo1 substrates are less sensitive to phosphatases during mitotic exit than 
Fin1 substrates or that Plo1 activation is multiple steps downstream of Cdc2, 
generating a time lag in the response. There are multiple possible mechanisms, 
which are not mutually exclusive, by which Plo1 substrate phosphorylation could be 
dependent on Cdc2 activity. Cdc2 phosphorylates Plo1 and other SPB proteins that 
may serve to activate Plo1. So when CDK is inactivated Plo1 or its activators would 
then become dephosphorylated, reducing the rate of Plo1 substrate 
phosphorylation which in turn allows their net dephosphorylation. Plo1 is also a 
putative substrate of itself, suggesting that auto-phosphorylation may play a role in 
this process. Alternatively, Cdc2 may phosphorylate Plo1 substrates priming them 
for subsequent Plo1 phosphorylation as has been described for a number Plk1 
substrates in higher eukaryotes (see Introduction, section 1.2.3), consistent with 
the fact that putative Plo1 substrates are enriched on CDK substrates. One putative 
Fin1 substrate is Cut12 (T25) a SPB protein that has been characterised as a bona 
fide Fin1 and Cdc2 substrate, the phosphorylation of which is important for the 
recruitment and activation of Plo1 at the SPB3 (Grallert et al., 2013a). As such it is 
possible that part of the dependency of Plo1 on Cdc2 works via Fin1 
phosphorylation of substrates such as Cut12. Cut12 and most of the putative Fin1 
substrates are also Cdc2 substrates suggesting that Fin1 may work to immediately 
amplify the effects of Cdc2 phosphorylation on a number of Cdc2 substrates.  
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In contrast Ark1 substrate site phosphorylation is refractory to Cdc2 inhibition 
suggesting that once mitosis is initiated Ark1 activity is independent of Cdc2 activity. 
This allows Ark1 phosphorylation to persist long after mitotic exit until the point of 
S-phase/cytokinesis. Consistent with this Cdn2 (a major Ark1 substrates) function 
is required throughout mitosis as well for a period after anaphase completion 
(Nakazawa et al., 2011). As mentioned above different Ark1 substrates are 
dephosphorylated at different times as cells progress from mitosis to the end of 
cytokinesis. This could be due to different phosphatases, the activities of which are 
temporally regulated during mitotic exit, targeting different Ark1 substrates for 
dephosphorylation (Grallert et al., 2015). 
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5.3 Regulation of the NDR kinases, Sid2 and Orb6, as revealed 
by the dynamics of substrate phosphorylation 
In addition to the classic mitotic kinases described above, the Septum initiation 
network (SIN) ensures the appropriate coordination between cell division and 
nuclear division. SIN redundantly contributes to the assembly of the actomyosin 
ring and is essential for the maturation, constriction and disassembly of the 
cytokinetic ring (Pollard and Wu, 2010). The SIN pathway’s terminal output is Sid2 
kinase activity. A number of Sid2 substrates have been described including Clp1, 
Cdc11, Cdc12 and Klp2 (Bohnert et al., 2013, Chen et al., 2008, Feoktistova et al., 
2012, Mana-Capelli et al., 2012). Some of these were also identified in a 
proteomics screen for Sid2 substrates which identified the following proteins: Sog2, 
Nak1, Clp1 Rgf1, Ase1, Pos1, Ppk25, Mph1, Ipp1, Scw1, Cdc11 and Mug72 
(Gupta et al., 2013). Sid2 preferentially phosphorylates the sequence: R-X-X-S and 
Sid2 activity is thought to start to rise in anaphase (Chen et al., 2008, Feoktistova 
et al., 2012). Figure 5.06a shows all detected phosphorylated R-X-X-S motifs on 
the above proteins that increase during in mitosis (i.e. cluster A&B). These sites 
were defined as Sid2 substrate sites. Interestingly these phosphorylation sites fall 
into two categories: those that peak in mitosis and those that increase during 
mitosis but continue to rise in phosphorylation until cytokinesis. These two 
behaviours mirror the behaviour of four phosphorylation sites in the N-terminal 
domain of Sid2 itself. Two sites at the minimal CDK consensus (S42 & S86) peak 
in mitosis, one of which is a bona fide CDK substrate site (S86) (Chapter 2 & 
Sheet02). S56 and S99 rise during mitosis, peak during G1 and decline after 
cytokinesis. These two sites are 13/14 amino acids C-terminal to one of the S/T-P 
sites, suggesting there may be some importance to the local arrangement of 
phosphorylation sites of different kinases that phosphorylate Sid2, possibly 
involving a “hand-over” event in the activation of Sid2 from CDK to another kinase 
that targets proximate but distinct sites. This dual regulation may reflect or 
contribute to the change in phosphorylation of Sid2 substrates.  
 
Cluster E and G are enriched in R-X-X-S sites and phosphorylation peak during 
cytokinesis (Figure 5.02 & 5.03), but unlike the Sid2 substrates described above,  
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Figure 5.6 | Sid2 substrates and possible Orb6 substrates involved in polarised growth 
phosphorylation sites in cluster E and G do not increase in phosphorylation during 
mitosis. Some of these proteins (Figure 5.06b) are involved in process related to 
cytokinesis, for example Blt1 and Cdr2 are cortical node proteins that contribute to 
septum positioning. Cdr2 transiently dissociates from cortical nodes towards the 
end of mitosis: a possible function for this phosphorylation (Pollard and Wu, 2010). 
Klp5 and Klp6 are also in these clusters and contribute to the cytokinetic 
actomyosin ring contractility. However, none of the R-X-X-S phosphorylation events 
in cluster E or G are on proteins previously defined as Sid2 substrates by Gupta et 
al. (2013) suggesting they may be the substrates of other kinases that peak during 
G1/S. For instance the Cmk1 transcript and Cmk2 protein levels have been 
reported to peak during G1/S and are both orthologs of Calmodulin activated 
kinases that phosphorylate a minimal consensus site of R-X-X-S/T (Swulius and 
Waxham, 2008, Alemany et al., 2002, Rasmussen, 2000).  
 
During mitosis and cytokinesis cells arrest polarised growth (Mitchison and Nurse, 
1985) and Sid2 phosphorylation of Nak1, resulting in inactivation of the NDR-
related kinase Orb6, is thought to contribute to this arrest (Gupta and McCollum, 
2011, Ray et al., 2010). Nak1-S501 phosphorylation rises during mitosis and peaks 
just before cell division (Figure 5.06a). Orb6 organises the polarisation of the actin 
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patches to cell ends via the spatial regulation of Cdc42 activity, but to date no direct 
Orb6 substrates have been described (Das et al., 2009, Verde et al., 1998). The 
NDR kinase consensus motif is enriched in a -5 histidine and a -3 arginine or lysine 
(Hao et al., 2008). Interestingly Cluster C and D are enriched in both of these traits 
indicating that phosphoproteins in these clusters could represent direct Orb6 
substrates (Figure 5.03). The phosphorylation of NDR consensus sites in Cluster C 
and D show the inverse phosphorylation pattern to that of Sid2 substrates and are 
phosphorylated throughout G2. This is consistent with the hypothesis that when 
cytokinesis is completed Sid2 is inactivated, resulting in Nak1 dephosphorylation 
permitting Orb6 activation and Orb6 substrate phosphorylation and thus re-initiate 
polarised growth (Figure 5.06d). Consistent with Orb6’s role in polarised growth 
cluster C and D include the polarity factor Tea3 (Arellano et al., 2002) and are 
enriched in proteins involved in lipid transport and exocytosis (e.g. Sec72, Sec9 & 
Oxysterol-binding protein ortholog SPBC2F12.05c). The timing of phosphorylation 
and annotated functions of these phosphoproteins supports the conclusion that a 
number of these substrates may indeed be direct Orb6 substrates.	
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5.4 Discussion 
CDK seems to be responsible for an impressively large proportion of cell cycle 
regulated phosphorylation. However, a significant subset of non CDK consensus 
sites (non S/T-P) are also dynamic during the cell cycle. These phosphorylation 
events coordinate the execution of cell cycle processes, downstream of a number 
of cell cycle kinases besides CDK. Here five other kinases have been investigated: 
NIMA kinase, Polo-like kinase, Aurora Kinase, and two NDR kinases involved in 
the septation initiation network (Sid2) and the MOR pathway (Orb6). Analysing 
bona fide and putative substrate of these kinases reveals multiple sequential waves 
of phosphorylation that proceed as cells undertake the program of cell division. 
This phosphorylation is inversely related to interphase phosphorylation implicated 
in cell growth, possibly downstream of the Orb6 kinase. 
 
The crosstalk and connectivity between these kinases is striking and functions at 
two levels: the regulation of each other as well as the phosphorylation of common 
substrates. This diversity of kinases seems to allow the amplification and 
diversification (e.g. via persistence after CDK inactivation) of CDK signalling during 
mitosis. CDK substrate phosphorylation peaks early in mitosis and starts to decline 
once anaphase is initiated and Cyclin degradation starts. The phosphorylation of 
substrates, by other mitotic kinases, peaks in mitosis but have different 
phosphorylation dynamics during mitosis to CDK substrates. For instance, the 
phosphorylation of putative substrates of Fin1, Plo1 Ark1 and Sid2 increases after 
CDK activity rises at mitotic entry. Most of these sites are then dephosphorylated 
after Cdc2 inactivation at mitotic exit in sequential waves, in a manner 
corresponding to the respective kinase’s dependency on CDK activity. The altered 
profiles and persistence of other mitotic kinases downstream of Cdc2 allows the 
diversification of CDK signalling via these kinases. 
 
Furthermore, some kinase (e.g. Ark1 and Sid2) may have substrates with 
significantly different phosphorylation profiles suggesting that the progression 
through mitosis and cytokinesis may involve shifting exposure to, or specificity for, 
certain substrates. 
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Chapter 6. General discussion 
The main conclusions of this thesis are as follows. There are hundreds of 
CDK substrates in S. pombe that are first phosphorylated by CDK at different times 
during the cell cycle. The early phosphorylation of S-phase substrates persists and 
is not reversed during G2 and mitosis. Mitotic substrates are phosphorylated at 
mitotic entry, and both S-phase and mitotic substrates are dephosphorylated at 
mitotic exit. There is also a third intermediate category in which substrate 
phosphorylation increases significantly at both transitions, and peaks at G2/M 
(biphasic substrates). The differences between these categories of substrates can 
be accounted for by differences in their in vivo sensitivity to CDK activity: S-phase 
substrates being more sensitive than biphasic, which are in turn more sensitive 
than mitotic substrates. This supports the notion that rising CDK activity orders cell 
cycle events via the attainment of substrate specific CDK activity thresholds, with 
low activity resulting in S-phase substrate phosphorylation, and thus initiating DNA 
replication, and higher activity driving mitotic entry via the phosphorylation of mitotic 
substrates. Furthermore, when the order of CDK substrate phosphorylation is 
perturbed, there is a corresponding reordering of the cell cycle, supporting the 
conclusion that activity dependent differential phosphorylation of CDK substrates not 
only correlates with cell cycle events but is rate-limiting for the initiation of the 
respective cell cycle transition. 
 
Of those proteins phosphorylated in S-phase, there are a number of substrates 
previously described as involved in origin licensing (e.g. Orc1 and Orc2) and others 
involved in origin firing (e.g. Drc1 and Sld3) (see Introduction, section 1.2.1). Both 
become initially phosphorylated during the same window at G1/S, consistent with 
the notion that the inhibition of origin licensing has to occur at the same time as, or 
before, the initiation of origin firing to prevent fired origins from re-licensing and re-
firing. However, phosphorylation on Orc1 and Orc2 continues to increase 
significantly during G2/M, in contrast to Drc1 or Sld3. The significance of this is 
unclear, but it may reflect a preference to initially phosphorylate ORC proteins that 
are in complex with the rest of the ORC proteins. This is consistent with the 
observation in Chapter 3, that disruption of ORC stability also disrupts ORC subunit 
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phosphorylation. Prioritised phosphorylation of assembled ORC subunits could 
serve to enhance the stringency of re-licensing inhibition.  
There is a rise in phosphorylation of a number of sites after S phase (biphasic 
substrates) involved in DNA replication related processes. These substrates, as 
discussed in Chapter 3, may be involved in the termination of replication and/or 
preparation of chromosomes for mitosis, post-S-phase. Following this, mitotic 
substrates are phosphorylated during G2/M. Of the mitotic substrates, those that 
are more sensitive to CDK activity are phosphorylated earlier during G2/M, 
suggesting that the orderly progression through mitosis is organised via the 
passage through sequential substrate specific CDK activity thresholds. 
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6.1 The function of CDK-mediated phosphorylation is unknown 
for many substrates    
As discussed in the Introduction, CDK activity is important for the firing of origins 
upon S-phase initiation and the inhibition of origin licensing outside of G1. There is 
also a universal involvement of CDK in bipolar mitotic spindle assembly and 
attachment, chromosome condensation, phosphatase regulation, auto-regulatory 
CDK activation, as well as an array of other “typical” mitotic events (Introduction, 
section 1.2). Many CDK substrates defined here and by other large-scale 
approaches substantiate this picture (Holt et al., 2009). Numerous orthologs of S. 
cerevisiae Cdc28 substrates described in the literature are also novel S. pombe 
Cdc2 substrates. These include Rho-type GTPase activating proteins involved in 
polarised growth (Rga2, Rga3, Rga4, Rga7, Rga9), the Polo like kinase (Plo1), the 
DASH complex subunit Ask1, INCENP (Pic1), and the nucleoporin Nup40, 
amongst others (Enserink and Kolodner, 2010). 
 
However, there are numerous CDK substrates, reported in Chapter 2, for which a 
CDK regulated function has not been reported. Some CDK substrates identified 
here may represent fission yeast specific substrates that have evolved to account 
for the idiosyncrasies of the life cycle, cell cycle and ecology of fission yeast. Some 
of these substrates have also been identified by phosphoproteomics as being 
phosphorylated downstream of CDK in S. cerevisiae, hinting at additional 
conserved regulatory functions for CDK, for which the molecular mechanism 
remains to be elucidated. For example, Msh6 and Dfp1 both show a biphasic 
behaviour in phosphorylation, peaking after S-phase, and are also both orthologs of 
Cdc28 substrates in budding yeast (Holt et al., 2009). Dfp1 activates the S-phase 
kinase Cdc7 (S. pombe Hsk1) (Labib, 2010) (i.e. Dfp1 is the ortholog of S. 
cerevisiae Dbf4) and in both organisms is phosphorylated by CDK in the disordered 
N-terminal region. The only detected CDK dependent site in S. pombe Dbf1 (T80), 
is immediately adjacent to two nuclear localisation sequences, hinting at a possible 
mode of action. The S. cerevisiae and S. pombe DNA mismatch repair protein, 
Msh6, is also phosphorylated in a predicted disordered N-terminal region 
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suggesting another conserved CDK regulated function in DNA metabolism. Fission 
yeast Rad4 (Dpb11 ortholog) is phosphorylated at mitosis whilst the BRCT domain-
containing protein Mdb1 is a S-phase substrate pointing to additional instances of, 
as of yet, uninvestigated cross talk between the cell cycle machinery and the 
genome surveillance machinery.  
 
Holt et al. (2009) identified a number of protein involved in nuclear transport as 
Cdc28 substrates, two of which were also identified here as S. pombe CDK 
substrates (S. pombe Nup90 and Nup124) with multiple detected CDK dependent 
phosphorylation event that peaked in mitosis. Furthermore, phosphorylation events 
on S. pombe Nup40 and Nup146 are also dependent on CDK activity. This 
suggests a possible role for nucleopore regulation in the entry into, or execution of, 
mitosis. This is consistent with the observation that nucleopore function is required 
for timey mitotic entry in a dose dependent manner, as shown by the the fact that 
multiple S. pombe nucleoporin are haplo-insufficient for cell size (Jacqueline 
Hayles, personal communication). It has been proposed that CDK regulates the 
nuclear transport machinery at mitotic entry in human cell lines to accelerate 
nuclear import rates, and that Nup53 has also been defined as CDK substrates by 
in vitro covalent labelling of CDK substrates (Gavet and Pines, 2010a, Blethrow et 
al., 2008). The exact mechanism and importance of how the nuclear-cytoplasmic 
transport machinery changes during cell cycle transitions is not clear, but the fact 
that multiple nucloporins are CDK substrates suggests it merits further investigation.  
 
CDK dependent phosphorylation of Rif1 was also identified in S. pombe and S. 
cerevisiae. Rif1 is involved in the regulation of telomere length, the selection and 
timing of origin firing and the repair of double strand breaks by non-homologous 
end joining. (Kumar and Cheok, 2014, Yamazaki et al., 2013). The interaction 
between the N-terminus of Rif1 and PP1 (Dis2) is important in antagonising DDK 
phosphorylation at late firing origins (Hiraga et al., 2014). S pombe Rif1-S50 
phosphorylation peaks in mitosis, but how this phosphorylation relates to the known 
functions of Rif1 is unclear. S50 and a cluster of other proximate putative CDK sites 
are immediately adjacent to an NLS sequence and are situated between a S-I-L-K 
and R-V-X-F PP1 docking motif in the disordered Rif1 N-terminus, suggesting that 
CDK phosphorylation of Rif1 may release PP1 from Rif1 and/or regulate the 
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nuclear transport of Rif1 at the onset of mitosis. In addition to Rif1 there are a 
number of other telomere related proteins that are phosphorylated by CDK, 
including the telomere bouquet formation protein Bqt4 and telomere maintenance 
protein Ccq1.  
 
The inositol polyphosphate phosphatase Inp53 is also a CDK substrate in both 
yeasts, whilst the S. pombe protein Lnp1 (the luna park ortholog, thought to play a 
role in tubular endoplasmic reticulum) and the inner nuclear membrane protein 
Lem2 are also CDK substrates during mitosis. The CDK regulation of transcription 
factors seems especially prevalent with multiple phosphorylation sites in Sep1, Atf1, 
and Adn2, as well as more than ten phosphorylation sites detected across other 
transcription factors including Cdc10 and Fhk2. There are also phosphorylation 
sites in two subunits of the INO80 chromatin remodeller complex, in a subunit of 
the HIRA complex (Hip1, involved in DNA synthesis independent histone 
deposition), and in a range of factors related to chromatin modification such as the 
Clr6 histone deacetylase associated PHD protein-1 Cph1, and Epe1 the putative 
H3-K9 demethylase. 
 
The full list of CDK substrates defined here with the names of the human and S. 
cerevisiae orthologs and whether they were defined as having Cdc28-dependent 
phosphorylation in S. cerevisiae by Ubersax et al. (2003) and/or Holt et al. (2009) is 
listed in supplementary Sheet02.  
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6.2 What determines the differences in sensitivity to CDK 
between S-phase and mitotic substrates?  
Multiple possible biochemical properties of CDK substrates could explain the 
differences in sensitivity to CDK activity, as discussed at length in Chapter 3 
(section 3.5.1). The detailed characterisation of a handful of substrates will 
probably be required to elucidate the molecular principles that underpin these 
differences in behaviour. The observation that sites within the same protein behave 
similarly indicates that phosphorylation determinants are not all site autonomous. 
They could function at the level of the whole protein or simply at the level of a sub-
protein domain. A simple test of this would be to investigate how the 
phosphorylation of a candidate S-phase substrate and a candidate mitotic 
substrate behave when the two are fused together in a single chimeric substrate. If 
either half of such a chimera were to be dominant over the other (i.e. the S-phase 
substrate causing premature mitotic substrate phosphorylated, or the mitotic 
substrate delaying the phosphorylation of the S-phase substrate moiety) it would 
suggest that protein wide determinants operate to specify the timing of a substrate. 
If this were the case, it would also provide a well-controlled system to properly 
integrate the nature of such determinants by screening for which fragments of the 
dominant moiety are required to alter the phosphorylation of the recessive moiety. 
Alternatively, if the S-phase and mitotic moiety of such a chimera were to behave 
independently it would indicate that the determinants for phosphorylation exist at 
the sub-protein domain level or lower, ruling out, for example, sub-cellular 
localisation as a determinant.  
 
It is entirely plausible that numerous properties (e.g. docking motifs, domain 
structures, sub-cellular localisation) have differing significance in different 
substrates. Additionally, Cks1-dependent processive phosphorylation reactions 
could be necessary for the observation that sites in the same protein behave 
similarly. If a small number of sites in an S-phase substrate were more sensitive to 
CDK activity because of local sequence determinants, they could bind Cks1 once 
phosphorylated, positioning other less sensitive sites for enhanced phosphorylation 
by CDK in cis. Because Cks1 enables processive phosphorylation reactions there 
should be no detectable differences in the timing of phosphorylation of priming and 
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downstream sites. Such a scenario would allow a few sites to determine the 
phosphorylation of other CDK substrate sites, but would have to involve the 
appropriate spatial position of priming and downstream sites on the substrate. This 
could be simply tested by mutating CDK phosphorylated Threonines to Serines in 
candidate substrates, given that Cks1 can only bind phospho-threonine (Koivomagi 
et al., 2013).  
 
The inter-dependencies of Orc1 and Orc2 phosphorylation illustrate that the 
determinants for specificity can operate at the level of an entire complex. There are 
other examples of multi-subunit complexes that include multiple CDK substrates 
that theoretically could behave similarly, such as the CPC. It is also worth 
considering whether larger sub-cellular structures, such as the nucleopore, the 
spindle, the SPB and the kinetochore, function as if they are one large substrate. 
For example, one or a small number of “adaptor” substrates could be required to 
determine the phosphorylation of other substrates at specific locations/structures 
within the cell. A systematic analysis of the inter-dependencies between different 
substrates would help elucidate any such substrate networks with “secondary 
substrates” organised around “primary substrates nodes” that would provide the 
defining biochemical determinants for phosphorylation timing. Although there is 
little data supporting such a model at present the hypothesis is attractive because 
of the large number of CDK substrates that exist within the cell. 
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6.3 Why are there multiple cyclins? 
A significant body of work in other organisms has described the contribution of 
G1/S-phase cyclins as a combination of low activity Cyclin-CDK complexes with 
enhanced specificity towards certain substrates (see Introduction, section 1.4.1). 
The data presented in Chapter 4 suggest that S. pombe G1/S-phase cyclins form 
Cyclin-CDK complexes with lower activity than Cdc13-Cdc2, but do not provide any 
evidence of strong substrate specificity towards early substrates. To properly 
examine this CDK substrate phosphorylation should be quantified across a time 
course during the entry into and progression though a synchronised S-phase in the 
absence and presence of Cig1, Cig2 and Puc1. These and previous data are 
consistent with a model whereby S-phase is initiated by a larger number of less 
active Cyclin-CDK complexes that are, as such, better able to tune CDK activity 
around the lower threshold required for S-phase initiation, by resolving smaller 
differences in CDK activity. The low activity of G1/S-phase cyclins may also ensure 
that S-phase cyclins are never able to achieve sufficiently high CDK activity levels 
to initiate mitosis, helping to ensure the resolution of S-phase and mitosis, 
according to the quantitative model. Cdc13 is the only essential cyclin in fission 
yeast and there have been no successful attempts to re-engineer the expression or 
stability of other cyclins to complimenting cdc13∆. If any of Cig1, Cig2 and Puc1 
are indeed no different to Cdc13, other than being differentially expressed and 
producing lower CDK activity per Cyclin-CDK complex, they to should be able to 
drive the fission yeast cell cycle, under the appropriate expression conditions. 
Testing this will be important to further corroborating the quantitative model.  
 
6.3.1.1 The evolution of cyclins and cell cycle complexity 
 Phylogenetic analysis of cell cycle-related cyclin orthologs across eukaryotes 
indicates that the cyclin complement, in fungi, contracted and re-expanded. S. 
pombe and S. cerevisiae contain only B-type cyclins whilst the last common 
ancestor to all modern day eukaryotes (LECA) almost certainly contained A, B & D-
type cyclins, given that these cyclins are present from plants and algae through to 
animals (Cross et al., 2011). Fungi and animals are more closely related to each 
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other than they are to plants and form a monophyletic group: the opisthokonts. 
There are examples of basal fungi with both fungal cyclins and metazoan-related 
cyclins, whilst there are also basal fungi that have only a single fungal specific-
type cyclin, and no other cell cycle related cyclins (Nicolas Buchler, personal 
communication). All metazoan-related cyclins were lost in the transition to Dikarya 
(which include the Ascomycota S. pombe and S cerevisiae). This could have 
occurred via the expansion of fungal cyclins, to compensate for loss of metazoan 
cyclins. Alternatively, it could have arisen via an evolutionary intermediary with 
only a single cyclin, from which the ancestor to modern day Dikarya expanded its 
cyclin repertoire by gene duplication and diversification. Why this shuffling, 
contraction and re-expansion of the cyclin complement has taken place is not 
clear. However, the flexibility within the fungal lineages to reshuffle their cyclin 
complement, through evolutionary time, could be for one of two reasons: selective 
advantages to adapting regulation i) upstream or ii) downstream of Cyclin-CDK 
complexes. Downstream changes could be brought about by the emergence of 
new cyclins to target a small handful of specific substrates (e.g. S. cerevisiae 
Clns). However, this would only involve the expansion, not the contraction or 
shuffling, of the cyclin compliment. For instance, the transition away from 
metazoan cyclins to fungal specific cyclins could have been driven by selective 
pressures to rework the pool of substrates involved in major cell cycle transitions. 
This seems unlikely given the conservation of CDK targets across species, and the 
presumed relative ease in evolving changes in a substrate as opposed to a cyclin 
(which has to account for many substrates simultaneously). Alternatively, new 
cyclins could have emerged to replace old ones to provide an novel regulatory 
setup. For example, the substrates of Cyclin-CDK could be unchanged, but an 
alerted profile or regulation of the CDK activity could offer a fitness advantage, 
perhaps via the ability to incorporate more or different environmental information 
into the decisions to undertake cell cycle transitions, consistent with fungal life as 
a free living, and sometimes single celled, organisms. This expansion of cyclins 
could have then provided a platform from which cyclin-substrate specificity may 
have arisen to refine and add robustness to the execution of cell cycle transitions. 
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It is worth re-iterating that CDK activity does not rise linearly during the cell cycle 
(Draetta and Beach, 1988, Labbe et al., 1988b, Moreno et al., 1989) and the 
acquisition of different cyclins, and their differential expression could have aided 
this. Although the non-linear dynamics of CDK activity accumulation are also due, 
to a large extent, to the autocatalytic switch like response in CDK activity at mitotic 
entry to activate CDK by turning off inhibitory T14 and Y15 phosphorylation (Novak 
and Tyson, 1993). In the minimal CDK network where endogenous cyclins are 
deleted, cells can tolerate the phospho-mutation of T14 and Y15 (Coudreuse and 
Nurse, 2010). This could suggest that either, cells can appropriately temporally 
resolve all necessary thresholds when CDK activity accumulates linearly, or that 
additional mechanism are operating to uncouple cyclin accumulation from CDK 
activity. The synthetic lethality of this background with the deletion of the 
stoichiometric inhibitor of CDK, Rum1, or the major catalytic subunit of the PP2A 
phosphatase (Pp2a) is consistent with the latter (Navarro and Nurse, 2012, 
Coudreuse and Nurse, 2010).  
 
It has been proposed that quantitative model represented an ancestral eukaryotic 
state with a single Cyclin B-CDK-APC/C oscillator organising the cell cycle 
(Nasmyth, 1995). However the fact that the last common ancestor to all modern 
day eukaryotes (LECA) contained A, B & D-type cyclins (Cross et al., 2011) 
suggests that the LECA had acquired a cell cycle network as complex as modern 
day metazoa using multiple Cyclin-CDK complexes. This is also true of other 
eukaryotic attributes, such as the presence of mitochondrial genes, suggesting that 
the inferred properties of LECA may not represent that of a truly primitive or 
nascent eukaryote (Embley and Martin, 2006). Given that the cell cycle machinery 
present in LECA may not necessarily reflect that of the earliest eukaryotes it is an 
open question as to what regulatory principles underpinned the initial evolution of 
the Cyclin-CDK regulation of the cell cycle. A reasonable speculation would be that, 
in response to a selective advantage for the separation of DNA replication and 
chromosome segregation, the rising activity of a single kinase could have 
organised cell cycle events via differential substrate phosphorylation. This selective 
pressure would have presumably been related to an increase in genome size and 
complexity. The subsequent complexity that evolved in LECA could still have been 
underpinned by a simple CDK activity threshold model, as supported by the ability 
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of modern day eukaryotes (i.e. fission yeast) to drive the cell cycle with a single 
Cyclin-CDK. The inability to similarly strip down the cell cycle machinery of 
numerous other eukaryotes could be rationalised by two extreme views. Either they 
no longer operate on a predominantly quantitative model and are dependent on 
qualitative differences in cyclin specificity to execute the orderly progression 
through the cell cycle. Alternatively, no attempts to run a cell cycle from a single 
Cyclin-CDK complex has managed to recapitulate the appropriate activity profile, 
normally the product of multiple Cyclin-CDK complexes, with a single Cyclin-CDK 
complex.  
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6.4 Testing the universality of the quantitative model  
 
In higher eukaryotes different cyclins have the ability to complement each other 
and re-engineered Cyclin B1 constructs can be used to initiate DNA replication, as 
well as mitotic entry (see Introduction, section 1.4.3) (Moore et al., 2003). 
Furthermore only a single CDK; Cdk1, is required for cell division (Santamaria et al., 
2007). These observations are consistent with the conservation of the quantitative 
model. However, directly testing the quantitative model in higher eukaryotes, where 
other regulatory layers confound the core organising mechanism of cell cycle 
progression, could prove experimentally complex. A simple way to address this 
would be to ask two questions about vertebrate proteins ectopically expressed in S. 
pombe. Firstly, can any vertebrate Cyclin-CDK, like Cdc13-Cdc2, preferentially 
phosphorylate S. pombe S-phase substrates over mitotic substrates? Secondly, 
are vertebrate S-phase substrates more sensitive to CDK activity than mitotic 
substrates in S. pombe? If the answer to both of these questions were yes, then it 
would support the notion that higher eukaryotic Cyclin-CDK activity orders the cell 
cycle as per the quantitative model. If a vertebrate Cyclin-CDK was able to 
differentially phosphorylate S-phase and mitotic substrates, and was able to 
acquire the appropriate profile of CDK accumulation, then such a vertebrate Cyclin-
CDK should be able to drive the fission yeast cell cycle in the absence of 
endogenous S. pombe CDK or cyclins. The complementation of S. pombe cdc2 
mutant alleles with human Cdk1 was first reported in 1987 (Lee and Nurse, 1987), 
but there has been no reported attempt to complement fission yeast cdc13 with any 
other cyclins. One possible explanation for this could be the dynamic spatial 
regulation that Cyclin B1 is subjected to in higher eukaryotes, meaning it never 
even reaches the nuclear compartment in fission yeast. A possible way forward 
would be to re-engineer aspects of Cyclin B regulation or to undertake a saturating 
mutagenic screen for Cyclin B mutants that complement cdc13. 
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6.5 Concluding remarks  
The cell cycle network controls some of the most critical decision making process 
in cell biology. The molecular composition of the cell cycle control network is 
becoming increasingly well described but some of the major outstanding issues in 
the field seem to relate to the system properties and quantitative behaviour of these 
networks. That is to say, a reasonable amount is known about “who” makes the 
some of these decisions, but rather less about “how” and “why”.  
 
Kinases, and thus phosphorylation, sit at the heart of cell cycle control. As such, 
understanding the relationship between the major regulatory cell cycle kinases, 
such as CDK, and the dynamics of their substrate phosphorylation is a critical 
aspect of understanding the system and quantitative properties of cell cycle control. 
The work presented in this thesis supports the view that the directionality and order 
in the cell cycle is achieved predominantly by properties of CDK substrates that 
impart differential sensitivity to a rising profile of CDK activity. 
 
The major outstanding questions raised by this thesis are what substrate properties 
determine CDK substrate phosphorylation timing and what are the critical system 
properties (i.e. CDK activity dynamics and substrate sensitivity) that are conserved 
across eukaryotes that are central to ensuring proper cell cycle progression.  
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Chapter 7. Materials and methods 
7.1 Cell culture and S. pombe genetics 
S. pombe media and methods are as previously described (Moreno et al., 1991). Strains 
are listed in Sheet01 (sheet01_experiment and strain list) and Table 7-1. The following 
constructions are previously reported: ∆CCP (Martin-Castellanos et al., 2000), cdc13(as)-L-
cdc2 ∆2 ∆13 ∆CCP, cdc13-L-cdc2AF(as) ∆2 ∆13 ∆CCP (Coudreuse and Nurse, 2010), 
lys3-37, arg1-230 car2∆ (Bicho et al., 2010), sld3-5flag (Fukuura et al., 2011), nsk1-GFP 
(Chen et al., 2011), orc1-HA (Grallert and Nurse, 1996), rad3∆ (Kim et al., 2010),  
cdc2(as)M17 (Aoi et al., 2014), orc2-2 (Kiely et al., 2000), orc1-4 (Grallert and Nurse, 
1996). C-terminal tagging (orc2-3pk) and gene deletion cassette switching was performed 
as previously reported (Bahler et al., 1998b). For ectopic expression of C-terminally 5pk 
tagged drc1, sld3 and orc2: synthetic CDS (Integrated DNA technologies (gBlocks) and Life 
Technologies (GeneArt Strings)) were subcloned into RIP3X with an attenuated (nmt41) 
promoter (Basi et al., 1993, Maundrell, 1993). PacI linearised plasmids were transformed 
integrated at the nmt1 locus (ScLeu2 selection). Derivatives of the above were constructed 
by crosses and confirmed by marker selection and/or colony PCR. 
 
All experiments are performed in exponential growth. All experiment for proteomics were 
performed in SILAC media (EMM (6 nM ammonium chloride) + 0.25 mg/ml leucine, 0.15 
mg/ml uridine, 0.04 mg/ml arginine and 0.03 mg/ml lysine) (Bicho et al., 2010). For all 
heavy labelled samples (H) cells were grown in exponential growth for >8 generations in 
SILAC media supplemented with heavy arginine (L-arginine:HCL (U13C6, 99%)) and 
heavy lysine (L-lysine:2HCL (U13C6, 99%)) isotopes (Cambridge Isotope Laboratories 
Inc.). All other experiments are performed in EMM4S except where the use of YE4S media 
is specified (Moreno et al., 1991). G2 cell cycle arrests were imposed during exponential 
growth using 1 µM 1-NmPP1 treatment for one generation. Times (min) after wash and 
release are with respect to the initial re-suspension of cells during the first of three washes.  
 
DNA content was determined by flow cytometry (FACS). Ethanol (70%, v/v) fixed cells were 
washed and resuspended in 50 mM sodium citrate before incubation with RNase A (0.1 
mg/ml) (SIGMA) (>12 h, 37 °C). DNA was stained with propidium iodide (2 µg/ml) (SIGMA) 
before sample sonication. DNA content per cell was acquired for 10,000 events on a BD 
LSR-Fortessa. DNA content is displayed on a log scale after gating for single, whole cells 
in FlowJo X (Treestar Inc). 
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Nuclear division and cell division was scored in heat fixed samples by monitoring DNA 
(DAPI, SIGMA) and septum formation (calcofluor, SIGMA), respectively (Zeiss Axioskop 
microscope, 63×/1.4 NA objective) (cell photos taken with a QICAM Fast Digital Camera). 
 
7.2 Protein extractions and Western blotting  
Cell cultures were quenched by adding 100% (w/v) ice cold trichloroacetic acid to a final 
concentration of 10%. Cells were kept on ice for >20 min, pelleted and washed in acetone. 
Cell pellets were then washed and resuspended (100µl) in Lysis buffer (8M urea & 50mM 
ammonium bicarbonate + cOmplete Mini EDTA-free protease inhibitor cocktail (Roche) + 
PhosSTOP phosphatase inhibitor cocktail (Roche)). 1.2 ml acid wash glass beads (0.4mM, 
SIGMA) were added to cell suspensions, which were then beaten (FastPrep120) to beak 
cells. Cell debris was pelleted and supernatant was recovered as a protein extract (stored 
at -80 °C). Samples used for Lambda phosphatase assay (NEB) were extracted as above 
with the omission of PhosSTOP) 
 
Phosphorylation dependent band shifts in Orc1, Orc2, Sld3 and Bir1 were resolved using 
Phos-tag (Alpha Laboratories) supplemented SDS-PAGE under neutral pH conditions 
(Kinoshita and Kinoshita-Kikuta, 2011). Protein detection by Western blotting was 
performed using primary antibodies as follows. Cdc13-L-Cdc2: 1:6,000 SP4 antibody 
(rabbit polyclonal) (Moreno et al., 1989). Cdc2-Y15P: 1:500 phospho-Cdc2 (Tyr15) 
antibody (rabbit polyclonal, #9111 Cell Signalling Technology). Alpha tubulin: 1:10,000 
TAT1 antibody (mouse monoclonal) (Woods et al., 1989). Bir1: 1:1,000 anti-Bir1 antibody 
(rabbit polyclonal) (Tsukahara et al., 2010). Dis2: 1:1,000 anti-Dis2 antibody (rabbit 
polyclonal) (63-119, Bioacedemia). Dis2-T316P: 1:1,000 anti-Dis2-T316P (rabbit 
polyclonal) (63-121 Bioacedemia). Pk epitope tag: SV5-PK1 (mouse monoclonal, 1:1,000) 
(MCA1360, AbD seroTEC). HA epitope tag: 1:1,000 anti-HA-Tag C29F4 antibody (rabbit 
polyclonal) (#3724, Cell Signaling Technology). Flag epitope tag: 1:1,000 ANTI-FLAG M2 
antibody (mouse monoclonal) (F3165, SIGMA). Secondary antibodies: horse radish 
peroxidase-conjugated donkey anti-rabbit (NA934V, GE healthcare) or goat anti-mouse 
(STAR120P, abD SeroTEC) (1:25,000). Signal was detected using Amersham ECL Prime 
Western Blotting Detection Reagent (GE Healthcare) or SuperSignal West Femto 
Maximum Sensitivity Substrate (34095, Life Technologies) and imaged using ImageQuant 
LAS 4000. Quantification of Western blots was performed using ImageQuant TL software 
(GE Healthcare). 
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7.3 Sample preparation for mass spectrometry   
All heavy or light samples were mixed with a light or heavy reference samples respectively. 
Samples were mixed in 1:1 protein amount ratios (protein concentration determined by 
Bradford assay). All SILAC experiments and sample names are listed in Sheet01 
(sheet01_experiment and strain list). Members of The Francis Crick Institute Protein 
Analysis and Proteomics facility carried out sample preparation and data acquisition as 
follows. Samples were reduced with 1 M dithiothreitol  (DTT) (25 min, 56 °C), alkylated with 
500 mM iodoacetamide (30 min, rt, dark) and quenched with 1 M dithiothreitol. Samples 
were then diluted with 50 mM ammonium bicarbonate to reduce the urea concentration to 
<2 M, prior to trypsin digestion (37 °C, overnight). Peptides were acidified to 0.4% with 
trifluoroacetic acid (TFA) and centrifuged (14krpm at 4 °C for 30 min). Peptides were then 
desalted using a C18 SepPak Lite, 130 mg bed volume, under vacuum and dried. Peptides 
were then digested using Lys-C in 10% acetonitrile, 50 mM ammonium bicarbonate (37 °C, 
2 h), followed by trypsin digestion (37 °C, overnight). Digested peptides were then again 
desalted and dried.  
 
Titanium dioxide enrichment was then carried out as follows. Dried fractions were re-
suspended in 80% acetonitrile, 5% trifluoroacetic acid, 1 M glycolic acid, sonicated (10 min) 
and added to 5 mg of titanium dioxide beads. The beads were washed using 80% 
acetonitrile and 1% trifluoroacetic acid followed by 10% acetonitrile and 0.2% trifluoroacetic 
acid, and dried under vacuum centrifugation. For analysis of non-phosphorylated peptides, 
flowthroughs were retained. Phosphopeptides were then eluted from the beads by adding 
1% ammonium hydroxide followed by 5% ammonium hydroxide, and dried by vacuum 
centrifugation. Dried phosphopeptides were then re-suspended in 100 µl of 1% 
trifluoroacetic acid and sonicated (15 min). A C18 membrane was packed into a 200µl 
pipette tip and washed using methanol and equilibrated with 1% trifluoroacetic acid. The 
peptides were then loaded onto the Stage Tip and washed with 1% trifluoroacetic acid 
followed by elution with 80% acetonitrile, 5% trifluoroacetic acid. The eluted peptides were 
again dried under vacuum centrifugation. For analysis of non-phosphorylated peptides, the 
stored flowthroughs were dried, desalted using a C18 SepPak Lite, 130 mg bed volume, 
under vacuum and dried. Peptides were then separated into 12 fractions using strong 
cation exchange (SCX) liquid chromatography, and dried, if necessary, to 250 µl. 
 
For LC-MS/MS data acquisition analysis, the following was performed. Phosphopeptide 
mixtures were re-suspended in 35 µl 0.1% trifluoroacetic acid, and injected three times (10 
µl per injection). Non-phosphopeptide mixtures were diluted 1:10 (v/v) in 0.1% 
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trifluoroacetic acid, and injected three times (10 µl per injection). Each run consisted of a 3 
h gradient elution with one activation method per run: CID, MSA and HCD. An LTQ-
Orbitrap Velos was used for data acquisition of phosphopeptides, and an LTQ-Orbitrap 
Velos Pro was used for data acquisition of non-phosphorylated peptides.  
 
Data processing was performed using the MaxQuant bioinformatics suite as adopted by the 
Crick Protein Analysis and Proteomics facility, and protein database searching was 
performed by the Andromeda search engine using a UniProt database of S. pombe 
proteins amended with common contaminants. For all analyses (besides CCC6773) the 
UniProt database of S. pombe proteins was modified to account for the altered genetic 
background of the reference sample (P0000 = Cdc13-L-Cdc2). Default MaxQuant 
parameters were used with the following adjustments: Phospho (STY) was added as a 
variable modification (for the phospho-samples only), Lys6 and Arg6 were the heavy labels, 
‘Filter labelled amino acids’ was deselected, minimum ratio count was set as two, re-
quantify was selected with the instruction to keep low-scoring versions of identified 
peptides within parameter groups, and match between runs was selected. Experiments 
groups in which raw data was search are listed in Sheet01 (sheet01_experiment and strain 
list).  
7.4 Analysis of mass spectrometry data 
Members of the Francis Crick Institute Protein Analysis and Proteomics facility assisted 
with data analysis only where stated. 
 
Phospho STY.txt (phosphopeptides) and ProteinGroup.txt (peptides) MaxQuant outputs 
were uploaded into and analysed in Pereus1.4.0.2. Normalised H/L ratios were used for 
relative site phosphorylation and protein levels respectively. Where only singly 
phosphorylated peptides were analysed: PhosphoSTY_1 output were imported into 
Pereus1.4.0.2 instead. All linear regressions, non-linear curve fitting (sigmoidal function 
and exponential decay), AUC (Area Under Curve) calculations, student t-tests and binomial 
test were performed in Prism 6 on normalised H/L ratio exported from Pereus1.4.0.2.  
 
7.4.1 Defining CDK substrates and calculating one phase decay parameters  
CCC5977 & CCC5978 was filtered for phosphorylation events at S/T-P (minimal CDK 
consensus site) with a localisation probability (loc. prob.) > 0.9. Then the following 4 criteria 
were used to define CDK substrates in mitosis (CCC5978) or S-phase (CCC5977).  
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i) M00 is a null distribution (i.e. heavy and light samples are equivalent), so all H:L values 
should theoretically be 1. As such the dataset was filtered for phosphorylation sites for 
which M00 deviated less than twofold from H:L=1. S00 was filtered for sites identified in S-
phase with a H:L ratio greater than 0.25. (i.e. peptides for which a ratio was quantified but 
the peptide(s) was only detected in the light reference (ISO-MATCH) were excluded). ii) 
Phosphorylation events with less than 4 valid ratios were excluded. iii) Sites that had at 
least one ratio less than half the value of the initial time point ratio were kept. iv) A non-
linear one-phase decay was fitted to the data using the least squares (ordinary) fitting 
method (Prism 6). The curve was constrained such that the K > 0 and Plateau > 0. CDK 
substrates were defined as sites that fitted an exponential decay with R squared > 0.9 and 
a plateau < 0.5. v) Sites that did not pass the above criteria were screened for anomalous 
ratios as follows. The dataset was duplicated six times. Within each duplicate, one time 
point (except for 0 min from CDK inactivation (M00min & S00min) was removed. Each 
modified dataset was re-analysed by the four above criteria (i-iv). If a phosphorylation site 
in one of the six modified datasets was now defined as a substrate it was included as a 
substrate with the respective modified dataset values used to calculate all subsequent 
parameters (e.g. half life). Where multiple deletions independently permitted a site to pass 
the four above criteria, the one that gave the highest R squared value was used. 
Anomalous points are likely due to technical considerations such as the use of different 
species to quantify site phosphorylation at different time points (e.g. 31.1% of sites with an 
anomalous point(s) in the profile of dephosphorylation in mitosis satisfy the above criteria 
when only singly phosphorylated peptides were analysed before anomaly screening). 
 
7.4.2 Consensus sequences and annotation enrichments 
Consensus sequence surrounding phosphorylation events were generated in Perseus 
1.4.0.2. Annotation (including gene ontologies) enrichment was performed in Perseus 
1.4.0.2. 2D annotation enrichment (entire phosphoproteome) was performed for M12min 
and M24min in CCC5978 (loc. prob. > 0.9). Enrichment of CDK substrates was performed  
against all sites in CCC5977&CCC5978 (loc. prob. > 0.9) by Fisher exact test (B-H FDR < 
0.02). Enrichment of motifs and annotation (including gene ontologies) categories in 
Clusters A-H (Figure 5.02) was performed in by Fisher exact test (B-H FDR < 0.02) against 
non S/T-P sites in CCC6254 after missing values were replaced by imputation (loc. prob. > 
0.9). 
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7.4.3 Imputation and smoothing  
Imputation was applied to replace missing values. Only phosphorylation sites or protein 
groups with at least 50% valid values quantified, within the respective dataset, where 
analysed. The number of sites/proteins to which imputation was applied and the number of 
values imputed in the respective datasets are listed in Sheet01. Less than 15% of any 
dataset after imputation, constituted imputed values. Missing values were imputed using 
the R package DMwR (Torgo, 2010). Default parameters of knnImputation function were 
used (The Francis Crick Institute Protein Analysis and Proteomics facility). Imputed data is 
only used where stated. Smoothing was applied to imputed data as listed in Sheet01. An R 
script was applied in which five nearest neighbours for each site were identified by 
Euclidian distance. The mean value of these five nearest neighbours ratios was then 
substituted for each original ratio (The Francis Crick Institute Protein Analysis and 
Proteomics facility). Smoothed data is only used when stated.  
 
7.4.4 Principle component analysis (PCA) and hierarchical clustering 
analysis 
PCA and hierarchical clustering was performed on cell cycle dependent phosphorylation or 
protein levels, with missing values imputed (as above), in Perseus 1.4.0.2 (PCA settings: 
default. Clustering settings: cluster rows, euclidian distance, do not presuppose K-means). 
 
7.4.5 Secondary structure analysis  
DisEMBL algorithm was applied to categorise all potential Serine, Threonine and Tyrosine 
site in the S. pombe proteome into disordered or not disordered (The Francis Crick Institute 
Computational biology facility). One tailed binomial test was used to test the significance of 
difference between datasets.  
 
7.4.6 Calculation of substrate sensitivity to CDK activity  
Non-linear sigmoidal curve (four parameter logistic function) was fitted to the data (relative 
phosphorylation (L:H) across a range of 1-NmPP1 concentrations) using the least squares 
(ordinary) fitting method (Prism 6). The curve was constrained such that the Hill slope < 0 
and Bottom > 0. Outlier detection was used (Q = 10%). Sites with fitted curves (R square > 
0.9, Bottom < 0.5 and Top/Bottom > 2) were used to derive IC50 and Hill slope values. 
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7.5 Supplementary electronic files 
An electronic copy of this thesis along with three supplementary excel spreadsheets 
(Sheet01-03) are stored on a CD-ROM attached to the inside cover of this thesis. 
 
 
 
Table 7-1 | S. pombe strain list 
Strain ID 
 
mating type 
 
Genotype 
 
MS86 h (+?) 
 car2∆::hphMX6_arg1-230_lys3-37_leu1+_leu1Δ::Pcdc13::cdc13-L-cdc2AF (as)::cdc13 3'UTR::ura4+_cdc2Δ::KanMX6 
_cdc13Δ::natMX6_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS87 h (+?) 
rad3Δ::bsdMX6_car2∆::HphMX6_arg1-230_lys3-37_leu1+_leu1Δ::Pcdc13::cdc13-L-cdc2AF (as)::cdc13 3'UTR::ura4+ 
_cdc2Δ::KanMX6_cdc13Δ::natMX6_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS108 h + 
leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6_cig1Δ::ura4+_cig2Δ::ura4+ 
_puc1Δ::ura4+_ura4-D18 
MS122 h + 
car2∆::hphMX6_arg1-230_lys3-37_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::KanMX6 
_cdc13Δ::natMX6_ura4-D18 
MS131 h + cdc2-asM17::bsdMX6_car2∆::hphMX6_arg1-230_lys3-37 
MS132 h + 
Sld3-5flag::ura4+_orc2-3pk::hphMX6_nsk1-GFP::kanMX6_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+ 
_cdc2Δ::scLeu2_cdc13Δ::natMX6_(ura4-D18?) 
MS200 h + cdc2-asM17::bsdMX6_car2∆::hphMX6_arg1-230_lys3-37_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS212 h (+?) 
sld3-5flag::ura4+_orc2-3pk::hphMX6_Nsk1-GFP::KanMX6_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+ 
_cdc2Δ::scLeu2_cdc13Δ::natMX6_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_(ura4-D18?) 
MS213 h (+?) 
car2∆::hphMX6_arg1-230_lys3-37_leu1+_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::KanMX6 
_cdc13Δ::natMX6_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS230 h + 
 car2∆::hphMX6_arg1-230_lys3-37_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::KanMX6 
_cdc13Δ::natMX6_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS283 h (+?) 
orc2-2(ts)_orc1-HA leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::ScLEU2_cdc13Δ::natMX6 
_(ura4-D18?) 
MS284 h (-?) 
orc2-3pk::hphMX6_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_(ura4-D18?) 
MS285 h (+?) 
orp1-4(ts)_sld3-5flag::ura4+_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::scLeu2_cdc13Δ::natMX6 
_(ura4-D18?) 
MS286 h (+?) 
orc2-2(ts)_sld3-5flag::ura4+_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::scLeu2_cdc13Δ::natMX6 
_(ura4-D18?) 
MS395 h + 
nmt1::nmt41-drc1wt-5pk_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS396 h + 
nmt1::nmt41-drc1AGGA-5pk_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS397 h + 
nmt1::nmt41-orc2wt-5pk_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS398 h + 
nmt1::nmt41-orc2AGGA-5pk_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS399 h + 
nmt1::nmt41-sld3wt-5pk_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
MS400 h + 
nmt1::nmt41-sld3AGGA-5pk_leu1Δ::Pcdc13::cdc13-L-cdc2(as)::cdc13 3'UTR::ura4+_cdc2Δ::kanMX6_cdc13Δ::natMX6 
_cig1Δ::ura4+_cig2Δ::ura4+_puc1Δ::ura4+_ura4-D18 
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